{"id": "43", "boolean": "((\"Thyroid Neoplasms\"[MeSH] OR \"Adenocarcinoma, Follicular\"[MeSH] OR \"Adenocarcinoma, Papillary\"[MeSH] OR OPTC OR ((Thyroid[tiab] OR Follicular[tiab] OR Papillary[tiab] OR hurtle cell[tiab]) AND (cancer[tiab] OR cancers[tiab] OR carcinoma[tiab] OR carcinomas[tiab] OR Adenocarcinoma[tiab] OR Adenocarcinomas[tiab] OR neoplasm[tiab] OR neoplasms[tiab] OR nodule[tiab] OR nodules[tiab] OR tumor[tiab] OR tumour[tiab] OR Tumors[tiab] OR Tumours[tiab] OR cyst[tiab] OR cysts[tiab]))) AND (\"Autopsy\"[MeSH] OR \"Autopsy\"[tiab] OR \"Autopsies\"[tiab] OR \"Postmortem\"[tiab] OR Post-mortem[tiab] OR \"step-sectioned\"[tiab] OR \"step sectioned\"[tiab] OR  (Post[tiab] AND mortem[tiab])) AND (\"Prevalence\"[MeSH] OR \"Prevalence\"[tiab] OR \"Prevalences\"[tiab] OR Incidence[tiab] OR Epidemiology[tiab] OR Epidemiological[tiab] OR Frequency[tiab] OR Detected[tiab]) AND (\"Incidental Findings\"[MeSH] OR Incidental[tiab] OR Unsuspected[tiab] OR Discovery[tiab] OR Discoveries[tiab] OR Findings[tiab] OR Finding[tiab] OR Occult[tiab] OR Hidden[tiab] OR Latent[tiab] OR Consecutive[tiab]))", "generated_query": ["What is the prevalence or incidence of thyroid neoplasms, including adenocarcinoma, follicular, adenocarcinoma, papillary, and OPTC, as well as other types of thyroid cancer such as follicular, papillary, and hurtle cell, detected through autopsy, postmortem, step-sectioned, or other means of examination that result in incidental or unsuspected findings?", "What is the prevalence or incidence of incidental findings of thyroid neoplasms, including adenocarcinoma, follicular adenocarcinoma, papillary adenocarcinoma, OPTC, Hurtle cell, or any nodules, tumors, or cysts in the thyroid, detected through autopsy, post-mortem, or step-sectioned analysis?", "What is the prevalence and incidence of incidental findings of thyroid neoplasms, including adenocarcinoma, follicular adenocarcinoma, and papillary adenocarcinoma, detected during autopsies or post-mortem examinations that utilized step-sectioned techniques?", "What is the prevalence or incidence of incidental findings of thyroid neoplasms, including adenocarcinoma, follicular adenocarcinoma, papillary adenocarcinoma, OPTC, thyroid, follicular, papillary, and hurtle cell cancers, carcinomas, neoplasms, nodules, tumors, cysts, or their synonyms, in autopsy or post-mortem studies using step-sectioned techniques, and what is the epidemiological or frequency data on such findings?", "What is the prevalence or incidence of thyroid neoplasms, including adenocarcinoma (follicular, papillary, OPTC), hurtle cell, or any other nodules, cysts, or tumors in postmortem or autopsy reports, with a focus on incidental findings or hidden neoplasms?", "What is the prevalence or incidence of thyroid neoplasms, including adenocarcinoma, follicular adenocarcinoma, and papillary adenocarcinoma, as detected through autopsy or post-mortem examinations, including step-sectioned analysis? Also, what are the incidental or unsuspicious findings related to thyroid nodules, tumors, cysts, and other neoplasms discovered during these examinations?", "Retrieve articles on the prevalence and incidence of thyroid neoplasms, including adenocarcinoma, follicular and papillary tumors, as well as incidental and unsuspected findings in autopsies or post-mortem examinations using step-sectioned techniques. Include epidemiological and frequency data on these types of thyroid tumors and their incidence as detected in autopsies or post-mortem examinations.", "Can you provide me with information on the prevalence or incidence of thyroid neoplasms, including adenocarcinoma, follicular adenocarcinoma, papillary adenocarcinoma, or other related tumors or nodules, detected through autopsy or postmortem step-sectioned examinations and classified as incidental findings or unsuspected discoveries?", "What is the prevalence or incidence of thyroid neoplasms, adenocarcinoma (follicular or papillary), or OPTC, including incidental or unsuspicious findings, detected through autopsy, postmortem, or step-sectioned examinations?", "What is the prevalence or incidence of thyroid neoplasms, including adenocarcinoma, follicular adenocarcinoma, papillary adenocarcinoma, and other related terms such as hurtle cell, cancer, carcinoma, neoplasm, nodule, tumor, and cyst, detected through autopsy, postmortem, or step-sectioned examination, with a focus on incidental findings?"]}
{"id": "96", "boolean": "(\"Thyroid Neoplasms\"[Mesh] OR \"Adenocarcinoma, Follicular\"[Mesh] OR \"Adenocarcinoma, Papillary\"[Mesh] OR OPTC OR ((Thyroid[tiab] OR Follicular[tiab] OR Papillary[tiab] OR hurtle cell[tiab]) AND (cancer[tiab] OR cancers[tiab] OR carcinoma[tiab] OR carcinomas[tiab] OR Adenocarcinoma[tiab] OR Adenocarcinomas[tiab] OR neoplasm[tiab] OR neoplasms[tiab] OR nodule[tiab] OR nodules[tiab] OR tumor[tiab] OR tumour[tiab] OR Tumors[tiab] OR Tumours[tiab] OR cyst[tiab] OR cysts[tiab]))) AND (\"Autopsy\"[Mesh] OR \"Autopsy\"[tiab] OR \"Autopsies\"[tiab] OR \"Postmortem\"[tiab] OR Post-mortem[tiab] OR (Post[tiab] AND mortem[tiab])) AND (\"Prevalence\"[Mesh] OR \"Epidemiology\"[Mesh] OR \"Prevalence\"[tiab] OR \"Prevalences\"[tiab] OR Epidemiology[tiab] OR Epidemiological[tiab] OR Frequency[tiab]) AND (\"Incidental Findings\"[Mesh] OR Incidental[tiab] OR Unsuspected[tiab] OR Discovery[tiab] OR Discoveries[tiab] OR Findings[tiab] OR Finding[tiab] OR Occult[tiab] OR Hidden[tiab]) ", "generated_query": ["Can you find studies on the prevalence and epidemiology of incidental findings in autopsies of patients with thyroid neoplasms, including adenocarcinoma, follicular adenocarcinoma, papillary adenocarcinoma, and other related terms such as thyroid cancer, carcinoma, neoplasm, nodule, tumor, and cyst?", "What is the prevalence and epidemiology of incidental findings of thyroid neoplasms, follicular adenocarcinoma, papillary adenocarcinoma, and other thyroid-related tumors, nodules, cysts, and cancers discovered during autopsy or postmortem examinations?", "What is the prevalence and epidemiology of incidental findings of thyroid neoplasms, follicular adenocarcinomas, papillary adenocarcinomas, OPTC, or other thyroid-related tumors, nodules, or cysts discovered during autopsies or post-mortem examinations?", "What is the prevalence of incidental or unsuspicious findings of thyroid neoplasms, adenocarcinoma (follicular and papillary), and other related tumors or cysts in autopsies or postmortem studies? Can you provide information on the epidemiology and frequency of these findings?", "What is the prevalence and epidemiology of incidental findings of thyroid neoplasms, follicular adenocarcinoma, papillary adenocarcinoma, Hurtle cell, thyroid nodules, thyroid tumors, cysts, and other thyroid cancers in autopsies, post-mortems, and unsuspected discoveries?", "What is the prevalence and epidemiology of incidental findings of thyroid neoplasms, follicular adenocarcinoma, papillary adenocarcinoma, and OPTC in autopsies or post-mortem examinations, including unsuspected or hidden nodules, cysts, and tumors in the thyroid gland?", "What is the prevalence and epidemiology of incidental findings of thyroid neoplasms, adenocarcinoma (follicular and papillary), OPTC, and other thyroid-related conditions in autopsies or post-mortem examinations?", "What is the prevalence and epidemiology of incidental findings of thyroid neoplasms, adenocarcinoma (follicular and papillary), and other thyroid-related neoplasms (such as Hurtle cell) in postmortem or autopsy studies?", "Retrieve articles that explore the prevalence and epidemiology of incidental findings in autopsies related to thyroid neoplasms, including adenocarcinoma, follicular, papillary, and OPTC, as well as any other related terms such as thyroid, cancer, carcinoma, neoplasm, nodule, tumor, and cyst.", "What is the prevalence and epidemiology of incidental findings of thyroid neoplasms, follicular adenocarcinomas, papillary adenocarcinomas, and OPTC, as well as any other thyroid-related cancers such as Hurtle cell in autopsies or post-mortem reports?"]}
{"id": "103", "boolean": "(\"Drug Resistance, Microbial\"[Mesh] OR \"Drug resistance\"[tiab] OR \"Drug resistant\"[tiab] OR \"multidrug-resistant\"[tiab] OR \"multidrug resistant\"[tiab] OR \"Microbial resistant\"[tiab] OR \"Microbial resistance\"[tiab] OR \"Antibiotic resistance\"[tiab] OR \"Antibiotic resistant\"[tiab] OR \"Antibacterial resistance\"[tiab] OR \"Antibacterial resistant\"[tiab] OR \"Antimicrobial resistance\"[tiab] OR \"Antimicrobial resistant\"[tiab]) AND (\"Urinary Tract Infections\"[Mesh] OR \"Urinary Tract Infections\"[tiab] OR \"Urinary Tract Infection\"[tiab] OR UTIs[tiab] OR UTI[tiab] OR Cystitis[tiab]) AND (\"Primary Health Care\"[Mesh] OR \"General Practice\"[Mesh] OR \"Primary health\"[tiab] OR \"Primary care\"[tiab] OR \"General practice\"[tiab] OR \"General practices\"[tiab] OR \"General practitioners\"[tiab] OR Community[tiab] OR \"Consultation rates\"[tiab] OR \"Re-consultation rates\"[tiab]) AND (\"randomized controlled trial\"[pt] OR \"controlled clinical trial\"[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR \"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"case control\"[tiab] OR Cohort[tiab] OR \"Follow up\"[tiab] OR Observational[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR retrospective[tiab] OR \"cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Analysis[tiab] OR Statistics[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh])", "generated_query": ["What is the effectiveness of primary healthcare interventions in preventing and treating urinary tract infections caused by antibiotic-resistant bacteria? Can randomized controlled trials, observational studies, and cross-sectional studies provide insights on the impact of interventions such as consultation rates, re-consultation rates, and general practitioner practices on the prevalence of antibiotic resistance in the context of urinary tract infections?", "What is the efficacy of interventions for preventing multidrug-resistant urinary tract infections in primary care settings, as demonstrated by randomized controlled trials, observational studies, and epidemiological investigations of antibiotic-resistant and microbial-resistant UTIs?", "What is the effectiveness of interventions for urinary tract infections in primary health care settings, considering the impact of microbial drug resistance? Please provide results from randomized controlled trials, controlled clinical trials, cohort studies, case-control studies, or observational studies with investigated statistical data.", "Can you provide evidence-based recommendations for the treatment of urinary tract infections in primary care, considering the prevalence of microbial drug resistance? I am interested in randomized controlled trials, observational studies, and epidemiologic investigations that analyze the effectiveness of different antibiotics and their impact on consultation and re-consultation rates in general practice.", "What is the effectiveness of primary health care interventions in managing urinary tract infections that are resistant to antibiotics, and what randomized controlled trials, controlled clinical trials, case-control studies, cohort studies, or cross-sectional studies have investigated this?", "Can randomized controlled trials or observational studies investigate the impact of drug resistance on the incidence and management of urinary tract infections in primary healthcare settings?", "Can observational or controlled clinical trials on the effectiveness of primary healthcare interventions for treating drug-resistant urinary tract infections be found using search terms such as \"drug resistance,\" \"urinary tract infections,\" and \"primary healthcare\"?", "What is the efficacy of primary health care interventions for multidrug-resistant urinary tract infections, as determined by randomized controlled trials, observational studies, and epidemiologic investigations?", "Can randomized controlled trials and observational studies show the effectiveness of primary care interventions in preventing and managing urinary tract infections in patients with drug-resistant microbial strains?", "What are the most effective treatments for urinary tract infections in primary care, considering drug resistance and microbial resistance? I am looking for randomized controlled trials, controlled clinical trials, epidemiological studies, case-control studies, and cohort studies that analyze the effectiveness of different treatments, including antibiotics, placebo, or other interventions. The search should include terms such as \"drug resistance\", \"antibiotic resistance\", \"microbial resistance\", \"urinary tract infections\", \"primary health care\", \"general practice\", \"consultation rates\", \"re-consultation rates\", \"randomized controlled trial\", \"controlled clinical trial\", \"placebo\", \"epidemiological studies\", \"case-control studies\", \"cohort studies\", \"follow-up\", \"observational\", \"longitudinal\", \"prospective\", \"retrospective\", \"cross-sectional studies\", \"investigated\", \"analysis\", \"statistics\", and \"data\"."]}
{"id": "17", "boolean": "(\"Japan\"[Mesh] OR Japanese[tiab] OR Japan[tiab]) AND (\"Encephalitis\"[Mesh] OR Encephalitis[tiab] OR \"Brain Inflammation\"[tiab] OR \"Brain Inflammations\"[tiab] OR \"Rasmussen Syndrome\"[tiab] OR \"Rasmussen's Syndrome\"[tiab]) AND (\"Vaccines\"[Mesh] OR Vaccine[tiab] OR Vaccines[tiab] OR IXIARO[tiab] OR SA14-14-2[tiab]) AND (Inactivated[tiab] OR Immunogenicity[tiab] OR Attenuated[tiab] OR Live[tiab] OR \"Cell-derived\"[tiab] OR \"Cell derived\"[tiab]) AND (\"randomized controlled trial\"[pt] OR \"controlled clinical trial\"[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR Crossover[tiab] OR \"Comparative Study\"[pt] OR \"Evaluation Study\"[pt] OR \"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"case control\"[tiab] OR Cohort[tiab] OR \"Follow up\"[tiab] OR Observational[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR retrospective[tiab] OR \"cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Evaluated[tiab] OR Impact[tiab] OR Analysis[tiab] OR Statistics[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh])", "generated_query": ["What is the efficacy of vaccines (including IXIARO and SA14-14-2) for the prevention of encephalitis and brain inflammation in Japanese populations, as demonstrated through randomized controlled trials, comparative studies, epidemiologic studies, case-control studies, cohort studies, longitudinal studies, prospective studies, retrospective studies, cross-sectional studies, and analyses of relevant data and statistics? Specifically, I am interested in studies that investigate the use of inactivated, attenuated, and cell-derived vaccines, as well as their immunogenicity.", "What is the effectiveness of vaccines, including IXIARO and SA14-14-2, for preventing or treating encephalitis, brain inflammation, and Rasmussen Syndrome in Japanese populations, as evaluated through randomized controlled trials, controlled clinical trials, observational studies, or epidemiological analyses that investigate the immunogenicity or impact of inactivated, attenuated, or cell-derived vaccines?", "What is the impact of inactivated, immunogenic, attenuated, live, and cell-derived vaccines on encephalitis, brain inflammation, and Rasmussen syndrome among Japanese populations? I am interested in randomized controlled trials, controlled clinical trials, comparative studies, evaluation studies, epidemiologic studies, case-control studies, cohort studies, follow-up studies, observational studies, longitudinal studies, cross-sectional studies, and investigations that have evaluated the effectiveness of vaccines, including IXIARO and SA14-14-2, on these conditions. I am particularly interested in studies that have analyzed the immunogenicity, statistical data, and epidemiology of vaccines in relation to encephalitis, brain inflammation, and Rasmussen syndrome.", "Can vaccines prevent encephalitis and brain inflammation in Japanese populations? I am looking for randomized controlled trials, cohort studies, and observational studies that investigate the immunogenicity and impact of inactivated, attenuated, or cell-derived vaccines such as IXIARO and SA14-14-2. The studies should analyze the effectiveness of vaccines in preventing encephalitis, brain inflammation, and Rasmussen Syndrome. Please include comparative and evaluation studies, as well as follow-up and longitudinal studies, and provide data and statistics.", "What is the efficacy of vaccines, including IXIARO and SA14-14-2, in preventing encephalitis and brain inflammation, particularly Rasmussen Syndrome, among the Japanese population? I am looking for randomized controlled trials, observational studies, and epidemiologic studies that have investigated the immunogenicity and impact of inactivated, attenuated, and cell-derived vaccines, as well as the comparative analysis of these vaccines with placebos or other interventions, using various statistical and numerical data.", "What are the results of randomized controlled trials or comparative studies investigating the immunogenicity of vaccines (including IXIARO and SA14-14-2), either inactivated, attenuated or cell-derived, on the prevention or treatment of encephalitis or brain inflammation (including Rasmussen Syndrome) in Japanese populations, as evaluated through epidemiologic, case-control, cohort, follow-up, observational, longitudinal, prospective or retrospective studies, and analyzed using statistical and numerical data or epidemiological methods?", "Can vaccines for encephalitis in Japan, including IXIARO and SA14-14-2, be effective in preventing brain inflammation or Rasmussen syndrome? Are there any randomized controlled trials or observational studies investigating the immunogenicity and efficacy of inactivated, attenuated, or cell-derived vaccines? What is the impact and statistical analysis of these studies on the epidemiology of encephalitis in Japan?", "What is the effectiveness of inactivated, attenuated, and live vaccines such as IXIARO and SA14-14-2 for the prevention of encephalitis and brain inflammation, including Rasmussen Syndrome, in Japanese populations? Can you provide evidence from randomized controlled trials, controlled clinical trials, comparative studies, epidemiologic studies, case-control studies, cohort studies, follow-up studies, observational studies, longitudinal studies, and cross-sectional studies, including analyses of impact, statistics, and numerical data?", "What is the impact of Japanese vaccines (including IXIARO and SA14-14-2) on the immunogenicity and effectiveness in preventing encephalitis (including Rasmussen Syndrome and other forms of brain inflammation) in randomized controlled trials or other comparative studies, including both cell-derived and attenuated vaccines, investigated through observational, longitudinal, cross-sectional, or cohort studies with evaluation of statistical data and epidemiology?", "What is the efficacy of vaccines for preventing encephalitis and brain inflammation in Japanese populations? Specifically, I am interested in randomized controlled trials, controlled clinical trials, comparative studies, and observational studies that investigate the immunogenicity and impact of inactivated, attenuated, and cell-derived vaccines such as IXIARO and SA14-14-2. I am also interested in studies that evaluate the epidemiology of encephalitis and brain inflammation in Japan and utilize statistical or numerical data analysis."]}
{"id": "40", "boolean": "(\"Education, Professional\"[Mesh] OR ((Medical[tiab] OR Biomedical[tiab] OR Health[tiab] OR Anatomy[tiab] OR Anatomical[tiab] OR Neuroanatomy[tiab] OR Pathology[tiab] OR Genetics[tiab] OR pharmacology[tiab] OR bacteriology[tiab] OR Histology[tiab] OR Biochemistry[tiab] OR microbiology[tiab] OR Neurology[tiab] OR \"Basic Science\"[tiab] OR \"Basic Sciences\"[tiab] OR Physiology[tiab] OR Physiological[tiab]) AND (Education[tiab] OR Educational[tiab] OR Curriculum[tiab] OR Training[tiab] OR Learning[tiab]))) AND (\"Students, Medical\"[Mesh] OR Students[tiab] OR Student[tiab]) AND (\"Virtual Reality\"[Mesh] OR \"Virtual Reality\"[tiab] OR \"Virtual Realities\"[tiab] OR \"Augmented reality\"[tiab] OR \"Spatial Computing\"[tiab] OR \"Mixed Reality\"[tiab] OR AR[tiab] OR VR[tiab] OR MR[tiab]) AND (Assessing[tiab] OR Assessments[tiab] OR Assess[tiab] OR Assessed[tiab] OR ((Knowledge[tiab]) AND (Evaluate[tiab] OR Evaluation[tiab] OR acquire[tiab] OR acquirement[tiab] OR Retention[tiab]))) NOT (Review[pt] OR \"Systematic review\"[pt] OR \"Systematic review\"[ti])", "generated_query": ["What is the impact of using virtual and augmented reality in medical education and how effective are they in assessing and retaining medical knowledge among students?", "\"Retrieve articles that discuss the use of virtual and augmented reality technologies in medical education, with a focus on assessing their effectiveness in improving knowledge acquisition and retention among medical students. The search should also include basic science topics related to medical education and exclude systematic reviews.\"", "What are the benefits of using virtual reality and other spatial computing technologies in medical education for assessing knowledge acquisition and retention among medical students, and how do these technologies compare to traditional educational methods in terms of efficacy and efficiency?", "What is the impact of using virtual reality or augmented reality for assessing medical students' knowledge acquisition and retention in basic sciences education?", "What is the impact of virtual and augmented reality on the educational training and knowledge retention of medical students, and how are these technologies being assessed?", "What is the impact of using virtual reality or augmented reality in medical education to assess knowledge acquisition and retention among medical students, and how does it compare to traditional educational methods?", "What is the impact of virtual and augmented reality-based educational interventions on medical students' knowledge acquisition, evaluation, and retention?", "What is the impact of virtual and augmented reality technologies on the educational outcomes of medical students and how can their knowledge acquisition, evaluation, and retention be assessed in the context of basic sciences, including anatomy, physiology, biochemistry, microbiology, and pharmacology?", "\"Can virtual reality and augmented reality be effective tools for assessing medical students' knowledge retention in basic sciences education?\"", "What is the impact of using virtual and augmented reality technology in medical education to assess knowledge retention and evaluate student performance?"]}
{"id": "22", "boolean": "(\"rabies vaccines\"[Mesh] OR ((vaccination[Mesh]) AND (rabies[Mesh] OR \"rabies virus\"[Mesh])) OR ((Rabies[tiab]) AND (vaccine[tiab] OR Vaccines[tiab] OR Vaccination[tiab] OR Vaccinations[tiab] OR Immunise[tiab] OR Immunize[tiab] OR Immunisation[tiab] OR Immunization[tiab]))) AND (\"immunization, secondary\"[Mesh] OR \"antibodies, viral\"[Mesh] OR \"time factors\"[Mesh] OR secondary[tiab] OR booster[tiab] OR boost[tiab] OR boosters[tiab] OR boostability[tiab] OR titer[tiab] OR gmt[tiab] OR ((sero[tiab]) AND (conversion[tiab] OR protection[tiab])) OR seroconversion[tiab] OR seroprotection[tiab]) AND (\"administration and dosage\"[sh] OR Administer[tiab] OR Administered[tiab] OR Administration[tiab] OR Intramuscular[tiab] OR Intradermal[tiab] OR \"pre-exposure\"[tiab] OR \"pre exposure\"[tiab]) NOT (animals[Mesh] NOT humans[Mesh])", "generated_query": ["What is the effectiveness of different methods of administering rabies vaccines for secondary immunization, including boosters and time factors, in humans?", "What is the effectiveness of different doses, routes of administration, and schedules of rabies vaccines in providing secondary immunization, boosting antibody levels, and providing protection against rabies virus in humans, while minimizing adverse effects, when compared to standard vaccination practices?", "What is the effectiveness of rabies vaccines, vaccination, and immunization boosters in providing seroconversion and seroprotection in humans, while taking into account factors such as time, dosage, and administration routes?", "What is the efficacy of rabies vaccines and secondary immunization on antibody response and time factors when administered to humans intramuscularly or intradermally before exposure to rabies, and how does seroconversion and seroprotection contribute to the boostability of the vaccine, while excluding animal studies?", "What is the efficacy of rabies vaccines and secondary immunization protocols in humans, considering factors such as time, dosage, administration, and antibody titers, while excluding animal studies?", "\"What is the effectiveness of rabies vaccines, booster shots, and secondary immunizations on humans with regards to protection against the rabies virus, as administered through various routes and dosages, while excluding animal-related studies?\"", "\"What is the effectiveness of rabies vaccination in humans, including booster or secondary immunization, administered through intramuscular or intradermal routes, with consideration to time factors and seroprotection or seroconversion, while excluding animal studies?\"", "What is the effectiveness of rabies vaccines in providing secondary immunization against the rabies virus? How do factors such as booster shots, time, and antibody levels affect the administration and dosage of rabies vaccines for pre-exposure protection in humans?", "What is the effectiveness of different rabies vaccination regimens in providing secondary immunization and seroprotection against rabies virus in humans?", "What is the effectiveness of different types of rabies vaccines in secondary immunization, including the use of boosters and time factors, as administered through various routes such as intramuscular or intradermal, for pre-exposure protection in humans, while excluding studies involving animals?"]}
{"id": "47", "boolean": "( Deprescriptions[Mesh] OR Deprescription[tiab] OR Deprescribing[tiab] OR Deprescribe[tiab] OR Deprescribed[tiab] OR ((Inappropriate[tiab] OR Ceased[tiab] OR Cease[tiab] OR Substituted[tiab] OR Reduce[tiab] OR Reduced[tiab] OR Reduction[tiab] OR Stopped[tiab] OR Stop[tiab] OR Discontinue[tiab] OR Discontinued[tiab] OR Discontinuing[tiab] OR Withdraw[tiab] OR Withdrawing[tiab] OR Withdrawl[tiab] OR Withdrawal[tiab]) AND (Medication[tiab] OR Medications[tiab] OR Polypharmacy[Mesh] OR Polypharmacy[tiab] OR Prescribing[tiab])) ) AND (Aged[Mesh] OR Elderly[tiab] OR Older[tiab] OR Old[tiab]) AND (\"Terminal Care\"[Mesh] OR \"Nursing Homes\"[Mesh] OR \"Frail Elderly\"[Mesh] OR \"Aged care\"[tiab] OR Life[tiab] OR \"Last year\"[tiab] OR Hospitalization[tiab] OR Hospitalisation[tiab] OR Hospitalized[tiab] OR Hospitalised[tiab] OR Chronic[tiab]) AND (Effective[tiab] OR Effectiveness[tiab] OR Efficacy[tiab] OR Reduction[tiab] OR Implemented[tiab] OR Benefit[tiab] OR Adverse[tiab]) AND ((\"randomized controlled trial\"[pt] OR \"controlled clinical trial\"[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR \"Cohort Studies\"[Mesh] OR Cohort[tiab] OR \"Follow up\"[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR Investigated[tiab] OR Analysis[tiab] OR Statistics[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh]) OR (((Search[tiab] OR Searched[tiab]) AND (PubMed[tiab] OR MEDLINE[tiab])) OR (systematic[tiab] AND review[tiab]) OR ((systematically[tiab] OR reviewed[tiab]) AND literature[tiab]) OR meta analysis[Publication Type]) OR (\"Cochrane Database Syst Rev\"[journal])) AND (\"Hospitals\"[Mesh] OR \"Hospital Medicine\"[Mesh] OR \"Intensive Care Units\"[Mesh] OR Hospitalization[tiab] OR Hospitalisation[tiab] OR Hospitalized[tiab] OR Hospitalised[tiab] OR Hospital[tiab] OR \"Intensive care\"[tiab])", "generated_query": ["What are the most effective interventions for deprescribing medications in elderly patients in nursing homes or hospitals, specifically in relation to improving quality of life and reducing adverse effects? Please only include results from randomized controlled trials, controlled clinical trials, cohort studies, follow-up studies, longitudinal studies, prospective studies, systematic reviews, meta-analyses, or Cochrane database reviews, and limit the search to hospitals, hospital medicine, and intensive care units.", "What is the effectiveness of deprescribing in elderly patients with chronic conditions receiving terminal care or living in nursing homes or hospitalized in intensive care units, and what are the benefits and adverse effects of such interventions? Are there any randomized controlled trials or cohort studies investigating the efficacy and reduction of inappropriate medication use, polypharmacy, and other prescribing practices in this population, as well as the implementation of deprescribing strategies? The search should be systematic and include PubMed, MEDLINE, and Cochrane Database Syst Rev, as well as literature that has been systematically reviewed or meta-analyzed, using a combination of keywords such as deprescriptions, deprescribing, inappropriate medication, polypharmacy, elderly, terminal care, nursing homes, hospitalized, and intensive care.", "What is the effectiveness of deprescribing in the elderly population in hospitals or nursing homes receiving terminal care or suffering from chronic illnesses, as investigated through randomized controlled trials, cohort studies, systematic reviews, or meta-analyses? The query should also include terms related to medication reduction or cessation, polypharmacy, and adverse effects, while focusing on hospital medicine and intensive care units.", "What is the effectiveness of deprescription interventions in reducing polypharmacy among older adults in nursing homes, terminal care, or those with chronic conditions requiring hospitalization? Specifically, what are the benefits and adverse effects of deprescription interventions, and what randomized controlled trials, cohort studies, or systematic reviews have investigated this topic in hospitals, hospital medicine, or intensive care units?", "What is the effectiveness of deprescribing in elderly patients receiving terminal care or residing in nursing homes, and what are the benefits and adverse effects associated with this practice? Is this approach implemented effectively, and are there any randomized controlled trials, cohort studies, or systematic reviews investigating this topic? Additionally, what is the role of hospitals and intensive care units in deprescribing for this population?", "What is the effectiveness of deprescribing medications in older adults receiving end-of-life care, nursing home care, or hospitalization, and how does it impact their outcomes? Are there randomized controlled trials or cohort studies that have investigated the benefits and adverse effects of deprescription interventions in this population? Have systematic reviews or meta-analyses been conducted to evaluate the efficacy of deprescribing interventions in hospitals, intensive care units, or hospital medicine?", "What are the most effective methods of reducing medication use among older adults in hospitals, nursing homes, and end-of-life care settings, while still maintaining efficacy and minimizing adverse effects? Specifically, I am interested in deprescription strategies such as discontinuing, reducing, substituting, or ceasing medications, as well as exploring the potential benefits and risks of polypharmacy, and any potential interventions that have been investigated in randomized controlled trials or cohort studies.", "What is the effectiveness of deprescribing medications in the elderly population residing in nursing homes or receiving terminal care, and what are the benefits and adverse effects? Are there any randomized controlled trials or cohort studies that have investigated this topic, and what is the evidence from systematically reviewed literature or meta-analyses? Additionally, how does deprescribing affect hospitalization rates and outcomes in the elderly, including those in hospital medicine or intensive care units?", "What is the effectiveness of deprescribing medication in older patients receiving terminal care or in nursing homes? Are randomized controlled trials or cohort studies investigating the efficacy or potential benefits and adverse effects of deprescription in the elderly population available in PubMed or Cochrane Database of Systematic Reviews? Additionally, are there any studies investigating deprescription in hospitals or intensive care units?", "What is the effectiveness of deprescribing interventions in improving outcomes in frail elderly patients in hospital or nursing home settings, as investigated in randomized controlled trials or cohort studies? Additionally, what is the impact of deprescribing on medication-related adverse events and the implementation of deprescribing interventions? The search should focus on studies involving older adults in hospital or nursing home settings and should include terms related to deprescribing, inappropriate medication use, polypharmacy, and effectiveness, as well as search strategies such as systematic review, meta-analysis, and literature review. The search should also cover the use of deprescribing interventions in hospital, intensive care units, and other healthcare settings."]}
{"id": "102", "boolean": "(\"Anti-Bacterial Agents\"[Mesh] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab]) AND (\"Sepsis\"[Mesh] OR Sepsis[tiab] OR \"Septic shock\"[tiab] OR \"Systemic inflammatory response syndrome\"[tiab] OR Septicemia[tiab] OR Septicemias[tiab]) AND (\"Mortality\"[Mesh] OR \"Survival Rate\"[Mesh] OR \"Survival Analysis\"[Mesh] OR Mortality[tiab] OR Death[tiab] OR Deaths[tiab] OR Survival[tiab]) AND (\"Emergency Service, Hospital\"[Mesh] OR \"Emergency service\"[tiab] OR \"Emergency services\"[tiab] OR \"Emergency department\"[tiab] OR \"Emergency departments\"[tiab] OR \"Emergency Units\"[tiab] OR \"Emergency Unit\"[tiab] OR ED[tiab] OR \"Intensive Care Units\"[Mesh] OR \"Intensive Care Units\"[tiab] OR \"Intensive Care Unit\"[tiab] OR ICU[tiab] OR ICUs[tiab]) AND (\"Time-to-Treatment\"[Mesh] OR Timing[tiab] OR \"Time to\"[tiab] OR Hour[tiab] OR Hours[tiab]) AND (Administration[tiab] OR Appropriate[tiab] OR Appropriateness[tiab] OR Compliance[tiab]) AND (\"randomized controlled trial\"[pt] OR \"controlled clinical trial\"[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR \"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"case control\"[tiab] OR Cohort[tiab] OR \"Follow up\"[tiab] OR Observational[tiab] OR longitudinal[tiab] OR Prospective[tiab] OR retrospective[tiab] OR \"cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Analysis[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh])", "generated_query": ["What is the appropriate timing and administration of antibacterial agents for patients with sepsis or septic shock in the emergency department or intensive care unit to improve mortality and survival rate, as investigated in randomized controlled trials or observational studies in humans?", "What is the appropriate timing of administration of anti-bacterial agents for sepsis and septic shock in emergency departments or intensive care units to improve mortality rates? Please only include results from randomized controlled trials, controlled clinical trials, epidemiologic studies, case-control studies, cohort studies, cross-sectional studies, and observational studies that investigate humans. Exclude results related to animals.", "What is the effectiveness of antibiotics and antimicrobial agents in reducing mortality rates and improving survival in patients with sepsis, septic shock, or systemic inflammatory response syndrome who receive appropriate timing and administration of treatment in emergency services or intensive care units, based on randomized controlled trials or observational studies?", "Can administration of appropriate anti-bacterial agents in the emergency department or intensive care unit within a timely manner improve survival rates and mortality outcomes in patients with sepsis or septic shock? Are there any randomized controlled trials, cohort studies, or observational studies investigating this issue in humans?", "What is the appropriate timing and administration of anti-bacterial agents for sepsis and septic shock patients in emergency and intensive care units to improve survival rate and reduce mortality in randomized controlled trials, observational, cohort, and cross-sectional studies?", "What is the effect of anti-bacterial agents or antibiotics on mortality rates in patients with sepsis, septic shock, or systemic inflammatory response syndrome in emergency department or intensive care unit settings? How does timing and appropriateness of administration impact outcomes? Are there any randomized controlled trials or observational studies investigating this topic in humans?", "What is the effectiveness of administration and appropriate timing of anti-bacterial agents in the emergency department and intensive care units on mortality rates in patients with sepsis, septic shock, or systemic inflammatory response syndrome, as investigated by randomized controlled trials, case-control studies, and observational studies, excluding animal studies?", "What is the efficacy of antibacterial agents or antibiotics in the treatment of sepsis or septic shock in patients admitted to emergency departments or intensive care units, in terms of mortality, survival rates, and time-to-treatment? Are randomized controlled trials, observational or longitudinal studies, and cohort or case-control studies investigating the appropriateness and compliance of administration of such agents or antibiotics available, excluding studies conducted on animals?", "What is the efficacy of anti-bacterial agents or antibiotics in the treatment of sepsis, septic shock, or systemic inflammatory response syndrome in emergency service, hospital, or intensive care unit settings? Does the timing of treatment administration or compliance affect mortality rates in randomized controlled trials or observational studies? Excluding studies on animals, what are the findings of studies investigating the appropriateness of treatment in these contexts?", "Can administration of anti-bacterial agents or antibiotics improve survival rates in patients with sepsis or septic shock who receive treatment in emergency departments or intensive care units within a certain time frame, based on evidence from randomized controlled trials or observational studies?"]}
{"id": "60", "boolean": "(Bandages[Mesh] OR Alginates[Mesh] OR Hydrogels[Mesh] OR Silver[Mesh] OR \"Silver Sulfadiazine\"[Mesh] OR Honey[Mesh] OR \"Collagenases\"[Mesh] OR Bandage[tiab] OR Bandages[tiab] OR Dressing[tiab] OR Dressings[tiab] OR Pad[tiab] OR Pads[tiab] OR Gauze[tiab] OR Tulle[tiab] OR Film[tiab] OR Films[tiab] OR Alginate[tiab] OR Alginates[tiab] OR Hydrogel[tiab] OR Hydrogels[tiab] OR Silver OR Bead[tiab] OR Foam[tiab] OR Foams[tiab] OR non-adherent[tiab] OR \"non adherent\"[tiab] OR hydrocolloid[tiab] OR Hydrocolloids[tiab] OR Honey[tiab] OR Honeys[tiab] OR matrix[tiab] OR Collagenases[tiab] OR Collagenase[tiab]) AND (\"Pressure Ulcer\"[Mesh] OR \"Pressure ulcer\"[tiab] OR \"Pressure ulcers\"[tiab] OR Bedsore[tiab] OR Bedsores[tiab] OR \"Pressure Sore\"[tiab] OR \"Pressure Sores\"[tiab] OR \"Bed Sores\"[tiab] OR \"Bed Sore\"[tiab] OR \"Decubitus Ulcer\"[tiab] OR \"Decubitus Ulcers\"[tiab]) AND (\"Wound Healing\"[Mesh] OR \"Debridement\"[Mesh] OR Healing[tiab] OR Healings[tiab] OR \"Wound therapy\"[tiab] OR Debridement[tiab] OR Debridements[tiab] OR \"Wound treatment\"[tiab] OR Treating[tiab]) AND (randomized controlled trial[Publication Type] OR controlled clinical trial[Publication Type] OR randomized[Title/Abstract] OR randomised[Title/Abstract] OR placebo[Title/Abstract] OR \"drug therapy\"[MeSH Terms] OR randomly[Title/Abstract] OR trial[Title/Abstract] OR groups[Title/Abstract]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh]/))", "generated_query": ["What are the most effective wound dressings and therapies for treating pressure ulcers and bedsores in humans based on randomized controlled trials and clinical trials, excluding studies involving animals?", "Retrieve all controlled clinical trials, randomized controlled trials and placebo-controlled trials involving the use of bandages, alginates, hydrogels, silver, honey, collagenases, dressings, pads, gauze, tulle, film, beads, foam, hydrocolloids, or non-adherent treatments for the treatment of pressure ulcers, bedsores, pressure sores, or decubitus ulcers with a focus on wound healing and debridement in human subjects, while excluding studies involving animals.", "What are the most effective treatments for pressure ulcers in humans, and how do they impact wound healing? Please provide results from controlled clinical trials, randomized controlled trials, or placebo studies, using bandages, alginates, hydrogels, silver, honey, collagenases, dressings, pads, gauze, tulle, films, beads, foams, non-adherent materials, hydrocolloids, or matrices as interventions, but excluding studies on animals.", "What is the effectiveness of different types of bandages, alginates, hydrogels, silver sulfadiazine, honey, collagenases, and wound dressings in treating pressure ulcers and bed sores through wound healing or debridement? Only studies involving randomized controlled trials, controlled clinical trials, or placebo-controlled trials on human subjects will be included in the search. Studies involving animals will be excluded.", "What are the most effective wound dressings for treating pressure ulcers and bedsores? Include only studies that are randomized controlled trials, controlled clinical trials, or placebo-controlled trials in humans. Exclude studies that involve animals.", "What are the most effective interventions for treating pressure ulcers in humans, specifically focusing on bandages, alginates, hydrogels, silver, honey, collagenases, dressings, pads, gauze, tulle, films, beads, foams, non-adherent and hydrocolloid dressings, and wound healing therapies, based on randomized controlled trials or controlled clinical trials, excluding studies involving animals?", "What randomized controlled trials or controlled clinical trials have been conducted on bandages, alginates, hydrogels, silver sulfadiazine, honey, collagenases, dressings, pads, gauze, tulle, films, alginate, hydrocolloids, beads, foams, or non-adherent treatments for pressure ulcers, bedsores, pressure sores, or decubitus ulcers that assess wound healing or debridement without using animals as subjects?", "What are the most effective wound healing treatments for pressure ulcers, bedsores, and decubitus ulcers? Please include only randomized controlled trials, controlled clinical trials, randomized studies, and placebo-controlled studies involving bandages, alginates, hydrogels, silver, honey, collagenases, non-adherent materials, hydrocolloids, and matrix treatments. Exclude studies involving animals.", "Can randomized controlled trials or controlled clinical trials using various types of wound dressings such as bandages, alginates, hydrogels, silver sulfadiazine, honey, and collagenases effectively promote wound healing and debridement in patients with pressure ulcers, pressure sores, bedsores, or decubitus ulcers without including studies on animals?", "What is the effectiveness of wound dressings, including bandages, alginates, hydrogels, silver, honey, and collagenases, for the treatment of pressure ulcers and bedsores, and promoting wound healing through debridement and wound therapy, based on randomized controlled trials and controlled clinical trials, while excluding studies involving animals?"]}
{"id": "46", "boolean": "(((\"Dementia\"[MeSH] OR Dementia[tiab] OR Dementias[tiab] OR Demented[tiab] OR \"Neurocognitive Disorders\"[tiab] OR \"Neurocognitive Disorder\"[tiab] OR \"Memory disorders\"[tiab] OR \"Memory disorder\"[tiab] OR \"Cognitive decline\"[tiab] OR \"cognitive disorders\"[tiab] OR Alzheimer[tiab] OR Alzheimers[tiab] OR alzheimer\u2019s[tiab])) OR (\"Caregivers\"[Mesh] OR Caregivers[tiab] OR Caregiver[tiab] OR Carer[tiab] OR Carers[tiab])) OR ((Cultural[tiab] OR Culturally[tiab]) AND Care[tiab]) AND (\"africa, northern\"[Mesh] OR \"northern africa\"[tiab] OR \"North africa\"[tiab] OR \"algeria\"[Mesh] OR \"algeria\"[tiab] OR \"egypt\"[Mesh] OR \"egypt\"[tiab] OR \"libya\"[Mesh] OR \"libya\"[tiab] OR \"morocco\"[Mesh] OR \"morocco\"[tiab] OR \"tunisia\"[Mesh] OR \"tunisia\"[tiab] OR \"sudan\"[Mesh] OR \"sudan\"[tiab] OR \"middle east\"[Mesh] OR \"middle east\"[tiab] OR \"bahrain\"[Mesh] OR \"bahrain\"[tiab] OR \"iraq\"[Mesh] OR \"iraq\"[tiab] OR \"jordan\"[Mesh] OR \"jordan\"[tiab] OR \"kuwait\"[Mesh] OR \"kuwait\"[tiab] OR \"lebanon\"[Mesh] OR \"lebanon\"[tiab] OR \"oman\"[Mesh] OR \"oman\"[tiab] OR \"qatar\"[Mesh] OR \"qatar\"[tiab] OR \"saudi arabia\"[Mesh] OR \"saudi arabia\"[tiab] OR \"syria\"[Mesh] OR \"syria\"[tiab] OR \"united arab emirates\"[Mesh] OR \"united arab emirates\"[tiab] OR \"yemen\"[Mesh] OR \"yemen\"[tiab] OR \"somalia\"[Mesh] OR \"somalia\"[tiab] OR \"mauritania\"[Mesh] OR \"mauritania\"[tiab] OR \"djibouti\"[Mesh] OR \"djibouti\"[tiab] OR \"arabs\"[Mesh] OR \"arabs\"[tiab] OR Arab[tiab] OR \"comoros\"[Mesh] OR \"comoros\"[tiab] OR lebanese[tiab] OR libanaise[tiab] OR \"aden\"[tiab] OR \"sanaa\"[tiab] OR UAE[tiab] OR \"abu dhabi\"[tiab] OR dubai[tiab] OR \"muscat\"[tiab] OR palestina[tiab] OR palestinae[tiab] OR palestine[tiab] OR palestinians[tiab] OR gaza[tiab] OR \"west bank\"[tiab] OR KSA[tiab] OR tunis[tiab] OR MENA[tiab] OR EMRO[tiab] OR \"arabia\"[Mesh] OR \"arabia\"[tiab] OR somali[tiab] OR \"mauritania\"[Mesh] OR \"mauritania\"[tiab] OR levant[tiab] OR Gulf[tiab] OR \"Arabian Gulf\"[tiab] OR \"persian gulf\"[tiab]) AND (\"Aging\"[Mesh] OR \"Aged\"[Mesh] OR \"Aging\"[tiab] OR Aged[tiab] OR \"Senility\"[tiab] OR \"old age\"[tiab] OR \"elderly\"[tiab] OR Older[tiab]) AND (\"randomized controlled trial\"[pt] OR \"controlled clinical trial\"[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR \"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"case control\"[tiab] OR Cohort[tiab] OR \"Follow up\"[tiab] OR Observational[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR retrospective[tiab] OR \"cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Analysis[tiab] OR Statistics[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh])", "generated_query": ["What are the cultural and caregiver factors influencing dementia care for older adults in Northern Africa and the Middle East? Include randomized controlled trials, observational studies, longitudinal and cross-sectional studies, as well as epidemiological investigations and data analysis on dementia, neurocognitive disorders, memory disorders, cognitive decline, Alzheimer's disease, and caregivers in the countries of Algeria, Egypt, Libya, Morocco, Tunisia, Sudan, Bahrain, Iraq, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Syria, United Arab Emirates, Yemen, Somalia, Mauritania, and Djibouti?", "What randomized controlled trials, observational studies, and epidemiologic studies have investigated the relationship between dementia (including neurocognitive disorders and Alzheimer's disease) and caregiving in older adults in Northern Africa and the Middle East, specifically in Algeria, Egypt, Libya, Morocco, Tunisia, Sudan, Bahrain, Iraq, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Syria, United Arab Emirates, Yemen, Somalia, Mauritania, and Djibouti, considering cultural and aging factors?", "What is the effectiveness of interventions for dementia and caregivers in Northern Africa and the Middle East, particularly regarding cultural aspects, aging, and randomized controlled trials, as indicated by epidemiologic, case-control, cohort, cross-sectional, longitudinal, and prospective studies?", "What randomized controlled or observational studies have investigated the relationship between dementia or neurocognitive disorders and the care provided by caregivers in Northern Africa and the Middle East region, specifically Algeria, Egypt, Libya, Morocco, Tunisia, Sudan, Bahrain, Iraq, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Syria, United Arab Emirates, Yemen, Somalia, Mauritania, and Djibouti, among the aging population?", "What is the effectiveness of randomized controlled trials, controlled clinical trials, epidemiologic studies, case-control studies, and cohort studies on the cognitive decline and memory disorders in aging populations of Northern Africa and the Middle East, with a focus on the impact of culturally appropriate care for dementia patients and their caregivers?", "What is the impact of cultural care on the cognitive decline of older adults with dementia in Northern Africa and the Middle East? Can randomized controlled trials, cohort studies, and observational studies investigate the effectiveness of caregivers in providing culturally appropriate care for older adults with dementia in these regions?", "What is the efficacy of interventions for dementia or neurocognitive disorders in North African and Middle Eastern countries, focusing on the impact on caregivers and culturally-sensitive care for older adults? Please retrieve randomized controlled trials, controlled clinical trials, epidemiologic studies, case-control studies, cohort studies, cross-sectional studies, longitudinal studies, and observational studies, investigating interventions for aging, aged, senility, old age, or elderly populations, using keywords such as dementia, dementias, demented, neurocognitive disorders, memory disorders, cognitive decline, Alzheimer's, Alzheimer's disease, Alzheimer's dementia, caregivers, caregiver, carer, carers, cultural, culturally, culture, care, and specific country names including Algeria, Egypt, Libya, Morocco, Tunisia, Sudan, Bahrain, Iraq, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Syria, United Arab Emirates, Yemen, Somalia, Mauritania, and Djibouti.", "What are the randomized controlled trials, controlled clinical trials, epidemiologic studies, case-control studies, and cohort studies that investigate the effectiveness of interventions for dementia, neurocognitive disorders, memory disorders, cognitive decline, Alzheimer's, and other related conditions among older individuals and their caregivers in Northern Africa and the Middle East, including Algeria, Egypt, Libya, Morocco, Tunisia, Sudan, Bahrain, Iraq, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Syria, United Arab Emirates, Yemen, Somalia, Mauritania, and Djibouti, while considering cultural aspects of care?", "What is the impact of cultural caregiving practices on dementia and cognitive decline in Northern Africa and the Middle East, particularly in Algeria, Egypt, Libya, Morocco, Sudan, Bahrain, Iraq, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Syria, United Arab Emirates, Yemen, Somalia, Mauritania, and Djibouti? Include randomized controlled trials, controlled clinical trials, observational studies, epidemiological studies, case-control studies, and cohort studies that investigate the relationship between cultural caregiving practices and cognitive decline or dementia in the aging population in these regions.", "What are the randomized controlled trials, controlled clinical trials, case-control studies, and cohort studies investigating the effectiveness of interventions for dementia or neurocognitive disorders in Northern Africa and the Middle East, specifically in Algeria, Egypt, Libya, Morocco, Tunisia, Sudan, Bahrain, Iraq, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Syria, United Arab Emirates, Yemen, Somalia, Mauritania, and Djibouti, and involving caregivers from these regions, and utilizing a cultural perspective of care for aging individuals?"]}
{"id": "42", "boolean": "( (\"Checklist\"[Mesh] OR \"Forms and Records Control\"[Mesh] OR Checklist[tiab] OR Checklists[tiab] OR Tool[tiab] OR Tools[tiab] OR Scale[tiab] OR Scales[tiab] OR Score[tiab] OR Scores[tiab] OR Scored[tiab]) AND (\"Research Design/methods\"[Mesh] OR \"Research Design/standards\"[Mesh] OR Valid[tiab] OR Validity[tiab] OR Quality[tiab] OR \"Critical appraisal\"[tiab] OR \"Critical review\"[tiab] OR Bias[tiab] OR Biased[tiab]) AND (Assess[tiab] OR Assessed[tiab] OR Assessing[tiab] OR Assessment[tiab] OR Measure[tiab] OR Measures[tiab] OR Measured[tiab] OR Evaluate[tiab] OR Evaluated[tiab] OR Evaluating[tiab]) AND (\"Meta-Analysis as Topic\"[Mesh] OR \"Review Literature as Topic\"[Mesh] OR \"Clinical Trials as Topic\"[Mesh] OR Study[tiab] OR Studies[tiab] OR Article[tiab] OR Articles[tiab] OR Meta-Analysis[tiab] OR \"Meta Analysis\"[tiab] OR Metaanalysis[tiab] OR Meta-analyses[tiab] OR \"Meta analyses\"[tiab] OR Metaanalyses[tiab]) AND (\"Methods\"[Mesh] OR Method[tiab] OR Methodological[tiab] OR Methodology[tiab] OR Methodologic[tiab]) AND (\"Reproducibility of Results\"[Mesh] OR \"Quality Control\"[Mesh] OR Reproducibility[tiab] OR Evidence[tiab] OR Reliability[tiab] OR Reliable[tiab] OR Index[tiab] OR Proxy[tiab]) ) AND ( (Scale[ti] OR Scales[ti] OR Checklist[ti] OR Checklists[ti] OR Tool[ti] OR Tools[ti] OR Instrument[ti] OR Instruments[ti] OR Technique[ti] OR Techniques[ti] OR Score[ti] OR Scored[ti] OR Quality[ti] OR Assess[ti] OR Assessed[ti] OR Assessing[ti] OR Assessment[ti] OR Evaluate[ti] OR Evaluated[ti] OR Evaluating[ti]) )", "generated_query": ["What is the validity, reliability, and reproducibility of assessment tools and techniques for evaluating research design quality, critical appraisal, and bias in meta-analyses, systematic reviews, clinical trials, and studies? Specifically, what methods and methodologies are effective for quality control and evidence-based index and proxy development?", "What is the effectiveness of checklist, research design, assessment, meta-analysis, methods, and reproducibility of results tools, scales, instruments, techniques, scores, and quality measures in evaluating validity, bias, and reliability of studies and articles?", "What research design and methodological tools and techniques are used to assess the validity, reliability, and quality of studies and articles? Specifically, how are scales, checklists, tools, instruments, scores, and assessments employed in evaluating evidence and reproducing results in meta-analyses, clinical trials, and literature reviews?", "What research methods and tools are available for assessing the validity, reliability, and quality of studies using checklists, scales, scores, and other instruments in meta-analyses, clinical trials, and other literature reviews, while ensuring reproducibility of results and evidence-based practice?", "What research methods or tools have been used to assess the validity, quality, and reliability of checklists, scales, scores, or other instruments used in clinical trials or studies? Are there any critical reviews or meta-analyses that have evaluated the reproducibility or evidence of such methods or instruments, including their methodological and quality control aspects?", "What is the validity and reliability of checklists, forms, tools, scales, and scores used in research design and methodology, critical appraisal, and bias assessment, as well as their reproducibility and quality control, in studies, articles, and meta-analyses? Specifically, what are the instruments, techniques, and methodologies used to assess and evaluate the effectiveness of these measures?", "What are the most effective methods and tools for assessing the validity, quality, and reliability of research studies and articles, including those utilizing checklists, scales, and other forms of measurement or assessment, and what is the reproducibility of these results?", "What are the most effective tools, scales, and checklists for assessing research design and methodology validity, quality, and reliability? Additionally, how do meta-analyses, studies, and articles utilize these methods and what is their impact on reproducibility of results and evidence reliability?", "Can you recommend articles that assess the validity, reliability, and quality of various checklists, scales, tools, and instruments used in research design and methodology, particularly in the context of clinical trials and meta-analyses, and discuss the methods and reproducibility of results for these assessments? Please include articles that use the keywords scale, scales, checklist, checklists, tool, tools, instrument, instruments, technique, techniques, score, scored, quality, assess, assessed, assessing, assessment, evaluate, evaluated, and evaluating.", "What are the most reliable and valid methods, tools, and techniques for assessing and evaluating research quality, bias, and reproducibility, including scales, checklists, scores, and instruments, as well as critical appraisal and meta-analysis approaches, according to current evidence-based literature and best practices in research methodology?"]}
{"id": "64", "boolean": "((\"Diabetes, Gestational\"[Mesh] OR \"Gestational diabetes\"[tiab] OR \"Pregnancy-Induced Diabetes\"[tiab] OR \"Pregnancy Induced Diabetes\"[tiab]) OR ((Overweight[tiab] OR Obese[tiab]) AND (Pregnant[tiab] OR Pregnancy[tiab])) ) AND (\"Metformin\"[Mesh] OR Metformin[tiab] OR Dimethylbiguanidine[tiab] OR Dimethylguanylguanidine[tiab] OR Glucophage[tiab]) AND (\"Pregnancy Complications\"[Mesh] OR Prevention[tiab] OR Preventing[tiab] OR Complication[tiab] OR Complications[tiab] OR Risk[tiab] OR \"androgen excess\"[tiab] OR hyperandrogenism[tiab] OR \"polycystic ovary syndrome\"[tiab] OR \"polycystic ovarian syndrome\"[tiab] OR \"polycystic ovarian disease\"[tiab] OR \"polycystic ovaries\"[tiab] OR PCOS[tiab] OR hirsutism[tiab] OR acne[tiab] OR alopecia[tiab] OR \"menstrual dysfunction\"[tiab] OR anovulation[tiab] OR infertility[tiab] OR subfertility[tiab] OR \"ovulation induction\"[tiab]) AND (\"randomized controlled trial\"[pt] OR \"controlled clinical trial\"[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR \"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"case control\"[tiab] OR Cohort[tiab] OR \"Follow up\"[tiab] OR Observational[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR retrospective[tiab] OR \"cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Analysis[tiab] OR Statistics[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh])", "generated_query": ["What are the randomized controlled trials and observational studies investigating the use of Metformin for preventing pregnancy complications in women who have Gestational Diabetes, Pregnancy-Induced Diabetes, or are overweight/obese during pregnancy and have polycystic ovary syndrome, androgen excess, hyperandrogenism, hirsutism, acne, alopecia, menstrual dysfunction, anovulation, infertility, or subfertility?", "What are the randomized controlled trials and observational studies that investigate the effectiveness of Metformin, Dimethylbiguanidine, or Glucophage in preventing pregnancy complications, including Gestational diabetes, Pregnancy-Induced Diabetes, and diabetes in pregnant women who are overweight, obese, or have polycystic ovary syndrome, hirsutism, acne, alopecia, menstrual dysfunction, anovulation, infertility, or subfertility?", "What randomized controlled trials, cohort studies, and observational studies have investigated the effectiveness of Metformin in preventing pregnancy complications, particularly in women with gestational diabetes, pregnancy-induced diabetes, overweight, obesity, and conditions related to androgen excess such as polycystic ovary syndrome, hirsutism, acne, alopecia, menstrual dysfunction, anovulation, infertility, and subfertility?", "Retrieve articles on the prevention and treatment of gestational diabetes in pregnant women who are overweight or obese and have risk factors such as polycystic ovary syndrome, hirsutism, and menstrual dysfunction using metformin in randomized controlled trials, observational studies, and epidemiological studies.", "What is the effectiveness of metformin in preventing pregnancy complications in pregnant women with gestational diabetes, pregnancy-induced diabetes, overweight, obesity, and androgen excess-related conditions such as polycystic ovary syndrome, hirsutism, acne, alopecia, menstrual dysfunction, anovulation, infertility, and subfertility, as evaluated in randomized controlled trials, controlled clinical trials, epidemiologic studies, case-control studies, cohort studies, follow-up studies, observational studies, longitudinal studies, and cross-sectional studies, using the terms \"Metformin\", \"Diabetes, Gestational\", \"Gestational diabetes\", \"Pregnancy-Induced Diabetes\", \"Pregnancy Induced Diabetes\", \"Overweight\", \"Obese\", \"Pregnant\", \"Pregnancy\", \"androgen excess\", \"hyperandrogenism\", \"polycystic ovary syndrome\", \"polycystic ovarian syndrome\", \"polycystic ovarian disease\", \"polycystic ovaries\", \"PCOS\", \"hirsutism\", \"acne\", \"alopecia\", \"menstrual dysfunction\", \"anovulation\", \"infertility\", \"subfertility\", \"ovulation induction\", \"randomized controlled trial\", \"controlled", "What is the effectiveness of Metformin in preventing pregnancy complications in pregnant women with Gestational Diabetes or those who are overweight or obese, and also have androgen excess, hyperandrogenism, Polycystic Ovary Syndrome, hirsutism, acne, alopecia, menstrual dysfunction, anovulation, infertility, or subfertility, as determined by randomized controlled trials, controlled clinical trials, epidemiological studies, case-control studies, cohort studies, follow-up studies, observational studies, longitudinal studies, prospective or retrospective studies, cross-sectional studies, or statistical analyses?", "What is the effectiveness of Metformin in preventing pregnancy complications in women who have Gestational Diabetes, Pregnancy-Induced Diabetes, or who are Overweight or Obese during pregnancy, and also have Androgen Excess, Polycystic Ovary Syndrome, Hirsutism, Acne, Alopecia, Menstrual Dysfunction, Anovulation, Infertility, or Subfertility? Only randomized controlled trials, controlled clinical trials, epidemiologic studies, case-control studies, cohort studies, cross-sectional studies, observational, longitudinal, prospective, or retrospective studies, investigated through analysis, statistics, or numerical data, will be included.", "What is the effectiveness of metformin in preventing pregnancy complications and managing gestational diabetes among overweight or obese pregnant women with androgen excess or polycystic ovary syndrome, based on randomized controlled trials, controlled clinical trials, cohort studies, and cross-sectional studies?", "Can metformin prevent pregnancy complications in pregnant women with gestational diabetes, pregnancy-induced diabetes, overweight or obesity, and other risk factors such as androgen excess, polycystic ovary syndrome, hirsutism, and infertility? Are there any randomized controlled trials or observational studies that investigate the efficacy of metformin in preventing pregnancy complications in this population?", "Can metformin prevent pregnancy complications in women with gestational diabetes or those who are overweight/obese and pregnant, as well as those with androgen excess, polycystic ovary syndrome, menstrual dysfunction, anovulation, infertility, or subfertility? Are there any randomized controlled trials, controlled clinical trials, or observational studies that investigate this topic?"]}
{"id": "6", "boolean": "((\"Diabetes, Gestational\"[Mesh] OR \"Gestational diabetes\"[tiab] OR \"Pregnancy-Induced Diabetes\"[tiab] OR \"Pregnancy Induced Diabetes\"[tiab]) AND (\"Glyburide\"[Mesh] OR \"Acarbose\"[Mesh] OR \"Metformin\"[Mesh] OR \"Biguanides\"[Mesh] OR \"Sulfonylurea Compounds\"[Mesh] OR \"Thiazolidinediones\"[Mesh] OR \"Dipeptidyl-Peptidase IV Inhibitors\"[Mesh] OR \"Glycoside Hydrolase Inhibitors\"[Mesh] OR \"Sodium-Glucose Transporter 2 Inhibitors\"[Mesh] OR \"Insulin\"[Mesh] OR \"Glucagon-Like Peptide 1\"[Mesh] OR \"Exenatide\"[Mesh] OR \"Glipizide\"[Mesh] OR \"Insulin Lispro\"[Mesh] OR \"Isophane Insulin, Human\"[Mesh] OR \"Insulin, Isophane\"[Mesh] OR \"Insulin Glargine\"[Mesh] OR \"Insulins\"[Mesh] OR \"Xultophy\" [Supplementary Concept] OR \"Liraglutide\"[Mesh] OR \"Linagliptin\"[Mesh] OR \"repaglinide\" [Supplementary Concept] OR \"Sitagliptin Phosphate\"[Mesh] OR \"Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination\"[Mesh] OR \"empagliflozin\" [Supplementary Concept] OR \"dulaglutide\" [Supplementary Concept] OR Glyburide[tiab] OR Glybenclamide[tiab] OR Glibenclamide[tiab] OR Diabeta[tiab] OR \"Euglucon 5\"[tiab] OR Neogluconin[tiab] OR HB-419[tiab] OR \"HB 419\"[tiab] OR HB419[tiab] OR HB-420[tiab] OR \"HB 420\"[tiab] OR HB420[tiab] OR Maninil[tiab] OR Micronase[tiab] OR Daonil[tiab] OR \"Euglucon N\"[tiab] OR \"Acarbose\"[tiab] OR Glumida[tiab] OR Glucobay[tiab] OR Glucor[tiab] OR \"Bay g 5421\"[tiab] OR Prandase[tiab] OR Precose[tiab] OR \"Metformin\"[tiab] OR Dimethylbiguanidine[tiab] OR Dimethylguanylguanidine[tiab] OR Glucophage[tiab] OR biguanides[tiab] OR sulfonylureas[tiab] OR meglitinides[tiab] OR thiazolidinediones[tiab] OR \"dipeptidyl peptidase IV inhibitors\"[tiab] OR \"DPP-IV inhibitors\"[tiab] OR \"\u03b1-glucosidase inhibitors\"[tiab] OR \"SGLT2 inhibitors\"[tiab] OR gliflozins[tiab] OR Insulin[tiab] OR \"Glucagon like peptide\u20131\"[tiab] OR \"GLP-1 agonists\"[tiab] OR Amylinomimetics[tiab] OR Exenatide[tiab] OR Glicalzide[tiab] OR Glimepride[tiab] OR Glipizide[tiab] OR Mixtard[tiab] OR Actrapid[tiab] OR Humalog[tiab] OR Insulatard[tiab] OR Isophane[tiab] OR Glargine[tiab] OR \"Levemir Detemir\"[tiab] OR \"Degludec pen\"[tiab] OR \"Novomix pen\"[tiab] OR \"Novoraid vial\"[tiab] OR \"Saxenda liraglutide\"[tiab] OR Linagliptin[tiab] OR Dapagliflozin[tiab] OR Piogitazine[tiab] OR Repaglinide[tiab] OR \"Galvus met\"[tiab] OR Vidagliptin[tiab] OR Sitagliptin[tiab] OR Janumet[tiab] OR Empagliflozin[tiab] OR Dulaglutide[tiab]) AND (\"Therapeutic use\"[sh] OR Therapeutic[tiab] OR Therapy[tiab] OR Therapies[tiab]) AND (Effect[tiab] OR Effects[tiab] OR Impact[tiab] OR Modify[tiab] OR Decrease[tiab] OR Decreases[tiab] OR Declined[tiab] OR Declines[tiab] OR Reduce[tiab] OR Reducing[tiab] OR Reduces[tiab] OR Reduction[tiab] OR Differences[tiab] OR Difference[tiab] OR Different[tiab] OR Comparing[tiab] OR Versus[tiab]) AND (\"Female\"[Mesh] OR Female[tiab] OR Females[tiab] OR Women[tiab] OR Woman[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh])))", "generated_query": ["What is the impact of various therapies (glyburide, acarbose, metformin, biguanides, sulfonylurea compounds, thiazolidinediones, dipeptidyl-peptidase IV inhibitors, glycoside hydrolase inhibitors, sodium-glucose transporter 2 inhibitors, insulin, glucagon-like peptide 1, exenatide, glipizide, insulin lispro, isophane insulin, human, insulin glargine, Xultophy, liraglutide, linagliptin, repaglinide, sitagliptin phosphate, sitagliptin phosphate-metformin hydrochloride drug combination, empagliflozin, dulaglutide, and others) on gestational diabetes in women? The search should be limited to randomized controlled trials and controlled clinical trials involving female participants. The search should not include animal studies.", "What therapies or drugs are effective in reducing the impact of gestational diabetes in women, as evaluated in randomized controlled trials, and what are their therapeutic uses, among glyburide, acarbose, metformin, biguanides, sulfonylurea compounds, thiazolidinediones, dipeptidyl-peptidase IV inhibitors, glycoside hydrolase inhibitors, sodium-glucose transporter 2 inhibitors, insulin, glucagon-like peptide 1, exenatide, glipizide, insulin lispro, isophane insulin, human, insulin glargine, insulins, Xultophy, liraglutide, linagliptin, repaglinide, sitagliptin phosphate, sitagliptin phosphate, metformin hydrochloride drug combination, empagliflozin, dulaglutide, glyburide, glybenclamide, glibenclamide, diabeta, euglucon 5, neogluconin, HB-419, HB 419, HB419, HB-420, HB 420, HB420, maninil, micronase, daonil, euglucon N, acar", "What is the impact of various therapeutic interventions, including glyburide, acarbose, metformin, insulin, and glucagon-like peptide 1, on gestational diabetes in women? Specifically, I am interested in randomized controlled trials or controlled clinical trials that compare the effectiveness of these interventions on reducing the differences in glycemic control in pregnant females diagnosed with gestational diabetes, and exclude studies that involve animals.", "Can the use of specific diabetes medications during pregnancy, including glyburide, metformin, and insulin, reduce the risk or impact of gestational diabetes in women? Does therapy with these medications have a significant effect on improving outcomes for pregnant women with gestational diabetes compared to placebo or other treatments in randomized controlled trials involving female participants?", "What therapies are effective in reducing the impact of gestational diabetes in women, as compared to placebo or other therapies, in randomized controlled trials? Include interventions such as glyburide, acarbose, metformin, insulin, glucagon-like peptide 1 agonists, and SGLT2 inhibitors, among others, and limit the results to studies on female participants. Exclude animal studies and studies that do not involve humans.", "What are the therapeutic effects of Glyburide, Acarbose, Metformin, and other drugs on gestational diabetes in women, as compared to placebo or other drug therapies, based on randomized controlled trials and controlled clinical trials involving only human females?", "What is the impact of various diabetes medications, including Glyburide, Acarbose, Metformin, Insulin, and GLP-1 agonists, on the therapeutic management of gestational diabetes in female patients in randomized controlled trials?", "What is the impact of various therapies (including Glyburide, Acarbose, Metformin, Insulin, and other drugs) on gestational diabetes in women, as compared to placebo or other therapies, in randomized controlled trials or controlled clinical trials, and in human subjects only?", "What is the impact of various therapeutic approaches, including Glyburide, Acarbose, Metformin, and other drugs, on gestational diabetes in women? Specifically, how do these treatments affect glycemic control and maternal and fetal outcomes in randomized controlled trials involving female subjects with gestational diabetes?", "What are the therapeutic effects of glyburide, acarbose, metformin, biguanides, sulfonylurea compounds, thiazolidinediones, dipeptidyl-peptidase IV inhibitors, glycoside hydrolase inhibitors, sodium-glucose transporter 2 inhibitors, insulin, glucagon-like peptide 1, exenatide, glipizide, insulin lispro, isophane insulin, insulin glargine, insulins, Xultophy, liraglutide, linagliptin, repaglinide, sitagliptin phosphate, sitagliptin phosphate-metformin hydrochloride drug combination, empagliflozin, dulaglutide, glyburide, glybenclamide, glibenclamide, diabeta, euglucon 5, neogluconin, HB-419, HB-420, maninil, micronase, daonil, euglucon N, acarbose, glumida, glucobay, glucor, Bay g 5421, prandase, precose, metformin, dimethylbiguanidine, dimethylguanylguan"]}
{"id": "7", "boolean": "(\"Life Style\"[Mesh] OR \"Diet\"[Mesh] OR \"Exercise\"[Mesh] OR \"Patient Education as Topic\"[Mesh] OR \"Life Style\"[tiab] OR Lifestyle[tiab] OR Exercise[tiab] OR Counseling[tiab] OR Dietary[tiab] OR Dieting[tiab] OR Educational[tiab] OR \"Patient education\"[tiab] OR \"Eating habits\"[tiab] OR \"Eating patterns\"[tiab] OR \"Weight measurement\"[tiab]) AND (\"Pregnancy Outcome\"[Mesh] OR \"Pregnancy Complications\"[Mesh] OR \"Birth weight\"[Mesh] OR \"Pregnancy Outcome\"[tiab] OR \"Pregnancy Outcomes\"[tiab] OR \"Pregnancy Complications\"[tiab] OR \"Pregnancy Complication\"[tiab] OR ((Pregnancy[Mesh] OR Pregnancy[tiab] OR Gestational[tiab]) AND (\"Weight Gain\"[Mesh] OR \"Weight gain\"[tiab] OR \"Glucose metabolism\"[tiab]))) AND (\"Treatment Outcome\"[Mesh] OR Effect[tiab] OR Effects[tiab] OR Impact[tiab] OR Modify[tiab] OR Decrease[tiab] OR Decreases[tiab] OR Declined[tiab] OR Declines[tiab] OR Reduce[tiab] OR Reducing[tiab] OR Reduces[tiab] OR Reduction[tiab] OR Change[tiab] OR Changes[tiab] OR Differences[tiab] OR Difference[tiab] OR Different[tiab]) AND (\"Risk Reduction Behavior\"[Mesh] OR \"Primary Prevention\"[Mesh] OR \"prevention and control\"[sh] OR Prevent[tiab] OR Prevents[tiab] OR Preventing[tiab] OR Unfavorable[tiab] OR Adverse[tiab] OR Retention[tiab] OR Activity[tiab] OR Capacity[tiab] OR Negative[tiab] OR Restrict[tiab] OR Restricted[tiab] OR Adherence[tiab] OR Assess[tiab] OR Assessed[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh])) NOT (\"Case Reports\"[pt] OR Editorial[pt] OR Letter[pt] OR Meta-Analysis[pt] OR \"Observational Study\"[pt] OR \"Systematic Review\"[pt] OR \"Case Report\"[ti] OR \"Case series\"[ti] OR Meta-Analysis[ti] OR \"Meta Analysis\"[ti] OR \"Systematic Review\"[ti]) AND (\"Life Style\"[ti] OR Lifestyle[ti] OR Exercise[ti] OR Counseling[ti] OR Diet[ti] OR Dietary[ti] OR Dieting[ti] OR Educational[ti] OR \"Patient education\"[ti] OR \"Eating habits\"[ti] OR \"Eating patterns\"[ti] OR \"Weight measurement\"[ti] OR Pregnant[ti] OR \"Pregnancy Outcome\"[ti] OR \"Pregnancy Outcomes\"[ti] OR \"Pregnancy Complications\"[ti] OR \"Pregnancy Complication\"[ti] OR Pregnancy[ti] OR Gestational[ti] OR \"Weight gain\"[ti] OR \"Glucose metabolism\"[ti])", "generated_query": ["What are the effects of lifestyle interventions, including diet, exercise, counseling, patient education, and weight measurement, on pregnancy outcomes, such as birth weight and complications, in pregnant women with or without gestational diabetes, and how do these interventions reduce the risk of unfavorable or adverse outcomes in a randomized controlled trial setting? Exclude animal studies, case reports, editorials, letters, meta-analyses, observational studies, and systematic reviews.", "What is the impact of lifestyle interventions, patient education, and counseling on pregnancy outcomes such as birth weight, pregnancy complications, and glucose metabolism? Can these interventions reduce negative outcomes and prevent adverse effects during pregnancy? What are the treatment outcomes and risk reduction behaviors associated with these interventions in randomized controlled trials?", "What is the impact of lifestyle interventions, including diet, exercise, counseling, patient education, and weight measurement, on pregnancy outcomes, complications, and birth weight, while reducing risk behaviors and promoting primary prevention? Only studies conducted on human subjects, including randomized controlled trials and controlled clinical trials, will be considered, while case reports, editorials, letters, observational studies, systematic reviews, and meta-analyses will be excluded from the search. The query should include terms related to pregnancy and weight gain, such as \"pregnancy outcome,\" \"pregnancy complications,\" \"weight gain,\" and \"glucose metabolism,\" to ensure that all relevant literature is captured.", "What is the impact of lifestyle modifications, patient education, and counseling on pregnancy outcomes and birth weight? Can these interventions reduce the risk of adverse outcomes in pregnant women? Are there any randomized controlled trials that have evaluated the effects of such interventions on weight gain and glucose metabolism during pregnancy?", "What is the impact of lifestyle interventions, patient education, exercise, counseling, and dietary modifications on pregnancy outcomes, specifically birth weight and glucose metabolism? Do these interventions reduce unfavorable outcomes and promote risk reduction behavior in pregnant women? Only randomized controlled trials and controlled clinical trials involving pregnant women and excluding animal studies, case reports, editorials, letters, observational studies, and systematic reviews will be considered.", "What are the effects of lifestyle interventions, including diet, exercise, counseling, and patient education, on pregnancy outcomes and complications, birth weight, glucose metabolism, and weight gain in pregnant women? Are there any primary prevention strategies, such as risk reduction behaviors, that can modify or decrease unfavorable outcomes and adverse effects during pregnancy? The search should include only randomized controlled trials and controlled clinical trials involving pregnant women, excluding case reports, editorials, letters, meta-analyses, observational studies, and systematic reviews.", "What are the effects of lifestyle modifications, such as dietary changes, exercise, counseling, and patient education, on pregnancy outcomes, including birth weight and pregnancy complications? Additionally, how can these modifications reduce negative risks and improve primary prevention, and what is the impact of these modifications on treatment outcomes? Only relevant results from randomized controlled trials or controlled clinical trials on pregnant individuals, excluding animal studies, case reports, editorials, letters, observational studies, systematic reviews, and meta-analyses, will be considered.", "What are the treatment outcomes and risk reduction behaviors associated with lifestyle interventions, such as diet, exercise, counseling, and patient education, for pregnant women to prevent unfavorable pregnancy outcomes, pregnancy complications, and abnormal birth weight? Specifically, how do these interventions modify or reduce negative effects on glucose metabolism and weight gain? The search should be limited to randomized controlled trials involving pregnant women, excluding animal studies, case reports, meta-analyses, systematic reviews, and non-relevant articles.", "What are the treatment outcomes and risk reduction behaviors for pregnant women that modify or reduce the unfavorable effects of lifestyle, diet, exercise, and patient education on pregnancy outcomes, pregnancy complications, birth weight, and glucose metabolism? The search should include randomized controlled trials and controlled clinical trials in human subjects, while excluding animals and non-relevant study types. Relevant keywords and MeSH terms include lifestyle, exercise, counseling, diet, patient education, pregnancy outcomes, pregnancy complications, birth weight, weight gain, glucose metabolism, and primary prevention.", "\"What is the impact of lifestyle interventions such as dietary modifications, exercise, counseling, and patient education on pregnancy outcomes, including birth weight and pregnancy complications, while reducing the risk of negative behavior and adverse effects in pregnant women? Only randomized controlled trials and controlled clinical trials should be included in the search, and animal studies and non-relevant publications such as case reports, editorials, letters, and meta-analyses should be excluded. The query should also consider terms such as pregnancy, gestational, weight gain, glucose metabolism, and eating habits.\""]}
{"id": "67", "boolean": "(((\"Diabetes, Gestational\"[Mesh] OR Diabetes[tiab]) AND (\"Pregnancy\"[Mesh] OR Pregnancy[tiab] OR Pregnant[tiab] OR Pregnancies[tiab] OR Gestation[tiab] OR Gestational[tiab])) OR ((\"Pregnancy\"[Mesh] OR Pregnancy[tiab] OR Pregnant[tiab] OR Pregnancies[tiab] OR Gestation[tiab] OR Gestational[tiab]) AND (\"Obesity\"[Mesh] OR Obesity[tiab] OR Obese[tiab]))) AND (\"Life Style\"[Mesh] OR \"Insulin\"[Mesh] OR Metformin[Mesh] OR \"Life Style Intervention\"[tiab] OR \"Lifestyle Intervention\"[tiab] OR \"Exercise intervention\"[tiab] OR Metformin[tiab] OR \"Insulin sensitising\"[tiab] OR \"Lifestyle counseling\"[tiab] OR \"Glucose tolerance\"[tiab] OR \"Antenatal care \"[tiab] OR \"Dietary management\"[tiab]) AND (\"Treatment Outcome\"[Mesh] OR \"Pregnancy Outcome\"[Mesh] OR \"Pregnancy Complications\"[Mesh] OR \"Morbidity\"[Mesh] OR Prevention[tiab] OR Prevent[tiab] OR Preventing[tiab] OR \"Insulin resistance\"[tiab] OR Incidence[tiab] OR Prevalence[tiab] OR ((Improved[tiab] OR Adverse[tiab] OR Obstetric[tiab] OR Pregnancy[tiab]) AND (Outcome[tiab] OR Outcomes[tiab]))) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh]))", "generated_query": ["What are the treatment outcomes of randomized controlled trials investigating the effectiveness of lifestyle interventions, insulin, and metformin on improving pregnancy outcomes and preventing pregnancy complications in women with gestational diabetes or diabetes during pregnancy who are obese or have a high-risk pregnancy, and receiving antenatal care, dietary management, and glucose tolerance monitoring? The query should exclude non-human studies.", "Can lifestyle interventions, insulin, and metformin improve pregnancy outcomes in women with gestational diabetes or obesity? What are the treatment outcomes, morbidity, incidence, and prevalence of these interventions in randomized controlled trials conducted on pregnant women? Exclude studies conducted on animals.", "What are the best interventions for preventing or treating gestational diabetes in pregnant women with obesity or a history of diabetes? Specifically, I am looking for randomized controlled trials and controlled clinical trials that investigate lifestyle interventions, insulin, metformin, insulin sensitizing treatments, lifestyle counseling, antenatal care, dietary management, glucose tolerance, and exercise interventions, and report on treatment outcomes, pregnancy outcomes, morbidity, incidence, prevalence, improved or adverse obstetric or pregnancy outcomes. The search should exclude studies that involve animals.", "Can lifestyle interventions, insulin and metformin treatments, and antenatal care improve pregnancy and treatment outcomes for women with gestational diabetes or obesity during pregnancy in randomized controlled trials, while excluding animal studies?", "What are the treatment outcomes and prevention strategies for gestational diabetes and obesity during pregnancy, using lifestyle interventions such as exercise, insulin sensitising, glucose tolerance, antenatal care, and dietary management? Specifically, what are the pregnancy outcomes and morbidity rates associated with these interventions? The search should only include randomized controlled trials and controlled clinical trials, and exclude studies involving animals.", "What are the outcomes of randomized controlled trials assessing the effectiveness of lifestyle interventions, insulin, metformin, or other glucose-lowering therapies in preventing or managing gestational diabetes, obesity, or other pregnancy complications? The search should include studies involving pregnant women or those planning to conceive and should exclude animal studies.", "What lifestyle interventions, insulin sensitizing agents, and antenatal care treatments have been effective in preventing or improving pregnancy outcomes in women with gestational diabetes or obesity during pregnancy, as evaluated in randomized controlled trials with human subjects?", "What is the effectiveness of lifestyle interventions, insulin, metformin, and dietary management in the prevention and treatment outcomes of gestational diabetes in pregnant women with obesity or diabetes? Are there any randomized controlled trials investigating the incidence, prevalence, morbidity, improved or adverse obstetric or pregnancy outcomes, or insulin resistance in this population? (Note: Please exclude animal studies from the search results.)", "What lifestyle interventions, medications, and treatment outcomes have been studied for gestational diabetes and obesity during pregnancy, in randomized controlled trials involving humans?", "What are the most effective interventions for preventing gestational diabetes and obesity during pregnancy, and what are the treatment and pregnancy outcomes associated with these interventions? Please retrieve only randomized controlled trials and controlled clinical trials that involve humans and exclude studies on animals. The search terms should include \"Diabetes, Gestational\", \"Pregnancy\", \"Obesity\", \"Life Style\", \"Insulin\", \"Metformin\", \"Treatment Outcome\", \"Pregnancy Outcome\", \"Pregnancy Complications\", \"Morbidity\", \"Prevention\", \"Insulin resistance\", \"Incidence\", \"Prevalence\", \"Randomized controlled trial\", and \"controlled clinical trial\"."]}
{"id": "44", "boolean": "(\"Acne Vulgaris\"[Mesh] OR Acne[tiab] OR Blackheads[tiab] OR Whiteheads[tiab] OR Pimples[tiab]) AND (\"Phototherapy\"[Mesh] OR \"Blue light\"[tiab] OR Phototherapy[tiab] OR Phototherapies[tiab] OR \"Photoradiation therapy\"[tiab] OR \"Photoradiation Therapies\"[tiab] OR \"Light Therapy\"[tiab] OR \"Light Therapies\"[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh]))", "generated_query": ["\"What is the efficacy of phototherapy, including blue light and other forms of light therapy, versus drug therapy or placebo in treating acne vulgaris, blackheads, whiteheads, and pimples in human randomized controlled trials and controlled clinical trials, excluding studies involving animals?\"", "What is the effectiveness of phototherapy, blue light, and light therapy in treating acne vulgaris, blackheads, whiteheads, and pimples? Only randomized controlled trials, controlled clinical trials, and trials involving human participants will be considered, while excluding studies involving animals.", "Can phototherapy or light therapy improve the symptoms of acne vulgaris, blackheads, whiteheads, and pimples in a randomized controlled trial or controlled clinical trial without the use of animal subjects?", "What is the effectiveness of phototherapy, including blue light and other phototherapies, compared to drug therapy or placebo in the treatment of acne vulgaris, blackheads, whiteheads, and pimples, as assessed through randomized controlled trials or controlled clinical trials, excluding studies involving animals?", "What is the efficacy of phototherapy, blue light, phototherapies, or light therapies for treating acne vulgaris, blackheads, whiteheads, or pimples in randomized controlled trials or controlled clinical trials with human participants, while excluding any studies involving animals?", "What is the efficacy of phototherapy, blue light, or light therapies in the treatment of acne vulgaris, blackheads, whiteheads, and pimples in human randomized controlled trials or controlled clinical trials, while excluding studies conducted on animals?", "What is the efficacy of phototherapy or light therapy as drug therapy for treating acne vulgaris, blackheads, whiteheads, or pimples in randomized controlled trials, controlled clinical trials, or placebo-controlled trials, excluding studies conducted on animals?", "What is the effectiveness of phototherapy or light therapy in treating acne vulgaris, blackheads, whiteheads, or pimples, as evidenced by randomized controlled trials or controlled clinical trials, excluding studies involving animals?", "What is the efficacy of phototherapy, including blue light and other phototherapies, for treating acne vulgaris, blackheads, whiteheads, and pimples, as evaluated by randomized controlled trials, controlled clinical trials, and placebo-controlled trials conducted on human subjects? Exclude studies involving animals.", "What is the effectiveness of phototherapy, blue light, or light therapies in treating acne vulgaris, blackheads, whiteheads, or pimples in randomized controlled trials or controlled clinical trials, while excluding studies on animals?"]}
{"id": "105", "boolean": "(\"Lower Urinary Tract Symptoms\"[Mesh] OR \"Prostatic Hyperplasia\"[Mesh] OR \"Urinary tract symptoms\"[tiab] OR LUTS[tiab] OR Dysuria[tiab] OR Nocturia[tiab] OR Prostatism[tiab] OR \"Overactive bladder\"[tiab] OR \"Underactive bladder\"[tiab] OR \"Urinary Incontinence\"[tiab] OR \"Urinary Stress\"[tiab] OR \"Urinary Urge\"[tiab] OR \"Painful Urination\"[tiab] OR \"Frequent Urination\"[tiab] OR Nycturia[tiab] OR \"Urge Incontinence\"[tiab] OR \"Prostatic Hypertrophy\"[tiab] OR \"Prostatic Hyperplasia\"[tiab] OR \"Prostatic Adenomas\"[tiab] OR \"Prostatic Adenoma\"[tiab]) AND ( \"Self Care\"[Mesh] OR \"Behavior Therapy\"[Mesh] OR \"Life Style\"[Mesh] OR \"Self care\"[tiab] OR \"Self management\"[tiab] OR Self-management[tiab] OR SMP[tiab] OR Behavioral[tiab] OR Behavioural[tiab] OR \"Education\"[tiab] OR \"Fluid management\"[tiab] OR \"Bladder retraining\"[tiab] OR \"Bladder re-training\"[tiab] OR \"Toileting\"[tiab] OR \"Toilet training\"[tiab] OR \"Fluid input\"[tiab] OR \"Fluid manipulation\"[tiab] OR Lifestyle[ti] OR \"Life style\"[ti] OR Lifestyles[ti] OR \"Life styles\"[ti] OR ((Avoid[tiab] OR Avoiding[tiab]) AND (Constipation[tiab])) OR ((\"Fluid intake\"[tiab]) AND (Increase[tiab] OR Increasing[tiab] OR Decrease[tiab] OR Decreasing[tiab] OR Modify[tiab] OR Modifying[tiab])) OR ((\"Pelvic floor\"[tiab]) AND (training[tiab] OR exercise[tiab] OR exercises[tiab])) ) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh])) NOT (Female[Mesh] not (female[Mesh] and male[Mesh]))", "generated_query": ["\"Which self-care, behavior therapy, and lifestyle interventions have been studied in randomized controlled trials for improving lower urinary tract symptoms, including prostatic hyperplasia, urinary incontinence, and overactive bladder, in male patients, without involving animal studies?\"", "\"Can self-care interventions, behavior therapy, and lifestyle modifications improve lower urinary tract symptoms in men with prostatic hyperplasia or other urinary tract symptoms? Specifically, I am looking for randomized controlled trials or controlled clinical trials that investigate the effectiveness of self-management, bladder retraining, toileting, fluid management, and pelvic floor exercises in improving urinary symptoms, excluding studies on animals or only including female participants.\"", "What are the most effective self-care, behavior therapy, and lifestyle interventions for managing lower urinary tract symptoms such as prostatic hyperplasia, urinary incontinence, painful urination, and frequent urination in men? I am particularly interested in randomized controlled trials that focus on fluid management, bladder retraining, toilet training, pelvic floor exercises, and avoiding constipation. Please exclude studies on animals and females.", "What are the most effective self-care, behavior therapy, and lifestyle interventions for managing lower urinary tract symptoms, prostatic hyperplasia, urinary tract symptoms, LUTS, dysuria, nocturia, prostatism, overactive bladder, underactive bladder, urinary incontinence, urinary stress, urinary urge, painful urination, frequent urination, nycturia, urge incontinence, prostatic hypertrophy, prostatic hyperplasia, prostatic adenomas, and prostatic adenoma in adult men, as evaluated by randomized controlled trials and controlled clinical trials, while excluding studies involving animals or females?", "What are the randomized controlled trials that evaluate the effectiveness of self-care interventions, behavior therapy, lifestyle modifications, and bladder training in managing lower urinary tract symptoms, prostatic hyperplasia, urinary incontinence, and other urinary tract symptoms in men, while excluding studies that involve animals or only women, and that involve drug therapy, placebo, or other non-randomized designs?", "What randomized controlled trials and controlled clinical trials have been conducted on the effectiveness of self-care, behavioral therapy, and lifestyle modifications in managing lower urinary tract symptoms, including prostatic hyperplasia, urinary incontinence, painful urination, frequent urination, and overactive bladder in male patients? Exclude studies involving animals and studies focused solely on female patients.", "\"Can self-care, behavioral therapy, and lifestyle modifications improve lower urinary tract symptoms such as dysuria, nocturia, urinary incontinence, and prostatic hyperplasia in men? Please only include randomized controlled trials and exclude studies conducted on animals or only female populations.\"", "What is the effectiveness of self-care and behavioral therapy, including lifestyle modifications, fluid management, bladder retraining, and pelvic floor exercises, in the treatment of lower urinary tract symptoms, prostatic hyperplasia, urinary incontinence, and other urinary tract symptoms? Are there any randomized controlled trials or controlled clinical trials on this topic? The search should exclude studies conducted on animals or only involving females.", "What are the randomized controlled trials that investigate the effectiveness of self-care, behavior therapy, lifestyle modification, and bladder retraining in managing lower urinary tract symptoms, prostatic hyperplasia, urinary incontinence, painful urination, frequent urination, and other related urinary symptoms?", "What are the self-care and behavior therapy interventions that can improve lower urinary tract symptoms, prostatic hyperplasia, urinary incontinence, painful urination, frequent urination, and other related conditions in men? Specifically, I am looking for randomized controlled trials that focus on self-management strategies, education, fluid management, bladder retraining, toileting, pelvic floor training, and lifestyle modifications for men with these conditions. The search should exclude studies that involve animals or females."]}
{"id": "12", "boolean": "(\"Urinary Tract Infections\"[Mesh] OR \"Cystitis\"[Mesh] OR \"Bacteriuria\"[Mesh] OR \"Urinary Tract Infections\"[tiab] OR \"Urinary Tract Infection\"[tiab] OR UTIs[tiab] OR UTI[tiab] OR Cystitis[tiab] OR Bacteriuria[tiab]) AND (\"Methenamine hippurate\"[Supplementary Concept] OR \"Methenamine\"[Mesh] OR \"Hippurates\"[Mesh] OR Hexamine[tiab] OR Hippurate[tiab] OR Hippurates[tiab] OR Urex[tiab] OR Hiprex[tiab] OR Hip-Rex[tiab] OR Urotractan[tiab] OR Hexamethylenetetramine[tiab] OR Methenamine[tiab] OR Urotropin[tiab] OR Aminoform[tiab] OR \"Hippuric acid\"[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR \"therapeutic use\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh]))", "generated_query": ["Can methenamine hippurate or related compounds be effective in treating urinary tract infections or cystitis in human randomized controlled trials or controlled clinical trials, excluding studies on animals?", "What are the results of randomized controlled trials or controlled clinical trials evaluating the therapeutic effectiveness of Methenamine hippurate, Methenamine, Hippurates, Hexamine, Hippurate, Urex, Hiprex, Hip-Rex, Urotractan, Hexamethylenetetramine, Urotropin, Aminoform, or Hippuric acid for the treatment of Urinary Tract Infections, Cystitis, or Bacteriuria in humans? Exclude studies involving animals.", "What is the effectiveness of methenamine hippurate for the treatment of urinary tract infections, cystitis, and bacteriuria in randomized controlled trials or controlled clinical trials, excluding studies on animals?", "What is the effectiveness of methenamine hippurate or related compounds in treating urinary tract infections in humans, based on randomized controlled trials or controlled clinical trials?", "What is the effectiveness of methenamine hippurate in treating urinary tract infections, cystitis, or bacteriuria in human subjects as demonstrated in randomized controlled trials or controlled clinical trials, while excluding studies involving animals?", "What is the effectiveness of methenamine hippurate for treating urinary tract infections (UTIs), cystitis, and bacteriuria in human randomized controlled trials or controlled clinical trials, while excluding studies involving animals?", "What is the efficacy of methenamine hippurate or related compounds in treating urinary tract infections or cystitis in humans, as determined by randomized controlled trials or controlled clinical trials, excluding studies conducted on animals?", "What is the effectiveness of methenamine hippurate for the treatment of urinary tract infections, cystitis, and bacteriuria in humans, based on randomized controlled trials and controlled clinical trials, without including animal studies?", "Can methenamine hippurate or other related drugs be effective in the treatment of urinary tract infections or cystitis in human randomized controlled trials or clinical trials, without including animal studies?", "What are the most effective treatments for urinary tract infections, cystitis, and bacteriuria in humans, as studied in randomized controlled trials and controlled clinical trials, using methenamine hippurate, methenamine, hippurates, hexamine, hippurate, hippurates, urex, hiprex, hip-rex, urotractan, hexamethylenetetramine, urotropin, aminoform, or hippuric acid, while excluding studies on animals?"]}
{"id": "2", "boolean": "(\"Prognosis\"[Mesh] OR \"Natural history\"[tiab] OR \"Natural course\"[tiab] OR \"Clinical course\"[tiab] OR \"Watchful waiting\"[tiab] OR ((Symptom[tiab] OR Symptoms[tiab]) AND (Duration[tiab])) OR \"Wait and see\"[tiab] OR \"Active monitoring\"[tiab] OR Prognosis[tiab]) AND (Communication[tiab] OR Communicate[tiab] OR Framing[tiab] OR Discuss[tiab] OR \"Shared decision making\"[tiab] OR Presented[tiab] OR Perceptions[tiab] OR Perceive[tiab] OR Perceived[tiab]) AND (\"Decision Support Techniques\"[Mesh] OR \"Decision Making\"[Mesh] OR \"Decision Making, Shared\"[Mesh] OR \"Decision aid\"[tiab] OR \"Decision tool\"[tiab] OR Decision[tiab] OR Decisions[tiab]) AND (Graph[tiab] OR Graphs[tiab] OR Graphic[tiab] OR Graphics[tiab] OR Graphical[tiab] OR Chart[tiab])", "generated_query": ["Can decision support techniques that utilize graphical representations improve shared decision-making and communication about the natural history, prognosis, or clinical course of a medical condition?", "What are the natural history, clinical course, and prognosis of a condition or disease, and how does communication, decision making, and graphical representations impact shared decision making using decision support techniques and aids?", "\"What is the impact of communication and decision support techniques using graphical representation on the natural history, clinical course, and prognosis of medical conditions, as well as patients' perceptions and shared decision making?\"", "What is the effectiveness of decision support techniques that utilize communication strategies such as shared decision making and framing, and graphical aids like graphs and charts, in improving clinical prognosis, natural history, and the clinical course of symptoms with a focus on patient perceptions and decision making?", "What is the effectiveness of utilizing natural history, clinical course, and prognosis, as well as communication and decision-making techniques, in presenting information through graphical aids or charts for shared decision making and perceptions of patients?", "What is the effectiveness of decision support techniques that use graphical representations in communicating prognosis, natural history, clinical course, and symptom duration to patients and supporting shared decision making?", "\"What is the effectiveness of decision support techniques using graphical representation in communicating prognosis or natural history to patients for shared decision making?\"", "Can decision support techniques using graphical representation improve communication and shared decision making in patients with prognosis, natural history, or clinical course concerns?", "What is the impact of communication strategies, decision support techniques, and graphical aids on the prognosis or natural history of a disease or condition, as well as on patients' perceptions and decision making?", "What are the most effective communication and decision-making techniques for patients with various medical conditions, including natural history or clinical course, symptom duration, watchful waiting, active monitoring, and prognosis, that are presented using graphical aids such as graphs, graphics, and charts?"]}
{"id": "3", "boolean": "(\"Copper\"[Mesh] OR Copper[tiab]) AND (\"Infections\"[Mesh] OR \"Equipment Contamination\"[Mesh] OR \"Infection Control\"[Mesh] OR \"Cross Infection\"[Mesh] OR Infection[tiab] OR Infections[tiab] OR Colonization[tiab]) AND (\"Health Facilities\"[Mesh] OR Hospital[tiab] OR Hospitals[tiab] OR \"Healthcare facility\"[tiab] OR \"Healthcare facilities\"[tiab] OR  \"Intensive care\"[tiab] OR \"Intensive-care\"[tiab] OR ICU[tiab] OR PICU[tiab] OR Ward[tiab] OR Wards[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR Control[tiab] OR Controlled[tiab] OR Comparing[tiab] OR Compared[tiab]) NOT  (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh])) NOT (\"Case Reports\"[pt] OR Editorial[pt] OR Letter[pt] OR \"Comment\"[pt] OR Meta-Analysis[pt] OR \"Observational Study\"[pt] OR \"Systematic Review\"[pt] OR \"Case Report\"[ti] OR \"Case series\"[ti] OR Meta-Analysis[ti] OR \"Meta Analysis\"[ti] OR \"Systematic Review\"[ti])", "generated_query": ["What are the randomized controlled trials and controlled clinical trials that investigate the relationship between copper and the prevention of infections or equipment contamination in healthcare facilities such as hospitals, intensive care units, and wards, while excluding studies on animals or that fall under case reports, editorials, letters, comments, meta-analyses, observational studies, systematic reviews, case reports, case series, meta-analyses, and systematic reviews?", "What is the efficacy of copper in preventing infections or contamination of healthcare facilities, including hospitals, wards, and intensive care units, in randomized controlled trials, excluding animal studies and non-experimental articles?", "What is the effectiveness of copper in preventing infections in healthcare facilities, including intensive care units and wards, based on randomized controlled trials and controlled clinical trials, while excluding animal studies, case reports, editorials, letters, commentaries, observational studies, systematic reviews, case series, and meta-analyses?", "What is the efficacy of copper in preventing or treating infections or contamination in healthcare facilities, including intensive care units and hospital wards, as demonstrated in randomized controlled trials? Exclude studies on animals or those categorized as case reports, editorials, letters, comments, meta-analyses, observational studies, case series, or systematic reviews.", "What is the effectiveness of copper in preventing infections in healthcare facilities, specifically in intensive care units and wards, as shown in randomized controlled trials and controlled clinical trials, while excluding studies on animals and non-randomized studies?", "What is the effectiveness of copper in preventing infections and contamination in healthcare facilities, particularly in intensive care units and hospital wards, as evidenced by randomized controlled trials and controlled clinical trials, while excluding animal studies and non-original articles?", "What is the effectiveness of copper in preventing infections or controlling contamination in healthcare facilities such as hospitals, ICUs, and wards, based on randomized controlled trials and controlled clinical trials, excluding animal studies and non-relevant article types such as case reports, editorials, letters, comments, observational studies, systematic reviews, case series, and meta-analyses?", "What is the effectiveness of using copper for infection control in healthcare facilities, specifically in the intensive care units and wards, based on randomized controlled trials and controlled clinical trials, excluding animal studies and non-relevant document types such as case reports, editorials, letters, comments, meta-analyses, observational studies, and systematic reviews?", "What is the effectiveness of copper in preventing infections in healthcare facilities, particularly in intensive care units, as shown in randomized controlled trials, while excluding animal studies and non-experimental research?", "What are the results of randomized controlled trials investigating the effectiveness of copper in preventing infections in healthcare facilities, specifically in intensive care units, wards, and hospitals? Exclude studies that involve animals or have study designs of case reports, editorials, letters, comments, observational studies, systematic reviews, case series, or meta-analyses."]}
{"id": "13", "boolean": "(\"Resource Allocation\"[Mesh] OR Resource[tiab] OR Resources[tiab] OR Allocation[tiab] OR Demand[tiab] OR \"Prognostic certainty\"[tiab] OR \"External validation\"[tiab] OR Prognosticative[tiab] OR Prognosticating[tiab] OR \"Validation cohort\"[tiab]) AND (\"Decision rule\"[tiab] OR \"Decision Support\"[tiab] OR Prediction[tiab] OR Predictions[tiab] OR Predictor[tiab] OR Predicting[tiab] OR Predictive[tiab] OR \"Scoring systems\"[tiab] OR \"Scoring system\"[tiab] OR \"Decision making\"[tiab] OR \"Preparedness strategies\"[tiab] OR \"Preparedness strategy\"[tiab] OR \"Prioritization Criteria\"[tiab] OR \"Prioritizing access\"[tiab] OR \"Consensus Statement\"[tiab] OR \"Categorization decisions\"[tiab] OR \"Allocation decisions\"[tiab] OR \"Clinical guidelines\"[tiab]) AND (\"Triage\"[Mesh] OR \"Patient Selection\"[Mesh] OR Triage[tiab] OR Triaging[tiab] OR Admission[tiab] OR Discharge[tiab] OR \"Incident management\"[tiab] OR \"Treatment priority\"[tiab] OR \"Patient volumes\"[tiab] OR ((Managing[tiab]) AND (Cohort[tiab])) OR (Calculators[tiab] AND Patients[tiab])) AND (\"Emergency Medical Services\"[Mesh] OR \"Critical Care\"[Mesh] OR \"Intensive Care Units\"[Mesh] OR \"Intensive care\"[tiab] OR \"Critical care\"[tiab] OR ICU[tiab] OR PICU[tiab] OR \"Critically ill\"[tiab] OR \"Life saving\"[tiab] OR Life-saving[tiab] OR Life-sustaining[tiab] OR \"Life sustaining\"[tiab] OR \"Life support\"[tiab] OR \"Short-term death\"[tiab] OR \"Short term death\"[tiab] OR \"Death prediction\"[tiab] OR Hospital[tiab] OR Hospitals[tiab] OR \"Emergency department\"[tiab] OR \"Emergency departments\"[tiab]) AND (\"Pandemics\"[Mesh] OR Disasters[Mesh] OR \"Hospital Mortality\"[Mesh] OR \"COVID-19\" OR Pandemic[tiab] OR Pandemics[tiab] OR Disaster[tiab] OR Disasters[tiab] OR \"SARS CoV 2\"[tiab] OR \"COVID 19\"[tiab] OR \"COVID-19\"[tiab] OR \"Mass casualty\"[tiab] OR \"Severe sepsis\"[tiab] OR \"Septic shock\"[tiab] OR \"Short-term mortality\"[tiab])", "generated_query": ["What are the best resource allocation, decision-making, and triage strategies for emergency medical services, critical care, and hospitals during pandemics and disasters such as COVID-19? How do prediction models, scoring systems, and prioritization criteria impact short-term mortality and hospital mortality in critically ill patients, and what consensus statements or clinical guidelines are available to guide categorization and allocation decisions?", "What are the decision-making strategies, patient triage methods, and resource allocation protocols used in emergency medical services, critical care, and hospital settings during pandemics, disasters, and specifically COVID-19 to predict short-term mortality and prioritize patient access to life-saving treatments, while using scoring systems, clinical guidelines, and preparedness strategies for managing patient volumes and categorization decisions?", "What decision-making strategies, preparedness plans, prioritization criteria, and patient selection tools have been utilized in resource allocation, triage, and treatment prioritization in emergency medical services, critical care units, hospitals, and emergency departments during pandemics, disasters, and specifically COVID-19, to predict short-term mortality and improve life-saving outcomes?", "What are the best resource allocation and decision-making strategies, scoring systems, and prioritization criteria for triaging critically ill patients in emergency medical services, critical care, and intensive care units during pandemics, disasters, or COVID-19 outbreaks, while predicting short-term mortality, reducing hospital mortality, and improving preparedness strategies and patient outcomes?", "What are the best resource allocation strategies, decision-making tools, and triage protocols for emergency medical services, critical care, and hospitals during pandemics, disasters, and specifically COVID-19, to predict short-term mortality, prioritize patient access, and improve preparedness strategies?", "What are the most effective resource allocation decision-making and patient triage strategies for critically ill patients in emergency medical services, intensive care units, hospitals, and emergency departments during pandemics and disasters such as COVID-19, SARS CoV 2, severe sepsis, septic shock, and mass casualty incidents, as supported by decision rules, prediction models, scoring systems, preparedness strategies, prioritization criteria, categorization decisions, clinical guidelines, and consensus statements?", "What are the decision rules, preparedness strategies, and prioritization criteria for triage, patient selection, and resource allocation in emergency medical services and critical care during pandemics and disasters such as COVID-19, with a focus on predicting short-term mortality and external validation of scoring systems and clinical guidelines?", "What are the best resource allocation and decision-making strategies for triage and patient selection in emergencies and critical care situations, such as pandemics, disasters, and COVID-19, while considering scoring systems, preparedness strategies, prioritization criteria, and categorization decisions, as well as short-term mortality, life-saving measures, and validation cohorts in hospitals, emergency departments, and intensive care units?", "What are the prioritization criteria, decision rules, and preparedness strategies for resource allocation in emergency medical services, critical care, and hospitals during pandemics, disasters, and COVID-19, with emphasis on patient triage, prediction of short-term mortality, and decision-making support?", "What are the best resource allocation decision rules and preparedness strategies for patient triage and prioritization criteria in emergency medical services, critical care, and hospital settings during pandemics and disasters, with a focus on predicting short-term mortality rates and validating scoring systems and clinical guidelines for life-saving interventions and treatments for COVID-19, SARS CoV-2, severe sepsis, and septic shock?"]}
{"id": "66", "boolean": "(Aged[Mesh] OR Elderly[tiab] OR Older[tiab] OR decision-makers[tiab] OR Surrogates[tiab] OR Patients[tiab] OR Carers[tiab]) AND (\"Terminal Care\"[Mesh] OR \"Palliative Care\"[Mesh] OR \"Frail Elderly\"[Mesh] OR \"End of life\"[tiab] OR \"Last year of life\"[tiab] OR \"Limited life\"[tiab] OR Frail[tiab] OR Death[tiab] OR Dying[tiab] OR Palliative[tiab] OR \"Intensive care\"[tiab]) AND (\"Patient Preference\"[Mesh] OR Perception[tiab] OR perspective[tiab] OR perceived[tiab] OR experience[tiab] OR Experiences[tiab] OR opinion[tiab] OR views[tiab] OR satisfaction[tiab] OR discordance[tiab] OR discrepancy[tiab] OR dissonance[tiab]) AND (Consultation[tiab] OR Communication[tiab] OR \"focus groups\"[tiab] OR \"Focus group\"[tiab]) AND (\"Surveys and Questionnaires\"[Mesh] OR \"Interviews as Topic\"[Mesh] OR Qualitative[tiab] OR Surveys[tiab] OR questionnaires[tiab] OR Interview[tiab] OR Interviews[tiab] OR Survey[tiab] OR \"Thematic analysis\"[tiab])", "generated_query": ["What are the patient preferences and perspectives regarding communication and consultation at the end of life for aged, elderly, and older patients, as well as their surrogates, carers, and decision-makers, receiving terminal or palliative care, and how are these experiences perceived and measured using surveys, questionnaires, interviews, and thematic analysis, including discordance, discrepancy, and dissonance?", "What are the preferences, perceptions, and experiences of aged individuals, decision-makers, surrogates, patients, and carers in regards to terminal care, palliative care, and end-of-life issues? How do consultation, communication, and focus groups impact these preferences and experiences? What are the results of surveys, questionnaires, interviews, and qualitative thematic analysis in understanding these topics?", "What are the preferences and perspectives of aged individuals, decision-makers, surrogates, patients, and carers towards terminal and palliative care for the frail elderly and those in the last year of life? How do communication and consultation, including focus groups, impact their perception and satisfaction? What is the qualitative data, including surveys, questionnaires, and interviews, on their experiences, opinions, and views, with regards to end-of-life care, death, dying, and intensive care? Additionally, how is thematic analysis utilized in understanding the discrepancy, discordance, and dissonance in their preferences?", "What are the experiences and perspectives of aged patients, decision-makers, surrogates, and carers regarding terminal care, palliative care, and end-of-life issues? How does consultation, communication, and focus groups influence their perception, satisfaction, and preference? What is the role of surveys, questionnaires, interviews, and thematic analysis in investigating these issues qualitatively?", "What are the patient preferences and perceptions of communication during end-of-life care for aged individuals, frail elderly, and those in limited life? How can consultation and focus groups improve satisfaction and reduce discordance and discrepancy in care? Are qualitative methods such as surveys, questionnaires, and interviews with thematic analysis effective in understanding the perspectives and experiences of decision-makers, surrogates, patients, and carers in palliative care settings?", "What are the preferences, perceptions, and experiences of aged individuals, decision-makers, surrogates, patients, and carers regarding terminal care, palliative care, frail elderly, end-of-life, limited life, frailty, death, dying, palliative care, and intensive care, as expressed through consultation, communication, focus groups, and surveys and questionnaires using qualitative methods such as thematic analysis?", "What are the perceptions and preferences of patients, decision-makers, surrogates, and carers towards terminal care, palliative care, and end-of-life issues in older adults who are frail, dying, or have limited life expectancy? How do they experience communication and consultation with healthcare providers, including focus groups, surveys, questionnaires, and qualitative interviews, and what are their views on satisfaction, discordance, discrepancy, and dissonance?", "What are the patient and caregiver perspectives and preferences on end-of-life care for the elderly and frail, including those in intensive care, and how are these communicated and addressed through consultations, communication, and focus groups? Additionally, what qualitative methods, such as surveys, questionnaires, and thematic analysis, have been used to explore these perspectives and preferences?", "What are the patient preferences and experiences, perceptions, and views of aged individuals, decision-makers, surrogates, patients, and carers in relation to terminal care, palliative care, frail elderly, end of life, last year of life, limited life, frailty, death, dying, palliative, and intensive care? What role do consultation, communication, and focus groups play in gathering these perspectives? How can qualitative methods, such as surveys, questionnaires, interviews, and thematic analysis, help in understanding these perspectives?", "What are the preferences, perceptions, experiences, opinions, views, satisfaction, discordance, and discrepancy of aged individuals, decision-makers, surrogates, patients, and carers regarding terminal care, palliative care, frail elderly, end of life, last year of life, limited life, frailty, death, dying, palliation, and intensive care? How do consultations, communication, and focus groups influence these perspectives? What are the results of surveys, questionnaires, interviews, and thematic analysis in understanding the qualitative aspects of these issues?"]}
{"id": "14", "boolean": "(\"COVID-19\"[Supplementary Concept] OR \"COVID-19\"[tiab] OR COVID19[tiab] OR \"COVID 19\"[tiab] OR \"SARS-CoV-2\"[tiab] OR \"2019-nCoV\"[tiab] OR \"Novel coronavirus\"[tiab] OR \"Coronavirus 2019\"[tiab] OR \"Coronavirus 19\"[tiab] OR \"COVID 2019\"[tiab] OR \"2019 ncov\"[tiab] OR \"Wuhan coronavirus\"[tiab]) AND (((Pandemic[ti] OR Pandemics[ti] OR Outbreak[ti] OR Outbreaks[ti] OR Hospital[ti] OR Hospitals[ti] OR Emergency[ti] OR Surgery[ti] OR Surgical[ti] OR Department[ti] OR Departments[ti] OR Unit[ti] OR Units[ti] OR Clinic[ti] OR Clinics[ti] OR \"Primary care\"[ti]) AND (Admission[ti] OR Admissions[ti] OR Visit[ti] OR Visits[ti] OR Attendance[ti] OR Attending[ti] OR Activity[ti] OR Utilization[ti] OR Utilisation[ti] OR Impact[ti] OR Impacts[ti] OR Reduction[ti] OR Reductions[ti] OR Decrease[ti] OR Decreases[ti] OR Decreased[ti] OR Decline[ti] OR Decline[ti] OR Change[ti] OR Changes[ti] OR Increase[ti] OR Increases[ti] OR Increased[ti])) OR ((Pandemic[tiab] OR Pandemics[tiab] OR Outbreak[tiab] OR Outbreaks[tiab]) AND (((Hospital[tiab] OR Hospitals[tiab] OR Emergency[tiab] OR Surgery[tiab] OR Surgical[tiab] OR Department[tiab] OR Departments[tiab] OR Unit[tiab] OR Units[tiab] OR Clinic[tiab] OR Clinics[tiab] OR \"Primary care\"[tiab] OR Telemedicine[tiab] OR Telehealth[tiab]) AND (Admission[tiab] OR Admissions[tiab] OR Visit[tiab] OR Visits[tiab] OR Attendance[tiab] OR Attending[tiab] OR Activity[tiab] OR Utilization[tiab] OR Utilisation[tiab])) OR (Prescriptions[tiab] OR Prescribed[tiab] OR Vaccinations[tiab] OR Imaging[tiab] OR Scans[tiab] OR Endoscopy[tiab] OR Endoscopic[tiab] OR Endoscopies[tiab])) AND (Impact[tiab] OR Impacts[tiab] OR Reduction[tiab] OR Reductions[tiab] OR Decrease[tiab] OR Decreases[tiab] OR Decreased[tiab] OR Decline[tiab] OR Declines[tiab] OR Changes[tiab] OR Increase[tiab] OR Increases[tiab] OR Increased[tiab])))", "generated_query": ["What is the impact of COVID-19 on hospital admissions, emergency department visits, surgical activity, primary care utilization, and telemedicine? Also, what are the reductions, decreases, declines, changes, and impacts on prescriptions, vaccinations, imaging, scans, and endoscopy? Additionally, what is the effect of pandemics, outbreaks, and hospital utilization during the COVID-19 pandemic?", "What is the impact of COVID-19, SARS-CoV-2, and other related terms on hospital admissions, visits, attendance, activity, utilization, reduction, decline, changes, and increases in primary care, surgical departments, emergency units, clinics, and telemedicine/telehealth? Also, how have pandemics, outbreaks, and prescription/vaccination imaging/scanning impacted these areas?", "What is the impact of COVID-19 on hospital admissions, emergency departments, surgeries, clinics, primary care, telemedicine, prescriptions, vaccinations, imaging, and endoscopy? Are there any reductions, decreases, or changes in utilization or attendance? How do pandemics or outbreaks affect hospital activities and patient utilization?", "What is the impact of COVID-19, SARS-CoV-2, and related terms on hospital admissions, visits, attendance, surgeries, emergency departments, primary care, telemedicine, prescriptions, vaccinations, imaging, scans, and endoscopy? How have these healthcare utilization activities been affected by the pandemic, pandemics, outbreaks, and related terms, including reductions, decreases, declines, changes, and increases in utilization and impacts?", "What is the impact of COVID-19, SARS-CoV-2, and related terms on hospital admissions, visits, attendance, activity, utilization, and prescription patterns in pandemic or outbreak settings, as well as the effectiveness of interventions such as telemedicine, vaccinations, imaging, and endoscopy in reducing their impact on healthcare systems?", "What is the impact of COVID-19 on hospital admissions, utilization, and healthcare activities in the context of pandemics and outbreaks, including primary care and telemedicine? Additionally, how have reductions, decreases, declines, changes, and increases in healthcare activities, such as prescriptions, vaccinations, imaging, and endoscopy, been affected by the pandemic?", "What is the impact of the COVID-19 pandemic on hospital admissions, utilization, and activity in primary care settings? How have pandemics, outbreaks, and emergency situations affected hospital departments, units, clinics, and surgeries? Additionally, what is the impact of prescribed medications, vaccinations, imaging, scans, and endoscopies during the pandemic on hospital activity and utilization?", "What is the impact of COVID-19, SARS-CoV-2, and other related terms on hospitals, emergency departments, primary care clinics, surgical units, and imaging centers in terms of admission, utilization, attendance, and visitation during the pandemic or outbreak? Additionally, what are the effects of prescriptions, vaccinations, endoscopy, and telemedicine on the reduction or increase of these impacts?", "What is the impact of COVID-19 or SARS-CoV-2 pandemic on hospital admission, visits, attendance, utilization, and primary care, as well as the utilization of telemedicine or telehealth, vaccinations, imaging, scans, and endoscopy, and the reduction, decrease, decline, or change of these activities?", "What is the impact of the COVID-19 pandemic on hospital admissions, visits, and utilization, as well as on prescriptions, vaccinations, imaging, and endoscopy? Also, how have pandemics and outbreaks affected hospital departments, units, clinics, primary care, telemedicine, and telehealth, and what are the changes, reductions, decreases, declines, and increases in their activity, attendance, and impact?"]}
{"id": "1", "boolean": "(\"Telemedicine\"[Mesh] OR \"Videoconferencing\"[Mesh] OR Telehealth[tiab] OR Telemedicine[tiab] OR Videoconferencing[tiab] OR ((Telephone[tiab]) AND (Consultation[tiab] OR face-to-face[tiab] OR in-person[tiab])) OR telephone-delivered[tiab]) AND (\"Primary Health Care\"[Mesh] OR \"General Practice\"[Mesh] OR rehabilitation[sh] OR \"Outpatients\"[Mesh] OR \"Speech Therapy\"[Mesh] OR Outpatient[tiab] OR \"Primary health\"[tiab] OR \"Primary care\"[tiab] OR \"General practice\"[tiab] OR \"General practices\"[tiab] OR \"General practitioners\"[tiab] OR \"General practitioner\"[tiab] OR \"Family practice\"[tiab] OR Physician[tiab] OR Physicians[tiab] OR Clinician[tiab] OR Clinicians[tiab] OR Therapist[tiab] OR Nurse[tiab] OR Nurses[tiab] OR Physiotherapist[tiab] OR Rehabilitation[tiab] OR Diabetes[tiab] OR Diabetic[tiab] OR Asthma[tiab] OR Depression[tiab] OR \"\u00cfrritable bowel\"[tiab] OR IBS[tiab] OR PTSD[tiab] OR \"Chronic fatigue\"[tiab]) AND ((Face to face[tiab]) OR \"Usual care\"[tiab] OR Visits[tiab] OR Visit[tiab] OR In-person[tiab] OR \"In person\"[tiab] OR ((Clinic[tiab] OR Centre[tiab] OR Home[tiab]) AND (Based[tiab] OR Contact[tiab])) OR Conventional[tiab] OR \"Practice-based\"[tiab] OR \"Practice based\"[tiab] OR Traditional[tiab] OR \"Standard care\"[tiab] OR Homecare[tiab] OR ((Routine[tiab] OR Home[tiab]) AND (Care[tiab]))) AND (\"Delivery of Health Care\"[Mesh] OR Delivery[tiab] OR Delivered[tiab] OR Via[tiab] OR Received[tiab]) AND (\"Treatment Outcome\"[Mesh] OR \"Patient Satisfaction\"[Mesh] OR Therapy[sh] OR Diagnosis[sh] OR \"Clinical outcomes\"[tiab] OR Treatment[tiab] OR Diagnostic[tiab] OR Efficacy[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT  (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh])) NOT (\"Case Reports\"[pt] OR Editorial[pt] OR Letter[pt] OR Meta-Analysis[pt] OR \"Observational Study\"[pt] OR \"Systematic Review\"[pt] OR \"Case Report\"[ti] OR \"Case series\"[ti] OR Meta-Analysis[ti] OR \"Meta Analysis\"[ti] OR \"Systematic Review\"[ti] OR \"Systematic Literature Review\"[ti] OR \"Qualitative study\"[ti] OR Protocol[ti])", "generated_query": ["What are the outcomes of telemedicine, videoconferencing, telephone-delivered, and face-to-face interventions for patients receiving primary health care, general practice, rehabilitation, outpatient care, speech therapy, and treatment for conditions such as diabetes, asthma, depression, irritable bowel syndrome, PTSD, and chronic fatigue? How do these interventions compare to traditional, home-based, or clinic-based care in terms of treatment efficacy, patient satisfaction, and clinical outcomes, as measured in randomized controlled trials or controlled clinical trials? Exclude studies involving animals, case reports, editorials, letters, meta-analyses, observational studies, systematic reviews, qualitative studies, and protocols.", "What is the effectiveness of telemedicine, videoconferencing, or telephone-delivered consultations in improving treatment outcomes, patient satisfaction, and clinical outcomes in primary health care settings such as general practices, outpatient clinics, speech therapy centers, and rehabilitation centers, compared to usual care or traditional in-person visits, as demonstrated in randomized controlled trials or controlled clinical trials? (Excluding animal studies, case reports, editorials, letters, meta-analyses, systematic reviews, case series, qualitative studies, and protocols.)", "What is the effectiveness of telemedicine, telehealth, videoconferencing, and telephone-delivered consultations in the treatment of chronic conditions such as diabetes, asthma, irritable bowel syndrome, and chronic fatigue, when compared to traditional in-person care and usual care, in primary healthcare settings? Specifically, what are the clinical outcomes and patient satisfaction associated with the delivery and receipt of healthcare through telemedicine and telehealth technologies, as demonstrated in randomized controlled trials?", "What is the effectiveness of telemedicine, videoconferencing, telephone-delivered care, and conventional care in treating chronic conditions such as diabetes, asthma, irritable bowel syndrome, PTSD, and chronic fatigue, in primary care settings such as general practices, outpatient clinics, and rehabilitation centers, when compared to usual care or standard care, as measured by clinical outcomes, patient satisfaction, and treatment efficacy in randomized controlled trials excluding animal studies, case reports, editorials, letters, meta-analyses, qualitative studies, and systematic reviews?", "What are the outcomes and efficacy of telemedicine, videoconferencing, telehealth, and telephone-delivered interventions on treatment outcomes and patient satisfaction in primary healthcare, general practice, rehabilitation, outpatient care, speech therapy, and various medical conditions such as diabetes, asthma, PTSD, and chronic fatigue, when compared to conventional or standard care, delivered via face-to-face visits, in-person consultations, clinic or home-based visits, or routine care, in randomized controlled trials or controlled clinical trials? Exclude animal studies and non-original articles such as case reports, meta-analyses, and qualitative studies.", "What is the efficacy of telemedicine, videoconferencing, telehealth, and telephone-delivered consultations in treating patients with various conditions such as diabetes, asthma, PTSD, and irritable bowel syndrome in primary healthcare settings such as general practices, outpatient clinics, and rehabilitation centers, compared to traditional in-person care or usual care? The query should only retrieve randomized controlled trials and exclude animal studies, case reports, editorials, letters, meta-analyses, systematic reviews, case series, qualitative studies, and protocols.", "What are the outcomes and efficacy of telemedicine, telehealth, videoconferencing, and telephone-delivered healthcare services compared to traditional face-to-face care in primary health care, general practice, rehabilitation, outpatients, speech therapy, and various conditions such as diabetes, asthma, and depression? Only include randomized controlled trials and controlled clinical trials that study the delivery and outcomes of healthcare via telemedicine and telephone services. Exclude animal studies, case reports, editorials, letters, meta-analyses, observational studies, and qualitative studies.", "What are the clinical outcomes and patient satisfaction associated with the delivery of telemedicine, videoconferencing, telephone-delivered, and conventional care for primary health, general practice, outpatient, speech therapy, physiotherapy, rehabilitation, diabetes, asthma, depression, IBS, PTSD, and chronic fatigue patients, in randomized controlled trials, not involving animals or case reports?", "What is the effectiveness of telemedicine, telehealth, videoconferencing, and telephone-delivered consultations for treating primary health care, general practice, rehabilitation, outpatients, speech therapy, physicians, nurses, physiotherapists, and patients with conditions such as diabetes, asthma, depression, IBS, PTSD, and chronic fatigue? How do these telemedicine approaches compare to face-to-face, usual care, clinic-based, home-based, or conventional treatments in terms of delivery, treatment outcomes, and patient satisfaction, as demonstrated in randomized controlled trials and controlled clinical trials?", "What are the treatment outcomes and patient satisfaction for primary healthcare, general practice, rehabilitation, and outpatient services delivered via telemedicine, videoconferencing, telephone, or in-person visits, compared to usual care, conventional, or practice-based treatments, in randomized controlled trials? (Exclude animal studies, case reports, editorials, letters, observational studies, meta-analyses, case series, systematic reviews, qualitative studies, and protocols)."]}
{"id": "52", "boolean": "(\"Anti-Bacterial Agents\"[Mesh] OR \"Macrolides\"[Mesh] OR \"beta-Lactams\"[Mesh] OR \"Fluoroquinolones\"[Mesh] OR \"Sulfonamides\"[Mesh] OR \"Tetracyclines\"[Mesh] OR \"Aminoglycosides\"[Mesh] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Fluoroquinolones[tiab] OR Sulfonamides[tiab] OR Tetracyclines[tiab] OR Aminoglycosides[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Penicillins[tiab] OR Methicillin[tiab] OR ampicillin[tiab] OR azithromycin[tiab] OR Cephalexin[tiab] OR Maytansine[tiab] OR Mepartricin[tiab] OR Miocamycin[tiab] OR Natamycin[tiab] OR Nystatin[tiab] OR Oleandomycin[tiab] OR Troleandomycin[tiab] OR Oligomycins[tiab] OR Rutamycin[tiab] OR Sirolimus[tiab] OR Everolimus[tiab] OR Tacrolimus[tiab] OR Tylosin[tiab] OR Amphotericin[tiab] OR Antimycin[tiab] OR Brefeldin [tiab] OR Bryostatins [tiab] OR Candicidin[tiab] OR Epothilones[tiab] OR Erythromycin[tiab] OR Azithromycin[tiab] OR Clarithromycin[tiab] OR Ketolides[tiab] OR Roxithromycin[tiab] OR Filipin[tiab] OR Ivermectin[tiab] OR Josamycin[tiab] OR Leucomycins[tiab] OR Kitasamycin[tiab] OR Spiramycin[tiab] OR Carbapenems[tiab] OR Thienamycins[tiab] OR Cephalosporins[tiab] OR Cefamandole[tiab] OR Cefazolin[tiab] OR Cefonicid[tiab] OR Cefsulodin[tiab] OR Cephacetrile[tiab] OR Cephalexin[tiab] OR Cephaloridine[tiab] OR Cephamycins[tiab] OR Clavulanic[tiab] OR Monobactams[tiab] OR Aztreonam[tiab] OR Moxalactam[tiab] OR Amdinocillin[tiab] OR Cyclacillin[tiab] OR Methicillin[tiab] OR Nafcillin[tiab] OR Oxacillin[tiab] OR Penicillanic[tiab] OR Sulbactam[tiab] OR Ticarcillin[tiab] OR Amoxicillin[tiab] OR Ciprofloxacin[tiab] OR Fleroxacin[tiab] OR Enoxacin[tiab] OR Norfloxacin[tiab] OR Ofloxacin[tiab] OR Levofloxacin[tiab] OR Pefloxacin[tiab]) AND (\"Placebos\"[Mesh] OR Placebos[tiab] OR Placebo[tiab] OR Placeboes[tiab] OR \"Sham treatment\"[tiab] OR \"No treatment\"[tiab]) AND (\"Urinary Tract Infections\"[Mesh] OR \"Urinary Tract Infections\"[tiab] OR \"Urinary Tract Infection\"[tiab] OR UTIs[tiab] OR UTI[tiab] OR Cystitis[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh]))", "generated_query": ["What is the efficacy of various antibiotics (such as Anti-Bacterial Agents, Macrolides, beta-Lactams, Fluoroquinolones, Sulfonamides, Tetracyclines, Aminoglycosides, etc.) compared to placebos or sham treatments in treating urinary tract infections (UTIs) in randomized controlled trials or controlled clinical trials, without the use of animal subjects?", "What is the effectiveness of antibiotics, including Anti-Bacterial Agents, Macrolides, beta-Lactams, Fluoroquinolones, Sulfonamides, Tetracyclines, Aminoglycosides, and others, compared to placebos or no treatment in treating Urinary Tract Infections (UTIs) in randomized controlled trials? Exclude studies on animals.", "What is the efficacy of antibacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, and aminoglycosides, as well as other antimicrobial agents such as penicillins, carbapenems, and cephalosporins, in treating urinary tract infections in human randomized controlled trials compared to placebos, sham treatments, or no treatment?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, and aminoglycosides, in the treatment of urinary tract infections compared to placebos, sham treatment, or no treatment in randomized controlled trials involving human subjects?", "What randomized controlled trials have been conducted to assess the effectiveness of antibiotics and antimicrobial agents in treating urinary tract infections in humans, using placebos or no treatment as the control group?", "What is the efficacy of antibiotics and antimicrobial agents compared to placebo or no treatment for the treatment of urinary tract infections in human randomized controlled trials?", "What is the efficacy of antibiotics and antimicrobials for treating urinary tract infections in humans, as compared to placebos, as determined by randomized controlled trials and controlled clinical trials?", "What is the effectiveness of antibacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, and aminoglycosides, as well as other antimicrobial drugs such as penicillin, methicillin, and azithromycin, in treating urinary tract infections compared to placebos or no treatment in randomized controlled trials involving human subjects?", "What are the most effective antibiotics or antimicrobials for treating urinary tract infections in human clinical trials when compared to placebos or no treatment?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, aminoglycosides, and other antibiotics, compared to placebo or no treatment for treating urinary tract infections (UTIs) in randomized controlled trials and controlled clinical trials involving humans?"]}
{"id": "53", "boolean": "(\"Anti-Bacterial Agents\"[Mesh] OR \"Macrolides\"[Mesh] OR \"beta-Lactams\"[Mesh] OR \"Fluoroquinolones\"[Mesh] OR \"Sulfonamides\"[Mesh] OR \"Tetracyclines\"[Mesh] OR \"Aminoglycosides\"[Mesh] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Fluoroquinolones[tiab] OR Sulfonamides[tiab] OR Tetracyclines[tiab] OR Aminoglycosides[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Penicillins[tiab] OR Methicillin[tiab] OR ampicillin[tiab] OR azithromycin[tiab] OR Cephalexin[tiab] OR Maytansine[tiab] OR Mepartricin[tiab] OR Miocamycin[tiab] OR Natamycin[tiab] OR Nystatin[tiab] OR Oleandomycin[tiab] OR Troleandomycin[tiab] OR Oligomycins[tiab] OR Rutamycin[tiab] OR Sirolimus[tiab] OR Everolimus[tiab] OR Tacrolimus[tiab] OR Tylosin[tiab] OR Amphotericin[tiab] OR Antimycin[tiab] OR Brefeldin [tiab] OR Bryostatins [tiab] OR Candicidin[tiab] OR Epothilones[tiab] OR Erythromycin[tiab] OR Azithromycin[tiab] OR Clarithromycin[tiab] OR Ketolides[tiab] OR Roxithromycin[tiab] OR Filipin[tiab] OR Ivermectin[tiab] OR Josamycin[tiab] OR Leucomycins[tiab] OR Kitasamycin[tiab] OR Spiramycin[tiab] OR Carbapenems[tiab] OR Thienamycins[tiab] OR Cephalosporins[tiab] OR Cefamandole[tiab] OR Cefazolin[tiab] OR Cefonicid[tiab] OR Cefsulodin[tiab] OR Cephacetrile[tiab] OR Cephalexin[tiab] OR Cephaloridine[tiab] OR Cephamycins[tiab] OR Clavulanic[tiab] OR Monobactams[tiab] OR Aztreonam[tiab] OR Moxalactam[tiab] OR Amdinocillin[tiab] OR Cyclacillin[tiab] OR Methicillin[tiab] OR Nafcillin[tiab] OR Oxacillin[tiab] OR Penicillanic[tiab] OR Sulbactam[tiab] OR Ticarcillin[tiab] OR Amoxicillin[tiab] OR Ciprofloxacin[tiab] OR Fleroxacin[tiab] OR Enoxacin[tiab] OR Norfloxacin[tiab] OR Ofloxacin[tiab] OR Levofloxacin[tiab] OR Pefloxacin[tiab]) AND (\"Placebos\"[Mesh] OR Placebos[tiab] OR Placebo[tiab] OR Placeboes[tiab] OR \"Sham treatment\"[tiab] OR \"No treatment\"[tiab] OR \"No active treatment\"[tiab]) AND (\"Respiratory Tract Infections\"[Mesh] OR Nasopharyngitis[Mesh] OR Rhinitis[Mesh] OR Sinusitis[Mesh] OR Pharyngitis[Mesh] OR Laryngitis[Mesh] OR bronchitis[Mesh] OR bronchiolitis[Mesh] OR \"bronchiolitis, viral\"[Mesh] OR Pleurisy[Mesh] OR Cough[Mesh] OR Sneezing[Mesh] OR Pneumonia[Mesh] OR \"Respiratory Sounds\"[Mesh] OR \"Otitis Media\"[Mesh] OR Earache[Mesh] OR \"Influenza, Human\"[Mesh] OR \"Common Cold\"[Mesh] OR \"Respiratory infection\"[tiab] OR \"Respiratory infections\"[tiab] OR \"Respiratory Tract Infections\"[tiab] OR \"Respiratory Tract Infection\"[tiab] OR \"Respiratory inflammation\"[tiab] OR \"Respiratory tract inflammation\"[tiab] OR urti[tiab] OR lrti[tiab] OR ari[tiab] OR nasopharyngitis[tiab] OR rhinopharyngitis[tiab] OR sinusitis[tiab] OR nasosinusitis[tiab] OR rhinosinusitis[tiab] OR rhinitis[tiab] OR rhinorrhoea[tiab] OR rhinorrhea[tiab] OR pharyngitis[tiab] OR \"sore throat\"[tiab] OR Tonsillitis[tiab] OR laryngitis[tiab] OR croup[tiab] OR pseudocroup[tiab] OR tracheobronchitis[tiab] OR laryngotracheobronchitis[tiab] OR bronchitis[tiab] OR bronchiolitis[tiab] OR pneumonia[tiab] OR pleuropneumonia[tiab] OR bronchopneumonia[tiab] OR pleurisy[tiab] OR cough[tiab] OR Wheeze[tiab] OR Wheezing[tiab] OR \"otitis media\"[tiab] OR aom[tiab] OR ome[tiab] OR earache[tiab] OR influenza[tiab] OR flu[tiab] OR \"common cold\"[tiab] OR \"common colds\"[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh]))", "generated_query": ["What is the effectiveness of antibiotics, including anti-bacterial agents, macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, and aminoglycosides, as well as other antimicrobials such as penicillins, azithromycin, and carbapenems, compared to placebos or no treatment in treating respiratory tract infections such as rhinitis, sinusitis, pharyngitis, bronchitis, pneumonia, and otitis media, based on randomized controlled trials and controlled clinical trials in humans?", "What are the most effective antibiotics or antimicrobials for treating respiratory tract infections compared to placebos or no active treatment in randomized controlled trials involving human participants?", "What is the efficacy of antibacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, and aminoglycosides, in treating respiratory tract infections, such as nasopharyngitis, rhinitis, sinusitis, pharyngitis, bronchitis, pneumonia, and otitis media, compared to placebos or no treatment, based on randomized controlled trials that exclude animal studies?", "What is the efficacy of antibacterial agents, macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, aminoglycosides, and other antimicrobials in the treatment of respiratory tract infections, including nasopharyngitis, sinusitis, bronchitis, pneumonia, and otitis media, compared to placebos, sham treatments, or no treatment, in randomized controlled trials?", "What is the efficacy of anti-bacterial agents, macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, aminoglycosides, and other antibiotics in treating respiratory tract infections compared to placebos, sham treatment, no treatment, or no active treatment in randomized controlled trials excluding animal studies?", "What is the effectiveness of antibiotics and antimicrobials in treating respiratory tract infections compared to placebos or no treatment in randomized controlled trials?", "What is the effectiveness of antibiotics, including Anti-Bacterial Agents, Macrolides, beta-Lactams, Fluoroquinolones, Sulfonamides, Tetracyclines, Aminoglycosides, and others, in treating respiratory tract infections such as Nasopharyngitis, Rhinitis, Sinusitis, Pharyngitis, Laryngitis, Bronchitis, and Pneumonia when compared to placebos, sham treatment, or no treatment in randomized controlled trials that involve human participants?", "What is the effectiveness of antibiotics and antimicrobials compared to placebos in treating respiratory tract infections in randomized controlled trials?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, and aminoglycosides, in treating respiratory tract infections compared to placebos or no treatment in randomized controlled trials involving humans?", "What are the most effective antibacterial agents for treating respiratory tract infections in humans, compared to placebos or no active treatment, based on randomized controlled trials?"]}
{"id": "8", "boolean": "(Physicians[Mesh] OR Doctor[tiab] OR Doctors[tiab] OR Physician[tiab] OR Physicians[tiab] OR Clinician[tiab] OR Clinicians[tiab] OR \"General practitioner\"[tiab] OR \"General practitioners\"[tiab] OR Cardiologist[tiab] OR Cardiologists[tiab] OR Dermatologist[tiab] OR Dermatologists[tiab] OR Endocrinologist[tiab] OR Endocrinologists[tiab] OR Gastroenterologist[tiab] OR Gastroenterologists[tiab] OR Geriatrician[tiab] OR Geriatricians[tiab] OR Neurologist[tiab] OR Neurologists[tiab] OR Oncologist[tiab] OR Oncologists[tiab] OR Obstetrician[tiab] OR Obstetricians[tiab] OR Pediatrician[tiab] OR Pediatricians[tiab] OR Paediatrician[tiab] OR Paediatricians[tiab] OR Psychiatrist[tiab] OR Psychiatrists[tiab] OR \"Family Physician\"[tiab] OR \"Family Physicians\"[tiab] OR Surgeon[tiab] OR Surgeons[tiab] OR Urologist[tiab] OR Urologists[tiab] OR Psychiatrist[tiab] OR Psychiatrists[tiab] OR Resident[tiab] OR Residents[tiab] OR Registrar[tiab] OR Registrars[tiab] OR Consultant[tiab] OR Consultants[tiab] OR Specialist[tiab] OR Specialists[tiab]) AND (\"Practice Patterns, Physicians\"[Mesh] OR \"Clinical Competence\"[Mesh] OR Individual[tiab] OR Individuals[tiab]) AND (Variability[tiab] OR Variation[tiab] OR Vary[tiab]) AND (\"Outcome and Process Assessment, Health Care\"[Mesh] OR \"Quality of Health Care\"[Mesh] OR \"Patient Care\"[Mesh] OR \"Patient care\"[tiab] OR \"Care quality\"[tiab] OR ((Treatment[tiab] OR Medical[tiab] OR Surgical[tiab]) AND (Outcome[tiab] OR Outcomes[tiab]))) AND (\"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"Case control\"[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR Retrospective[tiab] OR \"Cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Analysis[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh]) AND (Doctor[ti] OR Doctors[ti] OR Physician[ti] OR Physicians[ti] OR Clinician[ti] OR Clinicians[ti] OR \"General practitioner\"[ti] OR \"General practitioners\"[ti] OR Cardiologist[ti] OR Cardiologists[ti] OR Dermatologist[ti] OR Dermatologists[ti] OR Endocrinologist[ti] OR Endocrinologists[ti] OR Gastroenterologist[ti] OR Gastroenterologists[ti] OR Geriatrician[ti] OR Geriatricians[ti] OR Neurologist[ti] OR Neurologists[ti] OR Oncologist[ti] OR Oncologists[ti] OR Obstetrician[ti] OR Obstetricians[ti] OR Pediatrician[ti] OR Pediatricians[ti] OR Paediatrician[ti] OR Paediatricians[ti] OR Psychiatrist[ti] OR Psychiatrists[ti] OR \"Family Physician\"[ti] OR \"Family Physicians\"[ti] OR Surgeon[ti] OR Surgeons[ti] OR Urologist[ti] OR Urologists[ti] OR Psychiatrist[ti] OR Psychiatrists[ti] OR Resident[ti] OR Residents[ti] OR Registrar[ti] OR Registrars[ti] OR Consultant[ti] OR Consultants[ti] OR Specialist[ti] OR Specialists[ti] OR Individual[ti] OR Individuals[ti] OR Variability[ti] OR Variation[ti] OR Vary[ti] OR \"Patient care\"[ti] OR \"Care quality\"[ti] OR ((Treatment[ti] OR Medical[ti] OR Surgical[ti]) AND (Outcome[ti] OR Outcomes[ti])))", "generated_query": ["What is the variability in practice patterns and clinical competence of physicians, including general practitioners, cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetricians, pediatricians, psychiatrists, surgeons, urologists, residents, registrars, consultants, and specialists, in relation to patient care quality and outcome assessment? What are the findings of epidemiologic studies, case-control studies, cohort studies, cross-sectional studies, and longitudinal and retrospective analyses on this topic?", "What is the variability in practice patterns and clinical competence among physicians, specialists, residents, and registrars in the assessment of patient care quality and outcomes? What are the epidemiologic and statistical data available from cohort studies, case-control studies, cross-sectional studies, and longitudinal studies in investigating this variability?", "What is the variability in practice patterns and clinical competence of physicians, clinicians, specialists, and other healthcare professionals, and how does this impact the quality of patient care and outcomes? What are the results of epidemiologic studies, including cohort studies and case-control studies, investigating this topic, and what is the variability observed among different types of healthcare professionals such as cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetricians, pediatricians, psychiatrists, surgeons, urologists, family physicians, residents, registrars, and consultants?", "What is the variability in practice patterns and clinical competence among physicians, including general practitioners, cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetricians, pediatricians, psychiatrists, surgeons, urologists, residents, registrars, consultants, and specialists, and how does this affect the quality of patient care, including treatment outcomes, in epidemiologic and case-control studies, as well as longitudinal, prospective, and retrospective analyses of data and statistics in healthcare?", "What is the variability and quality of health care practices among physicians and clinicians such as cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetricians, pediatricians, psychiatrists, surgeons, urologists, residents, registrars, consultants, and specialists in terms of individual clinical competence and patient care outcomes? What epidemiological and statistical evidence exists in the literature, including case-control studies, cohort studies, cross-sectional studies, and longitudinal or retrospective analyses, regarding the assessment of healthcare processes and outcomes?", "What is the variability in the practice patterns and clinical competence of physicians, including general practitioners, cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetricians, pediatricians, psychiatrists, surgeons, urologists, residents, registrars, consultants, and specialists, in terms of patient care quality and outcomes assessment, based on epidemiologic studies such as case-control, cohort, and cross-sectional studies, with a focus on individual variability and analysis of data?", "What is the variability of practice patterns and clinical competence among physicians, including general practitioners, cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetricians, pediatricians, psychiatrists, surgeons, urologists, residents, registrars, consultants, and specialists, and how does it affect the outcome and quality of patient care? Are there any epidemiological studies, including case-control, cohort, longitudinal, and cross-sectional studies, that have investigated this topic, analyzing data and using statistics and numerical data?", "What is the variability in practice patterns and clinical competence of physicians, clinicians, specialists, and other healthcare professionals such as cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetricians, pediatricians, psychiatrists, surgeons, urologists, residents, registrars, and consultants in delivering quality patient care? Can you provide epidemiological evidence from case-control, cohort, cross-sectional, and longitudinal studies that investigate the outcomes and process assessment of health care for individuals, as well as the statistical and numerical data analysis of such studies?", "What is the variability in practice patterns and clinical competence among physicians, including general practitioners, cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetricians, pediatricians, psychiatrists, surgeons, urologists, residents, registrars, consultants, and specialists, in relation to the quality of patient care and outcomes, as investigated in epidemiologic and case-control studies, cohort studies, cross-sectional studies, longitudinal studies, and prospective and retrospective analyses?", "\"Systematic review of practice patterns, clinical competence, and care quality among various healthcare professionals (physicians, specialists, clinicians, general practitioners, residents, and consultants) investigating variability and outcomes in patient care: A study on epidemiologic, case-control, cohort, cross-sectional, longitudinal, and prospective studies with statistical analysis and numerical data.\""]}
{"id": "112", "boolean": "(Physicians[Mesh] OR Doctor[tiab] OR Doctors[tiab] OR Physician[tiab] OR Physicians[tiab] OR Clinician[tiab] OR Clinicians[tiab] OR \"General practitioner\"[tiab] OR \"General practitioners\"[tiab] OR Cardiologist[tiab] OR Cardiologists[tiab] OR Dermatologist[tiab] OR Dermatologists[tiab] OR Endocrinologist[tiab] OR Endocrinologists[tiab] OR Gastroenterologist[tiab] OR Gastroenterologists[tiab] OR Geriatrician[tiab] OR Geriatricians[tiab] OR Neurologist[tiab] OR Neurologists[tiab] OR Oncologist[tiab] OR Oncologists[tiab] OR Obstetrician[tiab] OR Obstetricians[tiab] OR Pediatrician[tiab] OR Pediatricians[tiab] OR Paediatrician[tiab] OR Paediatricians[tiab] OR Psychiatrist[tiab] OR Psychiatrists[tiab] OR \"Family Physician\"[tiab] OR \"Family Physicians\"[tiab] OR Surgeon[tiab] OR Surgeons[tiab] OR Urologist[tiab] OR Urologists[tiab] OR Psychiatrist[tiab] OR Psychiatrists[tiab] OR Resident[tiab] OR Residents[tiab] OR Registrar[tiab] OR Registrars[tiab] OR Consultant[tiab] OR Consultants[tiab] OR Specialist[tiab] OR Specialists[tiab]) AND (\"Practice Patterns, Physicians\"[Mesh] OR \"Clinical Competence\"[Mesh] OR Individual[tiab] OR Individuals[tiab]) AND (Variability[tiab] OR Variation[tiab] OR Vary[tiab]) AND (\"Outcome and Process Assessment, Health Care\"[Mesh] OR \"Quality of Health Care\"[Mesh] OR \"Patient Care\"[Mesh] OR \"Patient care\"[tiab] OR \"Care quality\"[tiab] OR ((Treatment[tiab] OR Medical[tiab] OR Surgical[tiab]) AND (Outcome[tiab] OR Outcomes[tiab]))) AND (\"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"Case control\"[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR Retrospective[tiab] OR \"Cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Analysis[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh]) AND (Doctor[ti] OR Doctors[ti] OR Physician[ti] OR Physicians[ti] OR Clinician[ti] OR Clinicians[ti] OR \"General practitioner\"[ti] OR \"General practitioners\"[ti] OR Cardiologist[ti] OR Cardiologists[ti] OR Dermatologist[ti] OR Dermatologists[ti] OR Endocrinologist[ti] OR Endocrinologists[ti] OR Gastroenterologist[ti] OR Gastroenterologists[ti] OR Geriatrician[ti] OR Geriatricians[ti] OR Neurologist[ti] OR Neurologists[ti] OR Oncologist[ti] OR Oncologists[ti] OR Obstetrician[ti] OR Obstetricians[ti] OR Pediatrician[ti] OR Pediatricians[ti] OR Paediatrician[ti] OR Paediatricians[ti] OR Psychiatrist[ti] OR Psychiatrists[ti] OR \"Family Physician\"[ti] OR \"Family Physicians\"[ti] OR Surgeon[ti] OR Surgeons[ti] OR Urologist[ti] OR Urologists[ti] OR Psychiatrist[ti] OR Psychiatrists[ti] OR Resident[ti] OR Residents[ti] OR Registrar[ti] OR Registrars[ti] OR Consultant[ti] OR Consultants[ti] OR Specialist[ti] OR Specialists[ti] OR Individual[ti] OR Individuals[ti] OR Variability[ti] OR Variation[ti] OR Vary[ti] OR \"Patient care\"[ti] OR \"Care quality\"[ti] OR ((Treatment[ti] OR Medical[ti] OR Surgical[ti]) AND (Outcome[ti] OR Outcomes[ti])))", "generated_query": ["What is the variability in practice patterns, clinical competence, and quality of patient care among physicians, clinicians, general practitioners, cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetricians, pediatricians, psychiatrists, surgeons, urologists, residents, registrars, consultants, and specialists, as investigated through epidemiologic, case-control, cohort, cross-sectional, longitudinal, and prospective studies, and analyzed with statistical and numerical data?", "What is the variability in practice patterns and clinical competence of different types of physicians, including physicians, specialists, clinicians, general practitioners, cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetricians, pediatricians, psychiatrists, surgeons, urologists, residents, registrars, and consultants, in relation to patient care quality, outcomes, and process assessment? What are the results of epidemiological and statistical analyses, including case-control studies, cohort studies, cross-sectional studies, longitudinal studies, and prospective and retrospective studies, in investigating this issue?", "What is the variability in practice patterns and clinical competence among physicians, clinicians, specialists, and other healthcare professionals such as general practitioners, cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetricians, pediatricians, psychiatrists, surgeons, urologists, residents, registrars, and consultants? How does this variability impact the quality of patient care and outcomes, and what epidemiologic studies, including case-control, cohort, and cross-sectional studies, have investigated this issue and analyzed the data using statistics and numerical data and epidemiology?", "What is the variability in practice patterns and clinical competence among physicians, clinicians, general practitioners, cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetricians, pediatricians, psychiatrists, surgeons, urologists, residents, registrars, consultants, and specialists in providing quality patient care? How do epidemiologic studies such as case-control studies, cohort studies, and cross-sectional studies investigate the outcome and process assessment of healthcare, including treatment outcomes, medical and surgical care, and quality of care in relation to these healthcare professionals?", "What is the variability in practice patterns and clinical competence among different healthcare professionals, including physicians, clinicians, general practitioners, cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetricians, pediatricians, psychiatrists, surgeons, urologists, residents, registrars, consultants, and specialists? How does this variability impact the quality of patient care and treatment outcomes? Can epidemiologic studies, including case-control studies, cohort studies, longitudinal, prospective, and retrospective studies, shed light on this issue?", "What is the variability in practice patterns, clinical competence, and patient care outcomes among physicians including general practitioners, cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetricians, pediatricians, psychiatrists, surgeons, urologists, residents, registrars, consultants, and specialists, as assessed through epidemiologic studies such as case-control, cohort, longitudinal, and cross-sectional studies?", "What is the variability in practice patterns, clinical competence, and outcomes assessment among physicians, including general practitioners, cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetricians, pediatricians, psychiatrists, surgeons, urologists, residents, registrars, consultants, and specialists, in individual and group settings, based on epidemiological studies, case-control studies, cohort studies, longitudinal and prospective studies, and cross-sectional studies, as analyzed by doctors, clinicians, and individuals with regards to patient care and quality of care?", "What is the variability and quality of healthcare outcomes and processes among physicians, clinicians, and specialists (including cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetricians, pediatricians, psychiatrists, surgeons, urologists, family physicians, residents, registrars, and consultants) in individual and clinical competence settings, as investigated in epidemiologic studies, cohort studies, case-control studies, and cross-sectional studies with statistical analysis and numerical data?", "What is the variability in the practice patterns and clinical competence of physicians, clinicians, specialists, residents, and consultants in assessing the outcomes and quality of patient care, as investigated through epidemiologic studies, including cohort studies, case-control studies, and cross-sectional studies?", "\"Systematic review on the variability and quality of patient care provided by different types of healthcare providers including physicians, clinicians, specialists, and other healthcare professionals, analyzed through epidemiologic studies such as cohort studies, case-control studies, and cross-sectional studies, using outcome and process assessment and clinical competence as evaluation criteria.\""]}
{"id": "51", "boolean": "(\"Anti-Bacterial Agents\"[Mesh] OR \"Macrolides\"[Mesh] OR \"beta-Lactams\"[Mesh] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Methicillin[tiab] OR ampicillin[tiab] OR azithromycin[tiab] OR Cephalexin[tiab]) AND (\"Placebos\"[Mesh] OR Placebos[tiab] OR Placebo[tiab] OR Placeboes[tiab] OR \"Sham treatment\"[tiab]) AND (Erysipelas[Mesh] OR erysipelas[tiab] OR \"Skin Diseases, Infectious\"[Mesh] OR Cellulitis[Mesh] OR cellulitis[tiab] OR impetigo[tiab] OR Impetigo[Mesh] OR \"Soft Tissue Infections\"[Mesh] OR \"Ignis sacer\"[tiab] OR \"holy fire\"[tiab] OR \"st anthony's fire\"[tiab] OR \"Soft Tissue Infections\"[tiab] OR \"Soft Tissue Infection\"[tiab] OR \"Skin infections\"[tiab] OR \"Skin infection\"[tiab] OR ((*Staphylococcus[Mesh] OR staphylococc*[tiab] OR Streptococcus[Mesh] OR streptococc*[tiab]) AND Skin[Mesh]))", "generated_query": ["What is the effectiveness of anti-bacterial agents, macrolides, beta-lactams, and other antimicrobials compared to placebos or sham treatments for the treatment of erysipelas, cellulitis, impetigo, and other skin infections caused by Staphylococcus or Streptococcus bacteria in humans?", "What is the effectiveness of anti-bacterial agents, macrolides, beta-lactams, and other antimicrobials compared to placebos or sham treatments in treating erysipelas, cellulitis, impetigo, soft tissue infections, and skin infections caused by Staphylococcus or Streptococcus bacteria in patients with skin diseases?", "What is the efficacy of anti-bacterial agents, macrolides, beta-lactams, antibiotics, macrolides, beta-lactams, and other antimicrobial agents compared to placebo or sham treatment for the treatment of erysipelas, cellulitis, impetigo, soft tissue infections, and skin infections caused by Staphylococcus or Streptococcus bacteria?", "What is the efficacy of antibacterial agents, macrolides, beta-lactams, and other antimicrobial drugs in treating soft tissue infections such as erysipelas, cellulitis, impetigo, and other skin infections caused by Staphylococcus and Streptococcus, compared to placebos or sham treatments?", "What is the effectiveness of anti-bacterial agents, macrolides, beta-lactams, and other antibiotics compared to placebos or sham treatments for treating erysipelas, cellulitis, impetigo, soft tissue infections, and other skin infections caused by Staphylococcus or Streptococcus bacteria?", "What is the effectiveness of anti-bacterial agents, macrolides, beta-lactams, and other antimicrobials compared to placebos or sham treatment for treating skin infections such as erysipelas, cellulitis, impetigo, and other soft tissue infections caused by Staphylococcus or Streptococcus?", "What is the effectiveness of anti-bacterial agents, macrolides, beta-lactams, and other antimicrobial drugs compared to placebos or sham treatments for the treatment of erysipelas, cellulitis, impetigo, soft tissue infections, and skin infections caused by Staphylococcus or Streptococcus bacteria in patients with skin diseases or infectious skin conditions?", "What is the effectiveness of antibiotics, macrolides, beta-lactams, and antimicrobials compared to placebos or sham treatments for treating erysipelas, cellulitis, impetigo, soft tissue infections, skin infections caused by staphylococcus or streptococcus bacteria in the skin?", "What is the efficacy of antibiotics, macrolides, and beta-lactams in treating erysipelas, cellulitis, impetigo, and other soft tissue infections caused by Staphylococcus or Streptococcus, compared to placebos or sham treatments?", "What is the effectiveness of antibiotics, macrolides, and beta-lactams, compared to placebos or sham treatments, for the treatment of erysipelas, cellulitis, impetigo, and other soft tissue infections caused by Staphylococcus or Streptococcus bacteria in the skin?"]}
{"id": "27", "boolean": "(\"Tafenoquine\" [Supplementary Concept] OR Tafenoquine[tiab] OR Arakoda[tiab] OR \"WR 238605\"[tiab] OR \"WR-238605\"[tiab] OR Krintafel[tiab])AND(\"Malaria\"[Mesh] OR Malaria[tiab] OR \"Plasmodium infection\"[tiab] OR \"Plasmodium Infections\"[tiab] OR \"Remittent Fever\"[tiab] OR \"Marsh Fever\"[tiab] OR Paludism[tiab])AND(\"Pre-Exposure Prophylaxis\"[Mesh] OR \"Chemoprevention\"[Mesh] OR \"prevention and control\"[Subheading] OR Prophylaxis[tiab] OR Chemoprophylaxis[tiab] OR Prevention[tiab] OR Prevent[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh]))", "generated_query": ["Can Tafenoquine, Arakoda, WR 238605, or Krintafel be effective in preventing or controlling Malaria, Plasmodium infection, Remittent Fever, or Paludism through pre-exposure prophylaxis or chemoprevention in randomized controlled trials, without including animal studies?", "What is the effectiveness of Tafenoquine, Arakoda, WR-238605, and Krintafel in preventing or controlling Malaria or Plasmodium Infections through pre-exposure prophylaxis or chemoprevention in randomized controlled trials, excluding studies conducted on animals?", "What is the effectiveness of Tafenoquine, Arakoda, WR 238605, and Krintafel for preventing Plasmodium infection or Malaria in humans using pre-exposure prophylaxis or chemoprevention based on randomized controlled trials or controlled clinical trials?", "What randomized controlled trials have been conducted on Tafenoquine or its brand names Arakoda, WR 238605, or Krintafel for the chemoprevention or prophylaxis of malaria or Plasmodium infection in human subjects, excluding studies conducted on animals?", "What is the efficacy of Tafenoquine, Arakoda, WR-238605, and Krintafel for chemoprophylaxis or prevention of malaria or Plasmodium infections in humans? Limit results to randomized controlled trials and controlled clinical trials that involve human subjects. Exclude animal studies.", "What is the efficacy of Tafenoquine, Arakoda, WR 238605, or Krintafel for the prevention or chemoprophylaxis of malaria or Plasmodium infections in randomized controlled trials involving human subjects, while excluding any studies conducted on animals?", "What is the efficacy of Tafenoquine, Arakoda, WR-238605, or Krintafel for the prevention of malaria in humans through pre-exposure prophylaxis or chemoprevention in randomized controlled trials or controlled clinical trials excluding animal studies?", "What is the effectiveness of Tafenoquine, Arakoda, WR 238605, and Krintafel in preventing or controlling Malaria or Plasmodium Infections through chemoprevention or pre-exposure prophylaxis in randomized controlled trials that involve human subjects?", "What is the efficacy of Tafenoquine, Arakoda, WR-238605, and Krintafel in preventing Plasmodium infections, malaria, remittent fever, marsh fever, or paludism in humans through pre-exposure prophylaxis, chemoprevention, or other forms of prevention and control in randomized controlled trials or controlled clinical trials, without including animal studies?", "Can Tafenoquine, Arakoda, WR-238605 or Krintafel be used as pre-exposure prophylaxis or chemoprevention for malaria or Plasmodium infection in controlled clinical trials or randomized controlled trials on human subjects?"]}
{"id": "11", "boolean": "((\"Anti-Infective Agents\"[Mesh] OR \"Anti-Bacterial Agents\"[Mesh] OR \"Macrolides\"[Mesh] OR \"beta-Lactams\"[Mesh] OR \"Fluoroquinolones\"[Mesh] OR \"Sulfonamides\"[Mesh] OR \"Tetracyclines\"[Mesh] OR \"Aminoglycosides\"[Mesh] OR Antimicrobials[tiab] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Fluoroquinolones[tiab] OR Sulfonamides[tiab] OR Tetracyclines[tiab] OR Aminoglycosides[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Penicillins[tiab] OR Methicillin[tiab] OR ampicillin[tiab] OR azithromycin[tiab] OR Cephalexin[tiab] OR Maytansine[tiab] OR Mepartricin[tiab] OR Miocamycin[tiab] OR Natamycin[tiab] OR Nystatin[tiab] OR Oleandomycin[tiab] OR Troleandomycin[tiab] OR Oligomycins[tiab] OR Rutamycin[tiab] OR Sirolimus[tiab] OR Everolimus[tiab] OR Tacrolimus[tiab] OR Tylosin[tiab] OR Amphotericin[tiab] OR Antimycin[tiab] OR Brefeldin [tiab] OR Bryostatins [tiab] OR Candicidin[tiab] OR Epothilones[tiab] OR Erythromycin[tiab] OR Azithromycin[tiab] OR Clarithromycin[tiab] OR Ketolides[tiab] OR Roxithromycin[tiab] OR Filipin[tiab] OR Ivermectin[tiab] OR Josamycin[tiab] OR Leucomycins[tiab] OR Kitasamycin[tiab] OR Spiramycin[tiab] OR Carbapenems[tiab] OR Thienamycins[tiab] OR Cephalosporins[tiab] OR Cefamandole[tiab] OR Cefazolin[tiab] OR Cefonicid[tiab] OR Cefsulodin[tiab] OR Cephacetrile[tiab] OR Cephalexin[tiab] OR Cephaloridine[tiab] OR Cephamycins[tiab] OR Clavulanic[tiab] OR Monobactams[tiab] OR Aztreonam[tiab] OR Moxalactam[tiab] OR Amdinocillin[tiab] OR Cyclacillin[tiab] OR Methicillin[tiab] OR Nafcillin[tiab] OR Oxacillin[tiab] OR Penicillanic[tiab] OR Sulbactam[tiab] OR Ticarcillin[tiab] OR Amoxicillin[tiab] OR Ciprofloxacin[tiab] OR Fleroxacin[tiab] OR Enoxacin[tiab] OR Norfloxacin[tiab] OR Ofloxacin[tiab] OR Levofloxacin[tiab] OR Pefloxacin[tiab] OR Quinolone[tiab]) AND (\"Homes for the Aged\"[Mesh] OR \"Old Age Homes\"[tiab] OR \"Old Age Home\"[tiab] OR \"Nursing Homes\"[Mesh] OR \"Nursing Home\"[tiab] OR \"Geriatric center\"[tiab] OR \"Geriatric centers\"[tiab] OR \"Retirement communities\"[tiab] OR \"Retirement community\"[tiab] OR \"Nonhospitalized\"[tiab] OR \"Non Hospitalized\"[tiab] OR \"Nonhospitalised\"[tiab] OR \"Non Hospitalised\"[tiab] OR \"Aged care\"[tiab] OR \"Retirement home\"[tiab] OR \"Retirement homes\"[tiab]) AND (\"Aged\"[Mesh] OR \"Elderly\"[tiab] OR Old[tiab] OR Older[tiab]) AND (\"Adverse effects\"[sh] OR \"Infections\"[Mesh] OR \"Adverse effect\"[tiab] OR \"Adverse effects\"[tiab] OR \"Adversely affect\"[tiab] OR \"Adverse event\"[tiab] OR \"Adverse events\"[tiab] OR \"Poisoning\"[tiab] OR \"Toxicity\"[tiab] OR \"Discomfort\"[tiab] OR \"Pain\"[tiab] OR \"Physiological impacts\"[tiab] OR \"Physiological impact\"[tiab] OR Mortality[tiab] OR Survival[tiab] OR \"Infection\"[tiab] OR \"Infections\"[tiab] OR \"Symptomatic\"[tiab]) AND (\"Withholding Treatment\"[Mesh] OR Placebo[Mesh] OR Placebo[tiab] OR Untreated[tiab] OR \"No therapy\"[tiab] OR \"No Treatments\"[tiab] OR \"No Treatment\"[tiab] OR ((Withholding[tiab] OR Withdrawing OR Stopping OR Ceasing[tiab] OR Discontinuation[tiab]) AND (Treatments[tiab] OR Treatment[tiab] OR Therapy[tiab]))) AND (\"randomized controlled trial\"[pt] OR \"controlled clinical trial\"[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR \"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"case control\"[tiab] OR Cohort[tiab] OR \"Follow up\"[tiab] OR Observational[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR Retrospective[tiab] OR \"cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Evaluated[tiab] OR Impact[tiab] OR Analysis[tiab] OR Statistics[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh] OR Etiology[sh] OR Effect[tiab] OR Effects[tiab] OR Affect[tiab])) OR ((Antibiotics[ti] OR Antibiotic[ti] OR Penicillin[ti] OR Penicillins[ti] OR azithromycin[ti] OR Azithromycin[ti] OR Cephalexin[ti] OR Oxacillin[ti] OR Ciprofloxacin[ti] OR Ofloxacin[ti] OR Quinolone[ti]) AND (Elderly[ti] OR Old[ti] OR Older[ti] OR Aged[ti] OR Age[ti]) AND (Impairment[ti] OR Mortality[ti] OR Harms[ti] OR Harm[ti] OR Adverse[ti] OR Survival[ti]))", "generated_query": ["What is the impact of antibiotics on the elderly population residing in nursing homes, retirement communities, or other geriatric centers in terms of adverse effects, mortality, or impairment? Can withholding treatment or using placebo or no therapy mitigate these effects? Are there any randomized controlled trials, observational studies, or epidemiologic studies that have evaluated the effects of specific antibiotics such as penicillin, azithromycin, cephalexin, or quinolones on the health outcomes of the elderly population?", "What is the impact of withholding or withdrawing anti-infective agents or antibiotics on elderly patients in homes for the aged, nursing homes, and retirement communities, and what adverse effects such as impairment, mortality, or harm are associated with such interventions, as evaluated in randomized controlled trials, controlled clinical trials, epidemiologic studies, case-control studies, and cohort studies?", "What is the impact of antimicrobial use in elderly residents of nursing homes, retirement communities, and aged care facilities? Specifically, what are the adverse effects, including infections, mortality, and physiological impacts, of using antibiotics, such as Penicillin, Ciprofloxacin, and Quinolone, in this population? Are randomized controlled trials or observational studies, such as case-control and cohort studies, available that evaluate the effectiveness of withholding antibiotic treatment or using placebo in this setting?", "What is the effectiveness of antimicrobial agents, including antibiotics such as penicillin, azithromycin, cephalexin, and ciprofloxacin, in the elderly population residing in aged care facilities, nursing homes, and retirement communities? How do these treatments impact mortality, physiological well-being, and the occurrence of adverse events and infections in this population? Additionally, what is the effect of withholding or withdrawing treatment on these outcomes?", "What is the impact of antibiotics on the elderly population living in nursing homes or retirement communities, in terms of adverse effects, mortality, and physiological impacts, when treatment is withheld or placebo is used, as demonstrated in randomized controlled trials, controlled clinical trials, observational studies, case-control studies, and cohort studies?", "What are the adverse effects and infections associated with the use of antibiotics in elderly patients living in homes for the aged, nursing homes, and retirement communities, who receive no treatment or placebo, as determined by randomized controlled trials, cohort studies, and observational studies?", "What are the adverse effects, infections, mortality, and harm associated with the use of antibiotics in elderly populations residing in nursing homes, retirement communities, and aged care facilities? How effective are withholding treatments, placebo, or no therapy in managing these adverse effects in this population? Do randomized controlled trials, controlled clinical trials, cohort studies, or cross-sectional studies provide evidence on the impact of antibiotics on elderly populations in nursing homes, retirement communities, and aged care facilities?", "What is the impact of various antimicrobial agents, including but not limited to anti-infective agents, antibacterial agents, macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, and aminoglycosides, on elderly residents in nursing homes, retirement communities, and geriatric centers in terms of adverse effects, infections, mortality, and physiological impacts when treatment is withheld or placebo is given, based on randomized controlled trials, controlled clinical trials, epidemiological studies, case-control studies, and cohort studies?", "What is the impact of antimicrobial treatment on elderly residents of nursing homes, retirement communities, or aged care facilities in terms of adverse effects, infections, and mortality? Are there any differences in outcomes between randomized controlled trials and observational studies, or between treated and untreated groups?", "What is the impact of anti-infective agents, including antibiotics, macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, and aminoglycosides, on elderly populations residing in nursing homes, retirement communities, or aged care facilities? Are there any adverse effects or harms associated with these medications in this population, and how do they compare to withholding treatment or placebo in randomized controlled trials or observational studies?"]}
{"id": "16", "boolean": "(\"Anti-Bacterial Agents\"[Mesh] OR \"Macrolides\"[Mesh] OR \"beta-Lactams\"[Mesh] OR \"Fluoroquinolones\"[Mesh] OR \"Sulfonamides\"[Mesh] OR \"Tetracyclines\"[Mesh] OR \"Aminoglycosides\"[Mesh] OR Antimicrobials[tiab] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Fluoroquinolones[tiab] OR Sulfonamides[tiab] OR Tetracyclines[tiab] OR Aminoglycosides[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Penicillins[tiab] OR Methicillin[tiab] OR ampicillin[tiab] OR azithromycin[tiab] OR Cephalexin[tiab] OR Maytansine[tiab] OR Mepartricin[tiab] OR Miocamycin[tiab] OR Natamycin[tiab] OR Nystatin[tiab] OR Oleandomycin[tiab] OR Troleandomycin[tiab] OR Oligomycins[tiab] OR Rutamycin[tiab] OR Sirolimus[tiab] OR Everolimus[tiab] OR Tacrolimus[tiab] OR Tylosin[tiab] OR Amphotericin[tiab] OR Antimycin[tiab] OR Brefeldin [tiab] OR Bryostatins [tiab] OR Candicidin[tiab] OR Epothilones[tiab] OR Erythromycin[tiab] OR Azithromycin[tiab] OR Clarithromycin[tiab] OR Ketolides[tiab] OR Roxithromycin[tiab] OR Filipin[tiab] OR Ivermectin[tiab] OR Josamycin[tiab] OR Leucomycins[tiab] OR Kitasamycin[tiab] OR Spiramycin[tiab] OR Carbapenems[tiab] OR Thienamycins[tiab] OR Cephalosporins[tiab] OR Cefamandole[tiab] OR Cefazolin[tiab] OR Cefonicid[tiab] OR Cefsulodin[tiab] OR Cephacetrile[tiab] OR Cephalexin[tiab] OR Cephaloridine[tiab] OR Cephamycins[tiab] OR Clavulanic[tiab] OR Monobactams[tiab] OR Aztreonam[tiab] OR Moxalactam[tiab] OR Amdinocillin[tiab] OR Cyclacillin[tiab] OR Methicillin[tiab] OR Nafcillin[tiab] OR Oxacillin[tiab] OR Penicillanic[tiab] OR Sulbactam[tiab] OR Ticarcillin[tiab] OR Amoxicillin[tiab] OR Ciprofloxacin[tiab] OR Fleroxacin[tiab] OR Enoxacin[tiab] OR Norfloxacin[tiab] OR Ofloxacin[tiab] OR Levofloxacin[tiab] OR Pefloxacin[tiab]) AND (Erysipelas[Mesh] OR Erysipelas[tiab] OR \"Skin Diseases, Infectious\"[Mesh] OR Cellulitis[Mesh] OR Cellulitis[tiab] OR Impetigo[tiab] OR Impetigo[Mesh] OR \"Soft Tissue Infections\"[Mesh] OR \"Holy fire\"[tiab] OR \"st anthony's fire\"[tiab] OR \"Soft Tissue Infections\"[tiab] OR \"Soft Tissue Infection\"[tiab] OR \"Skin infections\"[tiab] OR \"Skin infection\"[tiab] OR ((Staphylococcus[Mesh] OR staphylococcus[tiab] OR Streptococcus[Mesh] OR streptococcus[tiab]) AND (Skin[Mesh] OR Skin[tiab]))) AND (\"Administration, Oral\"[Mesh] OR Oral[tiab] OR Orally[tiab]) AND (\"Infusions, Parenteral\"[Mesh] OR \"Injections, Intravenous\"[Mesh] OR Intravenous[tiab] OR Intravenously[tiab] OR IV[tiab] OR parenteral[tiab] OR parenterally[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] NOT (Animals[Mesh] AND Humans[Mesh]))", "generated_query": ["What is the effectiveness of oral and parenteral administration of antibacterial agents in treating skin infections such as erysipelas, cellulitis, and impetigo caused by Staphylococcus and Streptococcus bacteria, as assessed in randomized controlled trials?", "What is the effectiveness of orally administered antimicrobials, including anti-bacterial agents, macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, aminoglycosides, and other antibiotics, in treating skin infections such as erysipelas, cellulitis, and impetigo caused by Staphylococcus or Streptococcus? Are intravenous or parenteral forms of these antimicrobials more effective than oral administration? Only randomized controlled trials or controlled clinical trials involving human subjects should be included in the results.", "What is the effectiveness of oral and parenteral administration of antimicrobial agents in treating skin infections caused by Staphylococcus or Streptococcus, as compared to placebo, in randomized controlled trials with human participants?", "Can oral or intravenous administration of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, and aminoglycosides, effectively treat erysipelas, cellulitis, impetigo, soft tissue infections, or skin infections caused by Staphylococcus or Streptococcus in randomized controlled trials, but not including animal studies?", "What is the effectiveness of oral and parenteral administration of anti-bacterial agents for the treatment of erysipelas, cellulitis, impetigo, soft tissue infections, and skin infections caused by Staphylococcus or Streptococcus in randomized controlled trials?", "What is the effectiveness of antibacterial agents, macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, and aminoglycosides in treating erysipelas, cellulitis, impetigo, and other soft tissue infections caused by staphylococcus or streptococcus, when administered orally or parenterally, in randomized controlled trials?", "What is the effectiveness of anti-bacterial agents, macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, aminoglycosides, and other antimicrobial drugs when orally administered or parenterally infused in the treatment of erysipelas, cellulitis, impetigo, soft tissue infections, skin infections, and infections caused by Staphylococcus or Streptococcus, based on randomized controlled trials and controlled clinical trials, excluding studies involving animals?", "What is the effectiveness of oral and parenteral administration of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, and aminoglycosides, in the treatment of erysipelas, cellulitis, impetigo, and other soft tissue infections caused by Staphylococcus or Streptococcus bacteria in humans, based on randomized controlled trials and controlled clinical trials, excluding studies involving animals?", "What are the most effective antimicrobial treatments for skin infections caused by Staphylococcus or Streptococcus bacteria, when administered orally or intravenously, as demonstrated in randomized controlled trials, without animal subjects?", "What is the efficacy of oral or intravenous administration of various antimicrobial agents, including but not limited to beta-lactams, macrolides, fluoroquinolones, and tetracyclines, in treating skin infections caused by Staphylococcus or Streptococcus in randomized controlled trials involving human subjects, but not animals, with a focus on erysipelas, cellulitis, and impetigo?"]}
{"id": "15", "boolean": "((\"Influenza, Human\"[Mesh] OR Influenza[tiab] OR \"Respiratory viruses\"[tiab]) AND (Schools[Mesh] OR School[tiab] OR Schools[tiab] OR ((Children[tiab]) AND (Community)) OR ((\"Young Adult\"[Mesh] OR \"Adolescent\"[Mesh] OR Child[Mesh] OR Infant[Mesh]) AND (\"Population Surveillance\"[Mesh] OR Pandemics[Mesh] OR Pandemic[tiab] OR Pandemics[tiab]))) AND (\"Absenteeism\"[Mesh] OR Closure[tiab] OR Closures[tiab] OR Closed[tiab] OR Vacation[tiab] OR Holiday[tiab] OR Holidays[tiab] OR Outbreak[tiab] OR Outbreaks[tiab] OR Dismissed[tiab] OR Epidemiological[tiab] OR Surveillance[tiab]) AND (Incidence[Mesh] OR Morbidity[Mesh] OR \"Population Surveillance\"[Mesh] OR \"Disease Notification\"[Mesh] OR \"Disease Outbreaks\"[Mesh] OR Incidence[tiab] OR Morbidity[tiab] OR Mortality[tiab] OR Case[tiab] OR Cases[tiab]) AND (\"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"case control\"[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR retrospective[tiab] OR \"cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Analysis[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh]))", "generated_query": ["What is the incidence, morbidity, and mortality of influenza and respiratory viruses in schools and communities during pandemics and population surveillance, and how is absenteeism, closure, holiday, outbreak, and surveillance affecting the epidemiology? What are the results of epidemiologic studies, case-control studies, cohort studies, and cross-sectional studies analyzing the data and numerical statistics on this topic?", "What is the impact of school closures on influenza and respiratory virus outbreaks in children and young adults during pandemics or population surveillance? What is the incidence, morbidity, and mortality rate of influenza and respiratory viruses during school closures, holidays, and vacations? What are the findings of epidemiological studies, including case-control, cohort, longitudinal, and cross-sectional studies, investigating the relationship between school closures, absenteeism, and disease outbreaks of influenza and respiratory viruses in children and young adults?", "What is the impact of school closures on the incidence and morbidity of influenza, respiratory viruses, and pandemics in children, adolescents, and young adults? Are epidemiological studies, including case-control and cohort studies, as well as cross-sectional studies, able to investigate the relationship between absenteeism, closures, holidays, outbreaks, and surveillance with disease notification and mortality?", "What is the incidence, morbidity, and mortality of influenza and respiratory viruses among school-aged children and young adults during pandemics, as measured by epidemiologic studies such as case-control, cohort, and cross-sectional studies that investigate the impact of school closures, absenteeism, and outbreak surveillance?", "What is the impact of school closures or absenteeism due to influenza or respiratory viruses in children, young adults, and the community during pandemics or outbreaks? Are there any epidemiological studies, including case-control, cohort, or cross-sectional studies, that investigated the incidence, morbidity, mortality, and disease notification associated with school closures or absenteeism?", "What is the impact of school closures and other measures aimed at reducing absenteeism on the incidence, morbidity, and mortality of influenza and other respiratory viruses among children, young adults, and the wider community, during epidemics, pandemics, and outbreaks? What epidemiologic, case-control, cohort, cross-sectional, longitudinal, prospective, retrospective, and statistical studies have investigated this question?", "What is the impact of school closures and absenteeism on the incidence, morbidity, and mortality of influenza, respiratory viruses, and pandemics in children, young adults, and adolescents? What epidemiologic studies, including case-control, cohort, longitudinal, prospective, and retrospective studies, have investigated the relationship between school closures, absenteeism, and the outbreak and spread of these viruses, as well as the effectiveness of population surveillance, disease notification, and outbreak analysis in mitigating their spread?", "What is the incidence of influenza, respiratory viruses, and pandemics in schools, among children, young adults, and adolescents in the community, during times of closures, holidays, and outbreaks? Can epidemiological, case-control, cohort, longitudinal, and cross-sectional studies be used to investigate the morbidity, mortality, and disease notification of these outbreaks, using statistical and numerical data and analysis?", "What is the impact of school closures and other forms of absenteeism on influenza and respiratory virus outbreaks among populations of children, young adults, and adolescents? The search should include epidemiologic studies, case-control studies, cohort studies, and cross-sectional studies that investigate the incidence, morbidity, mortality, and disease outbreaks related to influenza, respiratory viruses, and other factors such as vacation, holiday, outbreak, dismissal, surveillance, and closure in the community.", "Can epidemiologic studies, including case-control, cohort, cross-sectional, and longitudinal studies, investigate the incidence, morbidity, and mortality of influenza, respiratory viruses, and pandemics among children and young adults in schools and communities, affected by absenteeism, closures, holidays, outbreaks, dismissed cases, and epidemiological surveillance?"]}
{"id": "39", "boolean": "(\"Urinary Bladder, Underactive\"[Mesh] OR \"Urinary Retention\"[Mesh] OR \"Urodynamics\"[Mesh] OR \"Residual urine\"[tiab] OR \"Urinary retention\"[tiab] OR \"Urodynamic study\"[tiab] OR \"Urodynamic parameters\"[tiab] OR ((Underactive[tiab] OR Underactivity[tiab] OR Hypotonic[tiab] OR Acontractile[tiab] OR hypocontractility[tiab] OR Failure[tiab] OR Areflexia[tiab] OR Atonic[tiab] Impaired[tiab] OR Dysfunction[tiab]) AND (Bladder[tiab] OR Bladders[tiab] OR Detrusor[tiab] OR Detrusors[tiab]))) AND (\"Parasympathomimetics\"[Mesh] OR \"Parasympathomimetics\"[Pharmacological Action] OR  \"Receptors, Muscarinic\"[Mesh] OR \"Bethanechol\"[Mesh] OR \"Bethanechol Compounds\"[Mesh] OR \"Carbachol\"[Mesh] OR \"Diazepam\"[Mesh] OR \"Cisapride\"[Mesh] OR \"Phenoxybenzamine\"[Mesh] OR \"Dinoprost\"[Mesh] OR \"Neostigmine\"[Mesh] OR Parasympathomimetics[tiab] OR Parasympathomimetic[tiab] OR Muscarinic[tiab] OR Bethanechol[tiab] OR Bethanecol[tiab] OR Duvoid[tiab] OR Myotonine[tiab] OR Myocholine[tiab] OR PMS-Bethanechol[tiab] OR Urocarb[tiab] OR Myotonachol[tiab] OR Urecholine[tiab] OR Carbachol[tiab] OR Diazepam[tiab] OR Alfusozine[tiab] OR \"Cisapride\"[tiab] OR \"Distigmine bromide\"[tiab] OR Phenoxybenzamine[tiab] OR Prostaglandin[tiab] OR \"Neostigmine\"[tiab] OR (Myo[tiab] AND Hermes[tiab])) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR Report[ti]) NOT  (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh]))", "generated_query": ["What is the efficacy of parasympathomimetics in the treatment of urinary bladder underactivity, urinary retention, or urodynamic dysfunction, as measured in randomized controlled trials and controlled clinical trials, and excluding studies involving animals?", "Can parasympathomimetic drugs improve symptoms of underactive bladder or urinary retention in randomized controlled trials without involving animal subjects?", "What is the efficacy of parasympathomimetic drugs, such as Bethanechol and Carbachol, in treating urinary bladder underactivity, urinary retention, or urodynamic dysfunction in randomized controlled trials excluding animal studies?", "What is the efficacy of parasympathomimetic drugs in treating urinary bladder underactivity, urinary retention, and abnormal urodynamic parameters in humans, as evaluated by randomized controlled trials or controlled clinical trials, excluding studies on animals?", "What is the efficacy of parasympathomimetics, such as Bethanechol, Diazepam, and Neostigmine, for treating urinary bladder underactivity or retention, as assessed in randomized controlled trials and controlled clinical trials, excluding studies that involve animals?", "What is the efficacy of parasympathomimetics in treating urinary retention and underactive bladder? Only randomized controlled trials or controlled clinical trials will be included in the search. Animal studies will be excluded. The search will include the following keywords: \"Urinary Bladder, Underactive\", \"Urinary Retention\", \"Urodynamics\", \"Residual urine\", \"Urodynamic study\", \"Urodynamic parameters\", \"Parasympathomimetics\", \"Receptors, Muscarinic\", \"Bethanechol\", \"Carbachol\", \"Diazepam\", \"Cisapride\", \"Phenoxybenzamine\", \"Dinoprost\", \"Neostigmine\", \"Muscarinic\", \"Bethanecol\", \"Myotonine\", \"Myocholine\", \"Urocarb\", \"Myotonachol\", \"Urecholine\", \"Alfusozine\", \"Distigmine bromide\", and \"Prostaglandin\".", "What are the randomized controlled trials that investigated the efficacy of parasympathomimetics, such as Bethanechol, Carbachol, and Neostigmine, for the treatment of urinary bladder underactivity or urinary retention, as measured by urodynamic parameters or residual urine volume, excluding studies conducted on animals?", "What randomized controlled trials have investigated the use of parasympathomimetics, such as Bethanechol, Carbachol, and Neostigmine, for the treatment of underactive bladder, urinary retention, or impaired urodynamics? The search should exclude studies involving animals.", "What is the effectiveness of parasympathomimetics and related drugs for treating urinary bladder underactivity, urinary retention, and related conditions as compared to placebo or other drug therapies, as demonstrated in randomized controlled trials and controlled clinical trials in humans, while excluding studies involving animals?", "What is the efficacy of parasympathomimetic drugs in treating urinary bladder dysfunction characterized by urinary retention, underactivity, or impaired urodynamics? Specifically, I am interested in randomized controlled trials and controlled clinical trials that investigate the use of muscarinic receptors agonists such as bethanechol, carbachol, cisapride, and neostigmine in human subjects with bladder dysfunction. I do not want to include studies that involve animals."]}
{"id": "78", "boolean": "(\"Drug Resistance, Microbial\"[Mesh] OR \"Drug resistance\"[tiab] OR \"Drug resistant\"[tiab] OR \"multidrug-resistant\"[tiab] OR \"multidrug resistant\"[tiab] OR \"Microbial resistant\"[tiab] OR \"Microbial resistance\"[tiab] OR \"Antibiotic resistance\"[tiab] OR \"Antibiotic resistant\"[tiab] OR \"Antibacterial resistance\"[tiab] OR \"Antibacterial resistant\"[tiab] OR \"Antimicrobial resistance\"[tiab] OR \"Antimicrobial resistant\"[tiab]) AND (\"Anti-Bacterial Agents\"[Mesh] OR \"Macrolides\"[Mesh] OR \"beta-Lactams\"[Mesh] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Methicillin[tiab] OR Ampicillin[tiab] OR Azithromycin[tiab] OR Cephalexin[tiab] OR Apramycin[tiab] OR Streptomycin[tiab]) AND (\"Cattle\"[Mesh] OR \"Swine\"[Mesh] OR \"Poultry\"[Mesh] OR \"Farm animals\"[tiab] OR \"Food animals\"[tiab] OR Cattle[tiab] OR Beef[tiab] OR Swine[tiab] OR Pig[tiab] OR Pigs[tiab] OR Poultry[tiab] OR Chickens[tiab]) AND (\"Systematic review\"[tiab] OR \"Meta-analysis\"[tiab] OR Randomised[tiab] OR Randomized[tiab] OR Randomise[tiab] OR Randomize[tiab] OR Randomly[tiab] OR Controlled[tiab] OR \"Control group\"[tiab] OR Epidemiology[sh] OR \"Morbidity\"[Mesh] OR Comparison[tiab] OR Compared[tiab] OR Compare[tiab] OR Examined[tiab] OR Observations[tiab] OR Observed[tiab] OR Longitudinal[tiab] OR Experimental[tiab] OR Experiments[tiab] OR Investigate[tiab] OR (Before[tiab] AND After[tiab])) AND (\"Microbial Sensitivity Tests\"[Mesh] OR Isolates[tiab] OR Isolated[tiab] OR Samples[tiab] OR Strains[tiab] OR Strain[tiab] OR Carriage[tiab] OR Phylogenetic OR Metagenomic OR PCR) AND (\"Zoonoses\"[Mesh] OR \"Animal Diseases\"[Mesh] OR Zoonoses[tiab] OR Transmitted[tiab] OR Transmission[tiab] OR Susceptibility[tiab] OR Susceptible[tiab] OR Selective[tiab] OR Selection[tiab]) AND (\"Humans\"[Mesh] OR Humans[tiab] OR Human[tiab] OR Farmer[tiab] OR Farmers[tiab] OR \"Farm worker\"[tiab] OR \"Farm workers\"[tiab])", "generated_query": ["What is the prevalence of drug resistance among cattle, swine, and poultry, and what are the most effective antibiotics to combat this resistance? What systematic reviews, meta-analyses, and controlled experiments have investigated the susceptibility of isolated microbial strains in farm animals to antibacterial agents such as beta-lactams, macrolides, and penicillin, and how do these findings inform our understanding of zoonotic transmission and susceptibility among humans and farm workers?", "What is the evidence for drug resistance in farm animals, including cattle, swine, and poultry, to antibiotics such as beta-lactams, macrolides, and penicillin, as well as the impact of zoonotic transmission on human susceptibility to antibiotic-resistant strains? Specifically, the query should focus on systematic reviews, meta-analyses, and randomized controlled trials that investigate microbial sensitivity tests and isolates, as well as animal diseases, transmission, and selective pressure on farm workers and the general population.", "What is the effectiveness of antibiotics in treating drug-resistant bacteria in farm animals, specifically cattle, swine, and poultry? I am looking for systematic reviews, meta-analyses, randomized controlled trials, longitudinal studies, or experimental studies that investigate the susceptibility and selection of bacterial strains in these animals. I am interested in studies that also examine microbial sensitivity tests, isolates, samples, strains, carriage, phylogenetic, or metagenomic analysis. Additionally, I am interested in studies that explore zoonotic diseases, animal diseases, and transmission of antibiotic-resistant bacteria to humans, including farmers and farm workers.", "What is the effectiveness of antimicrobial and antibiotic treatments for drug-resistant bacteria in cattle, swine, and poultry? Specifically, this systematic review/meta-analysis examines the susceptibility and resistance patterns of various bacterial strains isolated from food animals, the impact of selective pressures on microbial populations, and the potential for zoonotic transmission of drug-resistant bacteria to humans, including farmers and farm workers. The search terms include \"Drug Resistance, Microbial,\" \"Antibiotic resistance,\" \"Antimicrobial resistance,\" \"Anti-Bacterial Agents,\" \"Macrolides,\" \"beta-Lactams,\" \"Penicillin,\" \"Methicillin,\" \"Ampicillin,\" \"Azithromycin,\" \"Cephalexin,\" \"Apramycin,\" \"Streptomycin,\" \"Cattle,\" \"Swine,\" \"Poultry,\" \"Systematic review,\" \"Meta-analysis,\" \"Randomised,\" \"Randomized,\" \"Randomise,\" \"Randomize,\" \"Controlled,\" \"Control group,\" \"Epidemiology,\" \"Morbidity,\" \"Comparison,\" \"Compared,\" \"Compare,\" \"Examined,\" \"Observations,\" \"Observed,\" \"Longitudinal,\" \"Experimental,\" \"Experiments,\" \"Investigate,\" \"Before and After,\" \"Micro", "What is the systematic review and meta-analysis evidence on the drug resistance of bacterial infections in cattle, swine, and poultry caused by antimicrobial agents such as macrolides, beta-lactams, and penicillin, and their susceptibility and transmission to humans, particularly farmers and farm workers?", "What is the impact of antibiotic-resistant farm animal-associated zoonotic infections on humans?", "What is the efficacy of antibiotics against drug-resistant bacteria in farm animals, specifically cattle, swine, and poultry, as assessed by systematic reviews, meta-analyses, randomized controlled trials, before-and-after studies, or other experimental designs that compare microbial sensitivity testing results, isolates, samples, strains, or carriage from these animals before and after antibiotic use, and investigate zoonotic transmission or susceptibility in humans or farmers?", "What is the impact of antibiotic resistance in cattle, swine, and poultry farming? Specifically, what is the prevalence and level of drug resistance in these food animals towards antibiotics such as beta-lactams, macrolides, and penicillin? I am interested in a systematic review or meta-analysis that includes studies involving microbial sensitivity tests, isolates, samples, strains, and carriage of resistant bacteria in farm animals. Additionally, I want the review to investigate zoonotic transmission of drug-resistant bacteria from farm animals to humans, including farmers and farm workers. The search should include terms such as drug resistance, antibiotic resistance, antimicrobial resistance, multidrug resistance, and animal diseases.", "What is the impact of antimicrobial resistance in cattle, swine, and poultry, and how does it affect human health? The query should include articles that are meta-analyses, randomized controlled trials, longitudinal studies, or experiments and should specifically examine microbial sensitivity tests, strains, isolates, samples, carriage, phylogenetic, metagenomic, and PCR, with a focus on zoonotic diseases and susceptibility in humans and farmers. Additionally, the query should take into account drug resistance and the use of antibacterial agents such as macrolides, beta-lactams, and penicillin.", "What is the impact of antimicrobial resistance in farm animals, particularly in cattle, swine, and poultry, and its transmission to humans, and how effective are different antibacterial agents, such as macrolides, beta-lactams, and antibiotics, in preventing or treating such resistance, as assessed by systematic reviews, meta-analyses, randomized controlled trials, or longitudinal studies that investigate the microbial sensitivity tests, isolates, samples, strains, or carriage of resistant or susceptible microorganisms, including zoonotic pathogens, in these animals and their human handlers or farmers?"]}
{"id": "88", "boolean": "(\"Patient Education as Topic\"[Mesh] OR \"Self Care\"[Mesh] OR \"Behavior Therapy\"[Mesh] OR \"Group Processes\"[Mesh] OR \"Psychotherapy, Group\"[Mesh] OR \"Self-Help Groups\"[Mesh] OR Patient education[tiab] OR Self care[tiab] OR Self management[tiab] OR Behavior therapy[tiab] OR Behaviour therapy[tiab] OR Group process[tiab] OR Group processes[tiab] OR Group psychotherapy[tiab] OR ((Education[tiab] OR Educational[tiab] OR psychoeducational[tiab] OR Training[tiab] OR Teaching[tiab] OR Lifestyle[tiab]) AND (Programme[tiab] OR Programmes[tiab] OR Program[tiab] OR Programs[tiab]))) AND (\"Diabetes Mellitus, Type 2\"[Mesh] OR MODY[tiab] OR NIDDM[tiab] OR T2DM[tiab] OR ((non insulin[tiab] OR noninsulin[tiab] OR \"Type 2\"[tiab] OR \"Type II\"[tiab] OR Ketosis-Resistant[tiab] OR Ketosis resistant[tiab] OR Maturity-Onset[tiab] OR Maturity onset[tiab] OR Mature-onset[tiab] OR Mature onset[tiab] OR Adult-onset[tiab] OR Adult onset[tiab] OR Slow-onset[tiab] OR Slow onset[tiab] OR Stable[tiab]) AND Diabetes)) AND (Group[tiab] OR Groups[tiab] OR Participants[tiab]) NOT (\"Diabetes Insipidus\"[Mesh] OR Diabetes Insipidus[tiab]) AND (randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[MeSH Terms] OR randomly[tiab] OR groups[tiab] OR Controlled[tiab] OR Control[tiab] OR Trial[tiab] OR Trials[tiab] OR Blind[tiab] OR Blinded[tiab] OR Volunteer[tiab] OR Volunteers[tiab]) NOT (animals[Mesh] NOT humans[Mesh])", "generated_query": ["What is the effectiveness of patient education, self-care, behavior therapy, group processes, psychotherapy, and self-help groups in managing and preventing Type 2 Diabetes among adult participants in randomized controlled trials or controlled clinical trials? The query should exclude studies on diabetes insipidus and non-human subjects.", "Can patient education, self-care, behavior therapy, group processes, psychotherapy, or self-help groups improve self-management of type 2 diabetes in adult participants, and are these interventions effective in randomized controlled trials?", "What is the effectiveness of patient education, self-care, behavior therapy, group processes, self-help groups, and various educational programs on type 2 diabetes management in adult participants in randomized controlled trials, excluding studies on diabetes insipidus, and utilizing blind or blinded, placebo, drug therapy, controlled, control, trial, trials, volunteer, or volunteers as criteria, while excluding animal studies?", "What is the effectiveness of patient education, self-care, behavior therapy, group processes, self-help groups, education programs, and lifestyle interventions for the management of type 2 diabetes in adult participants in controlled clinical trials, excluding studies on diabetes insipidus and animal subjects?", "Can patient education, self-care, behavior therapy, group processes, and psychotherapy improve the management of type 2 diabetes in adult participants, as demonstrated by randomized controlled trials, without including studies on diabetes insipidus or involving animals?", "What is the effectiveness of patient education, self-care, behavior therapy, group processes, and psychotherapy on diabetes mellitus type 2 management, particularly among participants in randomized controlled trials, excluding studies on diabetes insipidus and animal studies?", "What is the effectiveness of patient education, self-care, behavior therapy, group processes, and psychotherapy for managing diabetes mellitus type 2? Does educational or lifestyle intervention programs improve the management of type 2 diabetes in adult patients in group settings, and is this approach more effective than drug therapy or other standard treatments? I am specifically looking for randomized controlled trials or controlled clinical trials with human participants that exclude diabetes insipidus and animal studies.", "What is the effectiveness of patient education, self-care, behavior therapy, group processes, and psychotherapy on type 2 diabetes management among participants in randomized controlled trials? Exclude documents related to diabetes insipidus and animals.", "What are the most effective patient education, self-care, behavior therapy, group processes, psychotherapy, and self-help group programs for managing type 2 diabetes in adult participants in randomized controlled trials, excluding studies on diabetes insipidus and animal studies?", "What is the effectiveness of patient education, self-care, behavior therapy, group processes, and psychotherapy in managing and treating type 2 diabetes in adult participants? The search should only retrieve randomized controlled trials or controlled clinical trials with human participants and exclude any documents related to diabetes insipidus or studies involving animals."]}
{"id": "4", "boolean": "((\"COVID-19\"[Supplementary Concept] OR \"COVID-19\"[tiab] OR COVID19[tiab] OR \"COVID 19\"[tiab] OR \"SARS-CoV-2\"[tiab] OR \"2019-nCoV\"[tiab] OR \"Novel coronavirus\"[tiab] OR \"Coronavirus 2019\"[tiab] OR \"Coronavirus 19\"[tiab] OR \"COVID 2019\"[tiab] OR \"2019 ncov\"[tiab] OR \"Wuhan coronavirus\"[tiab])  AND (\"Asymptomatic Diseases\"[Mesh] OR Asymptomatic[tiab] OR Presymptomatic[tiab] OR \"Pre-Symptomatic\"[tiab] OR \"No symptoms\"[tiab] OR \"No symptom\"[tiab] OR \"Silent transmission\"[tiab] OR \"Silent carrier\"[tiab] OR \"Silent carriers\"[tiab]) AND (Letter[pt] OR \"Epidemiologic Studies\"[Mesh] OR \"Case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"Case control\"[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR Retrospective[tiab] OR \"Cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Analysis[tiab] OR Data[tiab] OR Cases[tiab] OR Ratio[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh]) ) OR ( (\"COVID-19\"[ti] OR COVID19[ti] OR \"COVID 19\"[ti] OR \"SARS-CoV-2\"[ti] OR \"2019-nCoV\"[ti] OR \"Novel coronavirus\"[ti] OR \"Coronavirus 2019\"[ti] OR \"Coronavirus 19\"[ti] OR \"COVID 2019\"[ti] OR \"2019 ncov\"[ti] OR \"Wuhan coronavirus\"[ti]) AND (Asymptomatic[ti] OR Presymptomatic[ti] OR \"Pre-Symptomatic\"[ti]))", "generated_query": ["What is the epidemiology of COVID-19 in asymptomatic or presymptomatic individuals, and what are the different types of studies investigating this, including case-control, cohort, cross-sectional, longitudinal, and prospective studies? Also, what are the different terms used to refer to asymptomatic or presymptomatic individuals, such as \"silent transmission,\" \"silent carrier,\" or \"no symptoms\"?", "What is the epidemiological evidence regarding asymptomatic and pre-symptomatic transmission of COVID-19 or SARS-CoV-2? Include case-control, cohort, cross-sectional, and longitudinal studies, as well as data analysis and investigations of cases, ratios, and statistical data. Also, consider the possibility of silent carriers or silent transmission of the virus.", "What is the epidemiological evidence for asymptomatic or presymptomatic transmission of COVID-19 caused by SARS-CoV-2, including analysis of case-control studies, cohort studies, longitudinal studies, retrospective studies, and cross-sectional studies, as well as investigations of cases, ratios, statistics, and numerical data? Additionally, what is the evidence for silent transmission and carriers of the virus, with a focus on COVID-19, COVID-19-related terms, and synonyms such as SARS-CoV-2, 2019-nCoV, Novel coronavirus, Coronavirus 2019, and Wuhan coronavirus?", "What is the epidemiology of COVID-19 in individuals with asymptomatic or presymptomatic disease, including silent carriers and those with no symptoms? Can you provide longitudinal, retrospective, cross-sectional, or case-control studies investigating the analysis of data and ratios related to COVID-19, SARS-CoV-2, Novel Coronavirus, Coronavirus 2019, Coronavirus 19, COVID 2019, 2019 ncov, or Wuhan coronavirus?", "What is the relationship between COVID-19 (or related terms such as SARS-CoV-2 and novel coronavirus) and asymptomatic/presymptomatic carriers or transmission? Specifically, are there any epidemiological studies (including case-control, cohort, longitudinal, prospective, retrospective, or cross-sectional studies) that have investigated the cases, ratios, data, and statistics/numerical data related to asymptomatic carriers or transmission of COVID-19?", "What is the relationship between COVID-19 and asymptomatic carriers or presymptomatic transmission, as investigated through epidemiological studies, case-control studies, cohort studies, cross-sectional studies, longitudinal studies, or retrospective studies? Additionally, are there any articles analyzing data or ratios related to COVID-19 and asymptomatic or presymptomatic carriers?", "What is the relationship between COVID-19 (or its variants) and asymptomatic or presymptomatic carriers? Can longitudinal, prospective, retrospective, or cross-sectional studies, as well as investigations and analyses, provide insights into the epidemiology of the disease in these carriers?", "Can asymptomatic or presymptomatic individuals transmit COVID-19 (or SARS-CoV-2 or 2019-nCoV or Novel coronavirus or Coronavirus 2019 or Coronavirus 19 or COVID 2019 or 2019 ncov or Wuhan coronavirus), and what is the epidemiology (including case-control, cohort, cross-sectional, and longitudinal studies) and statistics surrounding their potential transmission?", "What is the relationship between COVID-19 and asymptomatic/presymptomatic carriers, and how have they been studied? Specifically, are there any epidemiologic studies, case-control studies, or cohort studies that have investigated the transmission of COVID-19 from asymptomatic or presymptomatic carriers, and what is the ratio of asymptomatic to symptomatic cases? Additionally, what is the prevalence of silent transmission and silent carriers in COVID-19?", "What is the epidemiological analysis of COVID-19 and asymptomatic or pre-symptomatic carriers? What are the ratios of cases investigated in longitudinal, prospective, retrospective, and cross-sectional studies, and what are the statistics and numerical data on silent transmission or carriers? Additionally, what are the latest findings on COVID-19, SARS-CoV-2, and other related terms, specifically in relation to asymptomatic or pre-symptomatic carriers?"]}
{"id": "10", "boolean": "(\"Gastroesophageal Reflux\"[Mesh] OR \"Esophagitis\"[Mesh] OR \"Heartburn\"[Mesh] OR \"Dyspepsia\"[Mesh] OR \"Duodenogastric Reflux\"[Mesh] OR Reflux[tiab] OR GERD[tiab] OR Oesophagitis[tiab] OR Esophagitis[tiab] OR Heartburn[tiab] OR \"Heart burn\"[tiab] OR GORD[tiab] OR Dyspepsia[tiab] OR Dyspepsias[tiab] OR Indigestion[tiab] OR Indigestions[tiab]) AND (\"Sleep\"[Mesh] OR Sleep[tiab] OR Sleeping[tiab] OR Bed[tiab] OR Bed-Head[tiab] OR Bed-up[tiab] OR Bedrest[tiab] OR Bed-rest[tiab] OR Nocturnal[tiab] OR Wedge[tiab]) AND (\"Patient Positioning\"[Mesh] OR \"Supine Position\"[Mesh] OR Positioning[tiab] OR Position[tiab] OR Supine[tiab] OR Elevation[tiab] OR Elevated OR Raised[tiab] OR Semi-recumbent[tiab] OR Semireclined[tiab] OR Semi-reclined[tiab] OR \"Semi reclined\"[tiab] OR Left-side[tiab] OR Right-side[tiab] OR Side[tiab] OR Lateral[tiab])", "generated_query": ["Can patient positioning during sleep, including elevation, left-side, right-side, and semi-reclined positions, alleviate symptoms of gastroesophageal reflux, esophagitis, heartburn, and dyspepsia?", "What is the effect of different patient positions, such as supine, elevated, semi-recumbent, left-side, and right-side, on gastroesophageal reflux, esophagitis, heartburn, dyspepsia, or duodenogastric reflux, in individuals who experience sleep disturbances or have a history of sleep problems?", "What is the relationship between gastroesophageal reflux, sleep, and patient positioning? Specifically, are there any interventions or strategies related to patient positioning (such as supine, semi-reclined, left or right-side lying) that can improve sleep quality in patients with gastroesophageal reflux or related conditions like esophagitis, heartburn, dyspepsia, or duodenogastric reflux?", "What is the effect of patient positioning, sleep and bed elevation on gastroesophageal reflux disease, esophagitis, heartburn, dyspepsia, and duodenogastric reflux?", "What is the impact of patient positioning during sleep on gastroesophageal reflux, esophagitis, heartburn, dyspepsia, and duodenogastric reflux? Specifically, what is the effect of sleeping positions such as supine, elevated, semi-recumbent, left-side, and right-side on the incidence and severity of these conditions?", "What is the impact of patient positioning on sleep disturbances in individuals with Gastroesophageal Reflux Disease (GERD), Esophagitis, Heartburn, Dyspepsia, or Reflux, and what are the effects of supine position, elevated position, and lateral positioning on reducing GERD symptoms during sleep?", "What is the effectiveness of patient positioning, including supine, elevated, semi-recumbent, left-side, and right-side positions, for managing symptoms of gastroesophageal reflux disease (GERD), esophagitis, heartburn, dyspepsia, and duodenogastric reflux during sleep or in bed?", "What is the effectiveness of patient positioning, sleep, and bed elevation in reducing symptoms of gastroesophageal reflux disease, esophagitis, heartburn, and dyspepsia?", "What is the relationship between gastroesophageal reflux, esophagitis, heartburn, dyspepsia, duodenogastric reflux, reflux, GERD, Oesophagitis, indigestion, patient positioning, sleep, and elevated positioning or lateral positioning in managing symptoms?", "What is the effect of patient positioning, specifically supine, elevated, semi-recumbent, left-side, or right-side, on sleep quality in patients with gastroesophageal reflux, esophagitis, heartburn, dyspepsia, duodenogastric reflux, or reflux?"]}
{"id": "32", "boolean": "(\"Telemedicine\"[Mesh] OR \"Videoconferencing\"[Mesh] OR Telehealth[tiab] OR Telemedicine[tiab] OR Videoconferencing[tiab] OR ((Telephone[tiab]) AND (Consultation[tiab] OR face-to-face[tiab] OR in-person[tiab])) OR telephone-delivered[tiab]) AND (\"Primary Health Care\"[Mesh] OR \"General Practice\"[Mesh] OR rehabilitation[sh] OR \"Outpatients\"[Mesh] OR \"Speech Therapy\"[Mesh] OR Outpatient[tiab] OR \u201cPrimary health\u201d[tiab] OR \u201cPrimary care\u201d[tiab] OR \u201cGeneral practice\u201d[tiab] OR \u201cGeneral practices\u201d[tiab] OR \u201cGeneral practitioners\u201d[tiab] OR \u201cGeneral practitioner\u201d[tiab] OR \u201cFamily practice\u201d[tiab] OR Physician[tiab] OR Physicians[tiab] OR Clinician[tiab] OR Clinicians[tiab] OR Therapist[tiab] OR Nurse[tiab] OR Nurses[tiab] OR Physiotherapist[tiab] OR Rehabilitation[tiab] OR Diabetes[tiab] OR Diabetic[tiab] OR Asthma[tiab] OR Depression[tiab] OR \u201c\u00cfrritable bowel\u201d[tiab] OR IBS[tiab] OR PTSD[tiab] OR \u201cChronic fatigue\u201d[tiab]) AND ((Face to face[tiab]) OR \u201cUsual care\u201d[tiab] OR Visits[tiab] OR Visit[tiab] OR In-person[tiab] OR \u201cIn person\u201d[tiab] OR ((Clinic[tiab] OR Centre[tiab] OR Home[tiab]) AND (Based[tiab] OR Contact[tiab])) OR Conventional[tiab] OR \u201cPractice-based\u201d[tiab] OR \u201cPractice based\u201d[tiab] OR Traditional[tiab] OR \u201cStandard care\u201d[tiab] OR Homecare[tiab] OR ((Routine[tiab] OR Home[tiab]) AND (Care[tiab]))) AND (\"Delivery of Health Care\"[Mesh] OR Delivery[tiab] OR Delivered[tiab] OR Via[tiab] OR Received[tiab]) AND (\"Treatment Outcome\"[Mesh] OR \"Patient Satisfaction\"[Mesh] OR Therapy[sh] OR Diagnosis[sh] OR \u201cClinical outcomes\u201d[tiab] OR Treatment[tiab] OR Diagnostic[tiab] OR Efficacy[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT  (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh])) NOT (\u201cCase Reports\u201d[pt] OR Editorial[pt] OR Letter[pt] OR Meta-Analysis[pt] OR \u201cObservational Study\u201d[pt] OR \u201cSystematic Review\u201d[pt] OR \u201cCase Report\u201d[ti] OR \u201cCase series\u201d[ti] OR Meta-Analysis[ti] OR \u201cMeta Analysis\u201d[ti] OR \u201cSystematic Review\u201d[ti] OR \u201cSystematic Literature Review\u201d[ti] OR \u201cQualitative study\u201d[ti] OR Protocol[ti]) ", "generated_query": ["What are the outcomes and efficacy of telemedicine, videoconferencing, telephone-delivered consultations, and usual care in treating patients with various conditions such as diabetes, asthma, depression, and chronic fatigue in primary healthcare settings, and how do they compare to conventional or standard care? Only randomized controlled trials or controlled clinical trials that focus on treatment outcomes, patient satisfaction, therapy, diagnosis, and clinical efficacy should be included in the search, while excluding case reports, editorials, letters, meta-analyses, observational studies, systematic reviews, case series, qualitative studies, and protocols.", "What is the effectiveness of telemedicine, telehealth, videoconferencing, and telephone-delivered consultations in improving clinical outcomes, treatment efficacy, and patient satisfaction among primary care physicians, general practitioners, clinicians, therapists, nurses, physiotherapists, and outpatients with diabetes, asthma, depression, irritable bowel syndrome, chronic fatigue, and post-traumatic stress disorder? The search should only include randomized controlled trials and controlled clinical trials, exclude animal studies, case reports, editorials, letters, meta-analyses, and qualitative studies, and focus on interventions delivered via conventional, practice-based, homecare, or standard care settings.", "What is the efficacy and patient satisfaction of telemedicine, telehealth, videoconferencing, and telephone-delivered consultations in the delivery of primary healthcare, general practice, rehabilitation, outpatient care, speech therapy, and chronic conditions such as diabetes, asthma, and PTSD compared to traditional or in-person care, as demonstrated in controlled clinical trials and randomized trials that report clinical outcomes? Exclude case reports, editorials, letters, meta-analyses, observational studies, systematic reviews, qualitative studies, and protocols, as well as studies involving animals only or without human subjects.", "What is the effectiveness of telemedicine, videoconferencing, telephone consultations, and telephone-delivered interventions in improving clinical outcomes and patient satisfaction for primary care, general practice, outpatient, speech therapy, and rehabilitation settings? Are these interventions more effective than conventional, practice-based, or standard care, including visits, in-person consultations, and homecare? What is the impact of these interventions on the delivery and receipt of healthcare and treatment outcomes for chronic conditions such as diabetes, asthma, depression, IBS, PTSD, and chronic fatigue? Are there any randomized controlled trials or controlled clinical trials that compare these interventions with placebo or drug therapy?", "Can telemedicine or videoconferencing improve primary healthcare outcomes for patients with chronic conditions such as diabetes, asthma, and depression compared to conventional in-person visits in randomized controlled trials?", "What are the outcomes and efficacy of telemedicine, telehealth, videoconferencing, and telephone-delivered healthcare services for primary health care, general practice, rehabilitation, outpatients, speech therapy, and chronic diseases such as diabetes, asthma, and PTSD, when compared to usual care or in-person conventional practice-based treatment? The search should be limited to randomized controlled trials or controlled clinical trials, exclude animal studies and case reports, and focus on the delivery of healthcare services and patient satisfaction.", "What is the efficacy of telemedicine, videoconferencing, and telephone-delivered healthcare services in improving clinical outcomes and patient satisfaction in primary healthcare, general practice, rehabilitation, outpatient, speech therapy, and mental health settings? Specifically, are there randomized controlled trials that investigate the use of these telehealth technologies compared to traditional face-to-face or usual care in delivering healthcare services? Exclude animal studies, case reports, editorials, letters, meta-analyses, observational studies, systematic reviews, qualitative studies, and protocols.", "What is the effectiveness of telemedicine, videoconferencing, telephone-delivered services, or face-to-face consultations in primary health care, general practice, rehabilitation, outpatient care, speech therapy, or for specific conditions such as diabetes, asthma, depression, or PTSD? How do these methods compare to traditional, in-person care in terms of treatment outcomes and patient satisfaction, and have they been evaluated through randomized controlled trials or controlled clinical trials? Exclude any studies that involve animals or are not primary research studies such as case reports, editorials, letters, or meta-analyses.", "What are the outcomes of using telemedicine, videoconferencing, or telephone-delivered consultations in primary healthcare settings for conditions such as diabetes, asthma, depression, PTSD, and chronic fatigue, compared to face-to-face or standard care, and how do patients feel about the delivery of care? Specifically, this query should retrieve randomized controlled trials or controlled clinical trials that focus on clinical outcomes or patient satisfaction in primary care or outpatient settings and exclude animal studies or non-research articles such as case reports, editorials, letters, or meta-analyses.", "Can telemedicine or videoconferencing improve primary health care outcomes for patients with conditions such as diabetes, asthma, depression, IBS, or PTSD, when compared to traditional in-person care? Are these telehealth interventions effective in improving treatment outcomes and patient satisfaction in randomized controlled trials or controlled clinical trials, excluding animal studies and case reports?"]}
{"id": "18", "boolean": "((\"Kidney Transplantation\"[Mesh] OR \"Kidney Transplantation\"[tiab] OR \"Kidney Transplantations\"[tiab] OR \"Kidney Transplant\"[tiab] OR \"Kidney Transplants\"[tiab] OR \"Kidney Procurement\"[tiab] OR \"Kidney Procurements\"[tiab] OR \"Kidney Donation\"[tiab] OR \"Kidney Donations\"[tiab] OR \"Kidney donor\"[tiab] OR \"Kidney donors\"[tiab]) AND (\"Transplants\"[Mesh] OR \"transplantation\"[sh] OR \"Transplant Recipients\"[Mesh] OR \"Transplant Donor Site\"[Mesh] OR \"Organ Transplantation\"[Mesh] OR Transplant[tiab] OR Transplantation[tiab] OR Transplants[tiab] OR Transplantations[tiab]) AND (Promote[tiab] OR Law[tiab] OR Laws[tiab] OR Legislation[tiab] OR Champion[tiab] OR Champions[tiab] OR Pursuit[tiab] OR \"Promotion program\"[tiab] OR \"Promotion programs\"[tiab] OR \"Donation program\"[tiab] OR \"Donation programs\"[tiab] OR \"Transplantation program\"[tiab] OR \"Transplantation programs\"[tiab] OR \"Educational program\"[tiab] OR \"Educational programs\"[tiab] OR Application[tiab]) AND (Increase[tiab] OR Increased[tiab] OR Higher[tiab] OR Improved[tiab] OR Rate[tiab] OR Rates[tiab]) AND (\"randomized controlled trial\"[pt] OR \"controlled clinical trial\"[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR \"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"case control\"[tiab] OR Cohort[tiab] OR \"Follow up\"[tiab] OR Prospective[tiab] OR retrospective[tiab] OR Analysis[tiab] OR Implementation[tiab] OR Evaluated[tiab] OR Statistics[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh]))", "generated_query": ["What is the evidence for randomized controlled trials, clinical trials, cohort studies, and other epidemiological studies evaluating the effectiveness of programs promoting kidney donation and transplantation, including educational programs and legislative initiatives aimed at increasing donation rates? Specifically, how do these studies assess the impact of such initiatives on the rate of kidney transplants, and what statistics and numerical data have been evaluated to analyze the success of these initiatives?", "Can promotion programs or legislation increase rates of kidney donation, transplantation, and procurement in randomized controlled trials, cohort studies, and other epidemiological studies?", "What is the impact of promoting and increasing kidney transplantation through educational and donation programs, legislation, and championing efforts on the rates of kidney transplants? Are there any randomized controlled trials, controlled clinical trials, epidemiological studies, cohort studies, or analyses that have evaluated the effectiveness of such interventions in improving the rates of kidney transplantation, and if so, what are the findings?", "What randomized controlled trials, controlled clinical trials, epidemiologic studies, case-control studies, and cohort studies have been conducted to evaluate the effectiveness of programs, legislation, or initiatives aimed at increasing the rates of kidney transplantation, procurement, and donation, including promoting education, application, and championing, for kidney transplant recipients, donors, and transplantations?", "What are the effects of programs and legislation on increasing rates of kidney transplantation and donation, as evaluated through randomized controlled trials, controlled clinical trials, cohort studies, follow-up studies, and statistical analysis? Specifically, what is the impact of promotion programs, transplantation programs, educational programs, and champions or advocates on improving kidney transplantation and donation rates, as well as the role of laws and regulations on kidney procurement and donation?", "What is the impact of programs, laws, and legislation on increasing the rate and effectiveness of kidney transplantation and donation? Can randomized controlled trials, cohort studies, and prospective/retrospective analyses be used to evaluate the implementation of such programs?", "What is the evidence for the effectiveness of kidney transplantation promotion programs and legislation in increasing donation rates? Specifically, I am looking for randomized controlled trials, controlled clinical trials, epidemiologic studies, case-control studies, and cohort studies that evaluate the implementation of programs and laws promoting kidney donation, with a focus on statistics and numerical data related to increased donation rates. Relevant terms include kidney transplantation, transplants, transplant recipients, organ transplantation, transplant promotion programs, donation programs, transplantation programs, educational programs, randomized controlled trials, controlled clinical trials, placebo, epidemiologic studies, case-control studies, cohort studies, and statistics and numerical data.", "What is the impact of promotion programs, laws, and educational programs on the rate of kidney transplantation and donation? Are there any randomized controlled trials, controlled clinical trials, or cohort studies that have evaluated the effectiveness of these interventions in increasing kidney transplant rates or improving kidney procurement?", "What are the randomized controlled trials, cohort studies, and case-control studies that evaluated the effectiveness of programs, laws, or initiatives designed to increase the rate or improve the quality of kidney transplantation or donation? The search should include terms such as kidney transplantation, kidney donors, transplant recipients, transplantation programs, promotion programs, educational programs, legislation, and rates.", "Can randomized controlled trials, cohort studies, and case-control studies evaluate the effectiveness of programs and legislation aimed at increasing kidney donation, procurement, and transplantation rates?"]}
